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I INTRODUCTION 
The importance of prostheses and implants in medicine is growing. Due to increasing life expectancy, 
mankind will need a growing number of such synthetic devices to overcome the problems associated 
with deteriorating or failing body parts. Examples of implants are orthopedic joint prostheses, 
cardiovascular devices, dental implants, and others. An implant does not have to be located completely 
inside the body; skin-penetrating devices such as catheters for the infusion of fluids must be regarded as 
implants as well (see Table 1.1). Furthermore, the expected increase in the use of implants arises not 
only from medical perspectives, which make certain devices necessary. Also, the flourishing prosperity 
of the past few decades has meant that the use of implants for aesthetic reasons has become 
substantial. Implants are made of biomaterials that have a common property: biocompatibility. 
Although biocompatibility is a difficult term to define, it is strongly related to the success of an 
implanted device in fulfilling its intended function 1. This implies that a biomaterial used for the 
manufacturing of a prosthesis or implant and subsequently classified as biocompatible cannot 
necessarily be used for the manufacturing of implants with different functions. For instance, 
biomaterials with properties that resist the adhesion of biomolecules and cells may be classified 
biocompatible when used for the production of cardiovascular devices. However, the classification may 
not be legitimate for the use of such a biomaterial to manufacture artificial joints. 
 
TABLE 1.1: APPLICATIONS OF SYNTHETIC AND MODIFIED NATURAL MATERIALS IN REPARATIVE MEDICINE 
Material Application  Tissue response 
Titanium (alloys) Joint prostheses, oral implants, fixation plates, 
pacemakers, heart valves 
Inert 
Calcium phosphate ceramic(s) Joint prostheses, oral implants, bone replacement, 
middle ear replacement 
Bioactive 
Alumina Joint prostheses, oral implants Inert 
Carbon Heart valves Inert 
Polytetrafluoroethylene (PTFE) Joint prostheses, tendon and ligament replacement, 
artificial blood vessels, heart valves 
Inert 
Poly(methylmethacrylate) (PMMA) Eye lenses, bone cement Tolerant 
Poly(dimethylsiloxane) (PDMS) Brest prostheses, catheters, facial reconstruction, 
tympanic tubes 
Unknown 
Poly)urethane) (PU) Breast prostheses, artificial blood vessels, skin 
replacements 
Inert 
Poly(lactic acid) (PLA) Bone fixation plates, bone screws Inert 
Poly(glycolic acid) (PGA) Sutures, tissue membranes Inert 
 
Unfortunately, the classification of a biomaterial device as biocompatible does not necessarily imply its 
acceptance by its host. Most commonly, synthetic devices are recognized by their hosts as non-natural 
and regarded as intrusions of foreign bodies 2. For that reason, the possibility exists that although a 
biomaterial device is classified biocompatible, the coexistence of minor side effects of the implantation 
cannot be excluded. Although the potential side effects may not be detrimental to the functionality of 
the implanted device, these still can have consequences that are not desirable. Generally, the placement 
(via surgical procedures) of, and subsequent habituation (host reaction) to a synthetic device can be 
categorized as the establishment of a symbiosis of living and non-living materials. This symbiosis is 
characterized by contact of biological (e.g. biomolecules) with non-biological compounds (e.g. 
molecules that constitute the biomaterial device). For a proper comprehension of the interactions 
between implants and their biological surroundings, and possibilities to modulate these responses, 
these issues are addressed in sections II and III, respectively. In section IV, the rationale of using 
deoxyribonucleic acid (DNA) as a biomaterial coating is described, as well as the methods to fabricate 
DNA-based coatings. 
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II BIOLOGICAL PROCESSES 
In this section, biological processes that arise at the implant surface or in the direct vicinity of an 
inserted implant are described. These processes include wound healing, the role of macrophages, 
biomaterial interface processes, and the foreign body reaction. 
  
A. Wound Healing Processes 
The introduction of an implant into a living organism is commonly associated with surgical intervention. 
As noted earlier, an implant can be regarded as the intrusion of a foreign body that incontrovertibly 
initiates a response of the body toward the intruder through specific reactions arising from both the 
introduced material and the tissue damage or injury caused by the surgical procedure. In general, the 
response consists of wound healing processes that have the ultimate aim of healing the affected tissues, 
preferably without permanent damage. While this phenomenon, also known as ‘restitutio ad integrum’, 
is feasible for human and animal fetuses, wound healing produces scar formation in adult humans and 
higher vertebrates 3. Evidently, fibroproliferative responses rather than tissue regeneration control the 
repair of soft tissues. At this point, a striking difference exists between healing processes in soft tissues 
such as skin and hard tissues such as bone. While soft tissue healing is reparative, regenerative healing 
after wounding is feasible in hard tissues 4. This means that the formation of scar tissue is absent in 
healing of hard tissues. Although its appearance is radiographically different, healed hard tissue will 
eventually return to its pre-injury state 5 and possess the same or even improved characteristics 
compared with the original tissue. The biology behind the processes of soft and hard tissue healing has 
been studied extensively and several excellent reviews on this subject have been published 4;6-13. 
Although not all mysteries have been revealed yet, it is already evident that the healing processes 
involve a tight and regulated collaboration of specific cell types and their signaling products 14;15. The 
wound healing processes preceded by thrombus formation are roughly divided into three overlapping 
phases: (1) Inflammation, (2) repair, and (3) tissue remodeling 4;6;7. 
 
1. Thrombus Formation 
Prior to the initiation of the healing processes, fluids containing blood constituents surround the newly 
implanted biomaterial. These fluids originate from the disruption and increased permeability of blood 
vessels and the subsequent extravasation of blood constituents, all of which are consequences of tissue 
injury. Through changes in the environment, several components of the blood including platelets and 
the surrounding or even adjacent tissues become activated, thereby initiating the blood coagulation 
cascade 10. The activation of platelets results in increasing adhesiveness. This enables platelets to 
aggregate and form a plug to close perforations of damaged vessels and thus limit blood loss. The 
coagulation cascade also involves polymerization of fibrin. Activated platelets and strands of 
polymerized fibrin together form a fibrous clot that serves as a matrix for subsequent migration of a 
variety of cells into the area of injury. The recruitment of cells to the area of injury is at least partially 
orchestrated through the release of certain biologically active substances by platelets 16 and endothelial 
cells 17. The migratory cells include those that are important to the inflammatory response, the 
formation of new tissue, and the tissue remodeling processes.  
 
2. Inflammatory Phase 
Inflammation is a physiological response of tissue resulting from detrimental physical, chemical, or 
immunological stimuli or from infection 18. The inflammatory response is initiated as a reaction to the 
release of vasodilators, chemo-attractants, and other mediators, including platelet-derived growth 
factor (PDGF) and various isoforms of the  tumor growth factor-beta (TGF-β) family by platelets 19 and 
activation of the complement cascade within the coagulating fluid surrounding the implanted 
biomaterial 7. The release of these substances is responsible for the recruitment of inflammatory and 
other cells (chemotaxis), the development of new blood vessels (angiogenesis), and overall cell 
regulation at the site of injury. The response consists of non-specific defense mechanisms carried out by 
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cells and non-cellular components of the circulating blood (granulocytes, monocytes, and the 
complement system) as well as resident inflammatory cells (macrophages and mast cells) that 
collectively try to eliminate intruders. If necessary, specific immune responses such as the production of 
antibodies by B-lymphocytes and/or the activation of cytotoxic T lymphocytes can be initiated. 
 
3. Reparative Phase 
The formation of new tissue requires the activation and/or proliferation of distinct cell types, resulting in 
the replacement of lost or damaged tissue. In soft tissue healing, extremely important cells related to 
new tissue formation are fibroblasts and endothelial cells that are capable of new extracellular matrix 
formation and angiogenesis, respectively. The provisional extracellular matrix is important as a scaffold 
for the migration of cells into the damaged area. Additionally, the extracellular matrix and its 
components contain signals for the differentiation and stimulation of cells, mainly via receptor–ligand 
interactions. Through the development of new blood vessels, nutrients and oxygen become available 
for proliferating cells that replace the tissue at the damaged area. In hard tissue healing, the process of 
ossification (bone formation) is important and two types assure new bone formation: intra-
membranous and endochondral ossification 4. Intra-membranous ossification is carried out by 
osteoprogenitor cells present in the cambium layer of the periosteum. Endochondral ossification occurs 
at and overlies the defect site and undifferentiated mesenchymal cells attracted from tissues 
surrounding the defect (e.g., soft tissues and periosteum) become committed cartilage-producing cells 
13 under influence of local production and release of mediators, including growth factors. The 
mineralization of the cartilage tissue leads to bone formation. 
 
4. Tissue Remodeling 
Tissue remodeling involves the transition of newly formed, immature tissue into mature tissue. In 
contradistinction to the relatively short duration of both the inflammatory and reparative phases, the 
remodeling phase may last for several years. The general process of soft tissue remodeling involves 
rapid synthesis and degradation of connective tissue proteins 20. The degradation of these extracellular 
matrix (ECM) proteins is accomplished through the actions of matrix metalloproteinases (MMPs) 21. The 
common outcome of soft tissue remodeling is scar formation, which results mainly from an imbalance 
between the stimulation of collagen synthesis and degradation of extracellular collagen. Remodeling in 
hard tissues involves bone resorption by osteoclasts, followed by the synthesis of new bone matrix and 
its mineralization by osteoblasts. The remodeling process in hard tissues is subject to mechanical forces 
acting upon it (Wolff’s law 22). In contrast with soft tissue remodeling, hard tissue remodeling is devoid 
of scarring. Furthermore, healed hard tissue is able to resume its original configuration.  
 
B. Macrophages 
Several cell types are involved in the biological processes that occur after the implantation of a 
biomaterial. The interplay among these cells is extremely important because inadequate cellular 
responses could directly or indirectly impede the functionality of the implanted device. Cells respond to 
stimuli mostly via receptors on their surfaces. Via these receptors, cells can recognize a large variety of 
ligands including soluble mediators secreted by other cells (cytokines), molecules present on the 
surfaces of adjacent cells, and distinct patterns in molecules of ECM proteins. Due to their early 
appearance at an implantation site, their longevity, and the large number of cytokines they can produce 
and secrete, macrophages are generally considered the most important cell type in the vicinity of a 
newly-implanted device 23. Macrophages perform multiple functions at a site of implantation ranging 
from phagocytosis of cell debris and potential pathogens via initiation of an inflammatory reaction to 
orchestration of the processes necessary to heal the damaged tissue resulting from the surgical 
procedure. 
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C. Biomaterial Interface Processes 
Although an implant is subject to cellular biological processes upon introduction, as described above, 
the initial contact of implant and host relies on non-cellular interactions. A newly introduced implant is 
surrounded by an aqueous liquid. The water molecules in the direct vicinity of an implant can 
substantially alter the appearance of the biomaterial surface for the biological environment 24. The 
abundance of water molecules within this liquid means that water is the primary molecule involved in 
the first series of interactions of a biomaterial surface interface with its in vivo surroundings. An 
important parameter is the free energy of a biomaterial surface reflected by its water wettability. 
Biomaterial surfaces are often categorized as hydrophobic or hydrophilic. A related parameter of 
biomaterial surfaces is cell adhesion. Although some authors assert the existence of a correlation 
between surface free energy and cell adhesion 25;26, others impugn this correlation 27 or even postulate 
the inverse 28. The water molecules in the direct vicinity of the biomaterial surface will form a water 
monolayer or bi-layer in which the arrangement of the water molecules depends on the surface 
properties at the atomic scale and completely differs from that of liquid water 24. Subsequent to 
interface interactions with water molecules, a biomaterial surface will first encounter ions and then the 
proteins present within the surrounding liquid. In the monolayer or bi-layer of water molecules, natural 
ions (e.g., Na+ and Cl-) are incorporated as hydrated ions 29. The surface properties of the biomaterial 
determine the type, amount, and conformational state of the adsorbed proteins 30;31. Thus, the 
spectrum of adsorbed proteins will not necessarily reflect the amounts and ratios of the proteins within 
the surrounding liquid 32;33. Additionally, denaturation of the adsorbed proteins may occur. As a result, 
biologically important sites may become inaccessible or nonfunctional, limiting interactions with 
counter-receptors present on cellular membranes. Finally, living cells will become involved. The 
presence of a wide variety of membrane-bound receptors on the surfaces of cells enables them to 
adhere to adsorbed proteins on the biomaterial surface. Because the interaction of cells with the 
biomaterial surface does not rely on direct contact between cells and biomaterial, but merely on an 
indirect interaction mediated by adsorbed proteins, it has been suggested that the biomaterial is not 
what causes unwanted responses 34. The non-specific layer of proteins adsorbed on the biomaterial 
surface immediately after implantation is recognized by the host as a foreign or unnatural material. This 
assumption seems plausible because such an adsorbed mixture of proteins with random orientations 
and conformational states presents a divergence from natural, intentionally arranged protein layers. 
 
D. Foreign Body Reaction 
The cumulative effects of all separate contributive processes that occur at the biomaterial interface 
results in one of the following outcomes of implantation: (1) integration, (2) extrusion, (3) resorption, or 
(4) encapsulation. Although integration of the biomaterial device is the most favorable outcome, the 
number of cases in which true bio-integration is achieved is limited 35. Most frequently, true bio-
integration occurs after implantation of compatible biomaterials such as titanium coated with 
hydroxyapatite (HA) into bone tissue 36;37. Implantation of biomaterials into soft tissues usually results in 
one of the other three outcomes. Extrusion occurs when an implanted device is in direct contact with 
epithelial tissue. The epithelium will form a pocket continuous with the adjacent epithelial membrane 
that subsequently dissipates the implant. In the case of external epithelium, the implant will be 
externalized from the host. Resorption of the implant can occur when an implant is made of degradable 
material. After complete resorption, only a collapsed scar will remain at the implantation site. In most 
cases, implanted biomaterials in soft tissues become encapsulated by a process known as the foreign 
body reaction 2;38 (Figure 1) The capsule commonly consists of a relatively hypo-cellular membrane with 
a high collagen content 39. Adjacent to this collageneous membrane, a layer of myofibroblasts is 
occasionally observed. Furthermore, foreign body giant cells (FBGCs; i.e. fused macrophages) are  
frequently observed in the space between implant and capsule 40;41. In general, the organization of cells 
and matrix surrounding an implant is built up in such a way that a barrier between the foreign material 
and the body is created and this structure more or less isolates the implant from the body. The capsule, 
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including FBGCs, surrounding the implant may persist for the lifetime of the implant. However, it is not 
yet clear whether FBGCs present at the biomaterial surface remain activated during the lifetime of the 
implant or become quiescent 38. Since encapsulated implants can perform their functions for many 
years, the isolation of an implant in a collageneous capsule is not necessarily an unwanted 
phenomenon. It may even help the body live in symbiosis with a synthetic device, although the 
establishment of genuine symbiosis in this respect may be arguable. Unfortunately, the presence of 
myofibroblasts within the capsule may lead to contraction and thus cause pain and/or implant failure. 
Furthermore, the formation of a capsule, either or not associated with wearing of the biomaterial, may 
result in loosening. 
 
III BIOMATERIALS 
A. Introduction 
Biomaterials are substances used for the production of devices that interact with biological systems, 
which are known as medical devices. This definition inherently suggests that biomaterials can be widely 
used. For example, biomaterials are used for cell cultures in laboratories, for the production of 
diagnostic devices, for extracorporeal apparatus (heart–lung machines), and many other applications. 
The use of biomaterials for the production of implants is the focus of this section. 
The use of biomaterials in medicine is not a novel concept. As early as 2000 years ago, dental implants 
made of gold or iron were used 42. However, the practical use of implants in that era is not comparable 
to their present use. The increasing demands for safe and reliable implants have resulted in the 
evolution of biomaterials science as a distinct discipline. In addition to the somewhat old-fashioned 
biomaterials such as stainless steel, a high number of novel, mostly polymeric, biomaterials are now 
available and can be categorized as depicted in Figure 2. 
Figure 1: Foreign body reaction. 
The introduction of an implant (1) 
into a recipient leads to the 
adsorption of proteins in all 
possible configurations on the 
surface (2). Subsequently, cells 
(including macrophages) will 
attach to the implant surface via 
cell surface receptors that 
recognize corresponding ligands 
in the adsorbed protein layer (3). 
Attached cells secrete a wide 
variety of signal molecules that 
influence the behavior of 
perceptive cells (4)  that become 
activated and start to produce 
extracellular matrix (5). Finally, 
the implant becomes enclosed in a 
fibrous capsule that isolates the 
implant from the body (6). 
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B. Properties of Biomaterials 
In order to function appropriately, biomaterials must possess properties that allow them to be used 
successfully for their intended applications. In view of this, it is logical to distinguish bulk properties 
from surface properties. Bulk properties (together with the design) determine the (mechanical) strength 
of an implant, whereas the surface properties are important in view of the eventual interactions of an 
implant with biological systems.  
 
1. Bulk Properties 
Bulk properties of materials are determined by the organization of the atoms of which the materials are 
built and the forces by which the atoms are kept together (inter-atomic forces). Several types of inter-
atomic forces are known, including ionic bonding, covalent bonding, and metallic bonding 43. The 
mechanical properties of a biomaterial must be adjusted to its intended function; otherwise the implant 
is likely to fail. For example, if a device intended for the fixation of a bone fracture lacks the required 
strength, it may break, making the device unsuitable for this function. Hence, the intrinsic properties of 
biomaterials may be appropriate for a certain application, but play a role in the failure of an implant 
made from the same material and used for another application. Regarding specific requirements from a 
mechanical view, three intrinsic properties of materials are especially important: elastic modulus, yield 
stress, and ultimate stress 44. Together, these three parameters determine the stiffness, deformability, 
and strength of a material. Another important bulk property of a biomaterial is fatigue — the “process 
by which structures fail as a result of cyclic stresses that may be much less than the ultimate tensile 
stress 43.” Such cyclic stresses are common at many locations in the human body, such as in a pumping 
heart (artificial heart valves), in the mouth (tooth prostheses), and in joints (artificial hips/knees). 
 
2. Surface Properties 
In addition to intrinsic (bulk) properties of biomaterials, surface properties are also important to the 
success of an implant. Since the interaction of a synthetic device and biological system takes place at 
the biomaterial–tissue interface, it is evident that the surface properties of a biomaterial are pivotal for 
the regulation of implant integration. Several factors determine the surface characteristics of a material, 
including composition, roughness, release of ions, charge, and energy 45. Obviously, the interaction of 
biological constituents with the surface of a biomaterial device must not cause any detrimental effects 
to the surrounding viable cells, tissues, and organs. For that reason, the surface molecules of a 
biomaterial should not be toxic, carcinogenic, pyrogenic, cytotoxic, or antigenic to living cells in any 
way. If materials containing one or more of these characteristics are excluded, the reactions of body 
tissues to an implant surface still depend on the surface properties of the biomaterial in question. 
 
Figure 2: Classification of biomaterials 
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One commonly assessed property for biomaterial surface characterization is surface energy. As will be 
discussed later, this parameter may be an important factor in the establishment of cell adhesion to 
biomaterial surfaces. However, other factors that are probably important in monitoring the adhesion of 
cells to biomaterial surfaces are cell type and presence of adhesive proteins 46. Interaction of biological 
systems with biomaterial surfaces can be desirable to enhance the integration of the biomaterial in the 
body. In contrast, also the generation of non-interacting surfaces can be an aim in designing implants. 
In synthetic vascular grafts, for example, the deposition of biological material (bio-fouling or bio-
adhesion) is undesirable because it may lead to occlusion of blood vessels. Furthermore, control over 
bio-adhesion may eventually result in the generation of biomaterial surfaces that encourage adhesion 
of host cells but discourage adhesion of infectious bacteria — a common cause of implant failure 47;48. 
Processes of a biological nature can affect the integrity of biomaterials. Upon implantation, a 
biomaterial is subject to interactions with the constituents of the biological environment and may be 
subject to biodegradation, a process in which components of the biological environment (or host) 
attack the biomaterial. Metals are inherently susceptible to corrosion — an electrochemical process in 
which oxidative and reductive reactions take place 49. Due to such reactions, the integrity of a metal may 
be affected by the formation of metal ions from the solid metal, resulting in degradation. For ceramics, 
the extent to which the biological environment is capable of degradation is dependent on the chemical 
structure of the biomaterial. Increased knowledge in biomaterial science has resulted in the production 
of both polymeric and ceramic biomaterials whose degradation rates can be controlled. This has 
presented opportunities to generate and use biomaterial devices that in time can be replaced by native 
tissues. 
 
C. Modifications of the biomaterial surface 
From the previous descriptions of interfacial biological processes and biomaterial properties, it is 
evident that the placement of an implant into a living organism causes specific reactions of the 
biological environment. Since the biological environment recognizes the implant surface and not the 
bulk material, attempts to modulate biological responses have been focused at biomaterial surface 
modifications. The ultimate aim of biomaterial surface modifications is to gain control over biological 
responses against biomaterials, and hence increase implant functionality, performance, and longevity. 
Roughly, biomaterial surface modifications can be divided in (i) topographical modifications, (ii) 
biomaterial coatings, and (iii) incorporation of biologically active compounds at the biomaterial surface. 
 
(i) Surface topography 
The topography of biomaterial surfaces has been a major topic in biomaterials science in the past 
decade, and can be divided in texture (regular features) and roughness (random features). Surface 
topography can be of great importance with respect to area enlargement. An increase in surface area 
may provide greater potential for tissue integration (mechanical interlocking). Excellent reviews on this 
topic evidence a general consensus that topographical textures indeed influence cell behavior 50-54. An 
enormous diversity of textural cues was used: grooves, pits, ridges, cliffs, tunnels, steps, waves wells, 
tubes nodes pillars, pores, spheres, and cylinders. Researchers used many different cell types in studies 
to examine the effects of microscale textured topography on the behavior of primary isolated cells or 
immortalized cell lines, including fibroblasts, macrophages, epithelial cells, leukocytes, neuronal cells, 
endothelial cells, and osteoblasts. 
Unfortunately, the precise biological effects of microscale topographies remain unclear – various 
research groups have obtained contradictory results. Parker et al. 55 found no favorable effects of surface 
texturing on capsule formation around subcutaneous implants, but in vivo studies by others indicated 
that grooved implant surfaces produced beneficial effects on tissues surrounding the implant 52. In the 
latter studies, grooved textures appeared to encourage tissue organization and showed a reduction in 
fibrous capsule formation as compared to smooth implant surfaces. 
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Although the technology for creating textured topographical cues with nanoscale dimensions on 
biomaterial surfaces is a novelty, several studies have demonstrated the substantial effect these cues 
can exert on cell behavior. The effect on cell behavior of grooves with nanoscale dimensions has been a 
subject of interest in many in vitro studies 56-59. Regarding the effects of grooves with nanoscale 
dimensions, the findings generally indicate that cells become oriented and elongate along the surface 
groves. Furthermore, the activity of cells on nanotopographically modified substrates is increased 
compared to activity on smooth control substrates. This is demonstrated by higher proliferation rates 
and enhanced spreading of fibroblasts 60, increased phagocytic activity of macrophages 59, and a 
notable up-regulation of gene expression related to cell signaling, proliferation, and the production of 
cytoskeleton and ECM protein 61. 
 
(ii) Biomaterial coatings 
While synthetic surfaces lack specific signals cells can recognize, naturally-derived materials may 
possess numerous signals involved in a wide variety of biological processes. In view of this 
characteristic, modulation of a biomaterial surface with naturally occurring components of ECM proteins 
containing such signals has become a common modality. The effect of the immobilization of specific 
peptide sequences, especially the sequence arginine-glycine-aspartic acid (abbreviated as RGD), onto 
the surfaces of materials has been studied for biomaterials intended for implantation in both soft and 
hard tissues. Excellent reviews dealing with this topic 62;63 outline proven applications and promising 
potential for the future. 
 
TABLE 1.2: APPLICATION OF IMMOBILIZED PEPTIDES ONTO BIOMATERIALS 
Peptide ECM molecule source Application 
RGD Multiple ECM molecules, e.g. 
fibronectin, vitronectin, laminin, 
collagen, and thrombospondin 
Enhance bone and cartilage tissue 
formation in vitro and in vivo; 
regulate neurite outgrowth in vitro 
and in vivo; promote myoblast 
adhesion, proliferation, and 
differentiation; enhance endothelial 
cell adhesion and proliferation 
IKVAV YIGSR RNIAEIIKDI Laminin Regulate neurite outgrowth in vitro 
and in vivo  
Recombinant fibronectin fragment 
(FNIII7-10) 
Fibronectin Promote formation of focal contacts 
in preosteoblasts 
Ac-GCRDGPQGIWGQDRCG Common MMP substrates, e.g. 
collagen, fibronectin, and laminin 
Encourage cell-mediated proteolytic 
degradation, remodeling, and bone 
regeneration in vivo 
 
Biomaterial surfaces and matrices endowed with peptides for tissue engineering have been shown to 
enhance cellular behavior substantially (Table 1.2). Beneficial effects of such surfaces haven been 
demonstrated for cell types with different functions and originating from both soft and hard tissues, i.e. 
connective tissue (fibroblasts), muscle tissue (myoblasts and smooth muscle cells), bone (osteoblasts), 
and cartilage (chondrocytes). 
Especially for hard tissue implants, calcium phosphate-coatings are widely used. It is evident that 
calcium phosphate coatings improve the biological performance of endosseous implants 64-66 due to the 
capacity of these materials to form a direct bond with bone tissue without an intervening fibrous tissue 
layer. Concomitantly, the use of calcium phosphate ceramics as a coating onto material with 
appropriate mechanical properties allows their use at load-bearing sites, since their brittleness hinders 
their use as a bulk material for load-bearing applications. 
 
(iii) Biologically active compounds 
Biologically active compounds, such as growth factors, cytokines, and antibiotics, can be used to add a 
degree of functionalization to a biomaterial surface (coating). As such, functionalized implant surfaces 
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can provide drug availability in therapeutic concentrations directly at the intended target site for 
prolonged time. An overview of the advantages of local drug release over systemic drug therapy is 
presented in Table 1.3. 
 
TABLE 1.3: ADVANTAGES OF LOCAL DRUG RELEASE OVER SYSTEMIC DRUG THERAPY 
1 Lower dose required 
2 Greater control over toxicity and bioavailability of dose 
3 Less susceptibility to promoting antibiotic resistance 
4 Extended duration of release 
5 Possibilities to combine local and systemic drugs with different kinetics 
6 Controlled release from functionalized surfaces directly to the site 
7 Avoidance of systemic drug exposure 
8 Direct mitigation of implant-centered infection 
 
Exploiting the opportunities of functionalized implant surfaces, several targets have been addressed, 
including biomedical device-related infections, therapeutic angiogenesis, and bone formation. 
The functionalization of implant surfaces with antimicrobial compounds (antibiotics) is a 
straightforward method to minimize the risk of implant-associated infections. As discussed previously, 
implant-associated infections are a common cause of implant failure 67;68. Consequently, several 
approaches have been explored experimentally, and already several implants are commercially 
available, primarily focused at minimizing catheter-related bloodstream infections (reviewed in Wu and 
Grainger 69). 
Therapeutic angiogenesis is a pivotal element to achieve regrowth of, or engineer new tissue. Especially 
for tissue engineering, in which an artificial body part eventually will be replaced by native tissues, a 
proper supply of nutrients and oxygen and removal of waste products is needed. Additionally, if the 
tissue engineering construct consists of a combination of scaffold and cells, a delay in the development 
of the vascular network could result in loss of the cells within the tissue engineering construct. Although 
vascular endothelial growth factor (VEGF) is generally recognized as the most potent angiogenic factor, 
current approaches utilize mixed growth factor formulations (VEGF plus basic fibroblast growth factor 
[bFGF], platelet-derived growth factor [PDGF], or angiopoietin 1) as these would not only induce de 
novo formation of capillaries, but as well stabilize and maturate these capillaries 70. 
For bone implants, including oral and orthopedic implants, it is essential to become directly-bonded to 
the native bone tissue. The process of osseo-integration can be accelerated using osteoinductive 
factors, including members of the bone morphogenetic proteins (BMPs; especially BMP-2 and BMP-7) 
and transforming growth factor beta (TGF-β). In vivo , these compounds have been demonstrated to 
effectively accelerate the formation of new bone tissue, and thus more rapid healing of bone defects 
and integration of bone implants 71-73. 
For all of these biologically-active compounds it is important that their availability is such that they can 
exert their therapeutic function. In view of this, improper delivery of these compounds could result in, 
for instance, only short-term efficacy (overdose) or microbial resistance (underdose). 
 
IV DEOXYRIBONUCLEIC ACID (DNA) FOR BIOMATERIAL PURPOSES 
Deoxyribonucleic acid (DNA) represents the origin of life, as it is the repository of genetic information. 
The genetic information is allocated into genes, which via the process of transcription can be converted 
to ribonucleic acid (RNA), and, after further processing, can be translated into proteins. Although the 
genetic material of organisms usually is contained within DNA, several species, mainly viruses, use RNA 
as the main encoding molecule. Since the discovery of the three-dimensional structure of DNA by 
Watson and Crick in 1953 and its function, selective interference with the source of biological 
information became available. 
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Structure of DNA 
Deoxyribonucleic acid (DNA) molecules are composed of a polymeric conformation of a large number of 
deoxyribonucleotides, which consist of  a sugar, a phosphate group, and a nitrogenous base 74(Figure 3). 
In these deoxynucleotide units, the sugar component is represented by deoxyribose. The nitrogenous 
bases used in DNA molecules are derivatives of purine (i.e. adenine and guanine) or pyrimidine (i.e. 
thymine and cytosine). In the three-dimensional structure of DNA, two polymers of nucleotides form 
helical polynucleotide chains which run in opposite directions and are coiled around a common axis, 
with a sugar-phosphate backbone and a base-centre, resulting in the typical double-helical 
configuration of DNA. In this configuration, the diameter of the helix is 20 Å (= 2 x 10-9 m), whereas 
adjacent bases are separated by 3.4 Å (= 3.4 x 10-10 m) along the axis and related by a rotation of 36 
degrees 74. Together, this makes that the double-helical structure repeats after 10 deoxynucleotides at 
intervals of 34 Å (= 3.4 x 10-9 m). Through the intra-helical positioning of the bases, the two chains are 
held together by hydrogen bounds which are formed between distinct pairs of opposite bases. In this 
respect, the pairing of bases is restricted to adenine-thymine (two hydrogen bonds) and guanine-
cytosine (three hydrogen bonds). Although the pairing of the bases is restricted to the mentioned base-
pairs, this does not implicate a restriction in the sequence of base-pairs, as this sequence of the base-
pairs in DNA is  responsible for the unique genetic information of each individual. 
DNA-helices can have three conformational states, i.e. an A-, B-, or Z-form. Both the A- and B-form are 
right-handed double helices, with the difference that in the A-form, the rise per base pair is smaller, and 
the helix diameter is broader. Consequently, DNA in the A-form contains more base-pairs per turn of the 
helix, and thus forms a more concise style. On the contrary, the helices of the Z-form of DNA are left-
handed, and the diameter of the helix is smaller than that of the B-form. Although under physiologic 
conditions nearly all DNA is in the B-form, transformation into the A- or Z-form can occur under specific 
conditions 74. The A-form appears when the relative humidity is reduced below approximately 75%, and 
the Z-form can be adopted by short oligonucleotides that have sequences of alternating pyrimidines 
and purines. 
The unraveling of the genetic information encoded within the DNA, and the increased knowledge on 
genetic deficiencies related to pathological disorders have undoubtedly had their impact on ‘modern’ 
medicine and science, resulting in the development of an independent scientific discipline called 
‘genomics’.  
 
 
 
Figure 3: Structure of the DNA molecule. 
The DNA molecule consists of a double helical 
sugar/phosphate backbone, with centrally located bases. 
Pairing of the bases (adenine, a; thymine, t; guanine, g; 
and cytosine, c) is restricted to form base-pairs (a-t, c-g), 
which form hydrogen bonds that hold the two strands 
together. 
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Possibilities and limitations  of DNA as a coating material 
Although predominantly associated with genetics, DNA also represents an interesting natural polymeric 
molecule that can be used for purposes other than transfer of genetic information. Several properties of 
the DNA molecule, which derive from its stereochemical structure, may be beneficial in implantology. As 
a natural, non-proteinic polymer, DNA is suggested to be non- or low-immunogenic 75;76. Consequently, 
possible immune responses upon implantation of DNA-coated biomaterial devices, will be not 
specifically directed against the coating, and are expected to be low. Secondly, the structure of DNA 
allows interactions of DNA with molecules via either intercalation of groove-binding 77-79. This opens the 
applicability of DNA as a tissue-engineering scaffold and/or drug-delivery system, in which cells 
surrounding the DNA-coated implant can be influenced. Amongst potential molecules that can be 
applied for loading a DNA-coated implant are growth factors, immuno-regulatory molecules, and 
antibiotics. Finally, the high content of phosphate groups in DNA might be contributive for bone 
formation. As it is demonstrated that phosphate groups have a high affinity for calcium ions 80, and 
bone bonding to a polymeric material modified by surface graft polymerization of a phosphate-
containing monomer is firm 81, the polymeric, phosphate-containing DNA molecule might be an 
interesting candidate for a novel bone substitution material. 
Although the idea seems compelling, the application of DNA as a coating material necessitates solutions 
for some intrinsic properties of DNA. The major problem of using DNA in an in vivo situation is its 
solubility in aqueous solutions, hampering coating applications without modifications. Furthermore, 
extracellular DNA is easily degraded by DNases 82, which are ubiquitously present endogenously. 
In addition to these issues concerning the generation of a DNA-based coating, also safety issues are 
involved in the application of DNA for biomedical coating purposes. These safety issues include the risks 
of transfection and consequences of potential impurities of the DNA. To minimize these risks, the 
research described in this thesis was performed using specially prepared DNA from Nichiro Corporation 
(Japan). This DNA, derived from waist products of salmons for the food industry, is of vertebrate origin, 
randomly cut into molecules of approximately 300 base pairs, and purified to obtain extremely pure 
material. Consequently, this DNA shares the homogeneity of vertebrate DNA, is unlikely to contain 
encoding regions due to the limited size of the molecules, and minimizes immune responses directed 
against potential protein impurities. 
 
Method for the generation of DNA-based coatings 
To overcome the aforementioned problems of solubility and degradation, a method for the fabrication 
of stable coatings containing DNA was required. In this respect, an interesting technique is electrostatic 
self-assembly (ESA), also known as layer-by-layer (LbL) assembly. This technique was developed by 
Decher and co-workers in 1992 83;84 and is based on the electrostatic interactions between positively- 
(cationic) and negatively-charged (anionic) polyelectrolytes. These interactions can be used to build up 
polyelectrolyte multilayers (PEMs), as schematically depicted in Figure 4. PEM build up is achieved by 
alternate immersion of a substrate in aqueous solutions of cationic and anionic polyelectrolytes. Each 
immersion step allows the adsorption of a layer of polyelectrolytes that reverses the charge at the 
interface with the solution. This reversed surface charge prevents further polyelectrolyte adsorption and 
overcompensates the original surface charge. In the subsequent immersion step in an aqueous solution 
of an oppositely-charged polyelectrolyte, the original surface charge is restored by the adsorption of a 
next layer of polyelectrolytes, which makes the surface ready for further assembly. To remove excess 
free polyelectrolytes, the surface is rinsed with pure water after each adsorption step. Repetitive 
adsorption cycles of cationic and anionic polyelectrolytes allow tailoring of PEM thickness. 
A major advantage of this technique is that it can be employed for many substrate materials, 
irrespective of their geometry. Additionally, the wide range of available polyelectrolytes allows the 
selection of specific polyelectrolytes with desired properties. Consequently, the ESA-technique 
represents a simple technique for surface modification that allows tailoring of surface properties of both 
two- and three-dimensional supports. 
I General Introduction 
 21
Previously, multilayered coatings with DNA as the anionic component have been generated using the 
ESA-technique  85-92. These studies indicate the possibility to generate multilayered DNA-coatings but 
are not conclusive regarding coating characteristics. Furthermore, these studies do not suggest the use 
of multilayered DNA-coatings for biomaterial purposes. 
V OBJECTIVE & HYPOTHESES 
In view of the structural properties of the (vertebrate) DNA-molecule, a collaborative project between 
Laboratory for Macromolecular & Organic Chemistry (Eindhoven University of Technology) and the 
Department of Periodontology & Biomaterials (Radboud University Nijmegen Medical Center) was 
initiated to consider the use of DNA for biomaterial coating purposes. The hypothesis behind this 
bewildering intention is that the structural properties of the DNA-molecule (within a DNA-based 
coating) beneficially affect several facets of the interaction between implant and surrounding tissue(s), 
including the inflammatory response and mineral deposition. Additionally, it is hypothesized that DNA-
based coatings can be used as a drug-delivery vehicle to modulate cell and tissue responses using 
factors with desired biological activity (e.g. growth factors, antibiotics, cytokines, etc). 
The research described in this thesis was part of this project. More specifically, the subaims of this 
project were to: 
• fabricate and characterize DNA-based coatings; 
• evaluate cytological and histological responses to DNA-based coatings; 
• evaluate inflammatory responses to DNA-based coatings in vitro using macrophage models; 
• evaluate the effect of DNA-based coatings on the deposition of calcium phosphates, and the 
behavior of bone-forming cells; 
• evaluate the possibilities to functionalize DNA-based coatings with the osteoinductive factor 
BMP-2; 
• evaluate the effect of VEGF-functionalized DNA-based coatings on the angiogenic response of 
endothelial cells and implant-surrounding tissue(s). 
Figure 4: Schematic representation of the electrostatic self-assembly technique. The build up of a multilayered 
structure is achieved by the successive immersion of a substrate in aqueous solutions of a cationic polyelectrolyte 
(step 1) and a cationic electrolyte (step 3) with intermediate wash steps (steps 2 & 4). During these wash steps, 
loosely-bound polyelectrolytes are removed from the adsorbed polyelectrolyte layer. Repetition of steps 1-4 results in 
a multilayered coating with an accordingly number of double-layers.  
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I INTRODUCTION 
In implantology, a wide variety of materials are used to generate biomedical devices with satisfactory 
properties. Although bulk properties of materials largely determine their suitability for a given 
application, the biological response is mainly determined at the biomaterial surface, via the interactions 
with components of the biological surroundings 1;2. 
Modifications of the biomaterial surface have been a major research topic in the past decades. In view of 
this, an intriguing novel coating material for biomaterials is deoxyribonucleic acid (DNA), the repository 
of (individual-specific) genetic information. Irrespective of its genetic information, the structural 
properties of DNA give this unique, natural compound potential for use as a biomaterial coating. The 
specific build-up of the DNA molecule may ensure a versatile use at various implantation sites. The 
molecular structure of DNA in vertebrate species is homogenous 3;4, and the non- or low-immunogenic 
properties of DNA (compared to other biological antigens like proteins and sugars) may limit both 
innate and acquired immune responses 3;5;6. Additionally, DNA can incorporate other molecules via 
groove-binding and intercalation 7;8. This creates opportunities to specifically deliver desired biological 
mediators in the direct vicinity of the implantation site. Finally, the high phosphate content in DNA 
might, via the high affinity of phosphate for calcium ions 9;10, beneficially affect the deposition of 
calcium in the bone formation process. The use of DNA as a functional biomaterial, instead as a carrier 
for its genetic information, has already been suggested 11;12, and pioneering efforts have resulted in the 
fabrication of DNA-containing bulk (bio)material 13, which demonstrated to cause no adverse reactions 
upon subcutaneous implantation in the backs of rats. 
The application of DNA as a coating material, however, is hampered by (a) its easy nucleolytic 
degradation, and (b) its solubility in aqueous solutions. The use of the previously mentioned DNA-
containing bulk material 13 resulted in easily detaching  coatings on various substrates. Therefore other 
methods to obtain stable DNA-containing coatings for biomaterial purposes have to be explored. One 
applicable technique could be electrostatic self-assembly (ESA), also known as layer by layer (LbL) 
assembly. Via this technique, polyelectrolyte multilayers (PEMs) can be generated through the 
alternated progressive adsorption of oppositely-charged polyelectrolytes via electrostatic interactions 
14. 
The ESA technique has been applied successfully using DNA as a polyanionic building block 15-22. 
Interestingly, electrostatic interactions with positively charged polyelectrolytes have demonstrated to 
protect DNA from degradation by nucleolytic activity 23. Furthermore, the method of fabrication (i.e. 
under immersion in aqueous solutions) inherently evidences the water insolubility of PEMs. Even 
immersion of PEMs in high ionic solutions (i.e. exceeding those in physiological conditions) does not 
cause dissociation of the PEM structure. Instead, changes in the ionic content of the polyelectrolyte 
solutions in the fabrication process are one of the means to modulate PEM properties, including layer 
thickness 14;24. 
Irrespective of the progress made so far, the use of DNA-containing multilayered coatings in the 
biomaterials field still requires their complete characterization. Whereas the build-up mechanism of 
PEMs has been described previously, information on the morphological properties is scarce. 
Additionally, the hypothesized beneficial properties of DNA necessitate the quantification of the 
amount of DNA immobilized in the coatings. Therefore, the aim of this study was to fabricate and 
characterize two types of multilayered DNA-coatings, which differ in the type of cationic polyelectrolyte 
used, and assess their effects on cell behavior using in vitro-experiments. 
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II MATERIALS & METHODS 
Materials 
Polyanionic DNA (± 300 bp/molecule; sodium salt) was kindly provided by Nichiro Corporation 
(Yokosuka-shi, Kanagawa prefecture, Japan). Potential protein impurities in the DNA were checked 
using the BCA protein assay (Pierce, Rockford, Illinois, USA) and measured to be below 0.20% w/w (data 
not shown). Polycationic polyelectrolytes poly(allylamine hydrochloride) (PAH; MW ~70000) and poly-
D-lysine (PDL; MW 30000 – 70000) were purchased from Sigma (Sigma-Aldrich Chemie B.V., 
Zwijndrecht, the Netherlands). All materials were used without further purification. The monomeric 
structures of the cationic polyelectrolytes used are presented in Figure 1. 
Substrate preparation and cleaning 
Three types of substrates were used: 
1. Quartz substrates (45 x 12 mm; Hellma Benelux B.V., Rijswijk, the Netherlands) were used for 
UV-vis spectrophotometry, contact angle measurements, FTIR spectroscopy, and XPS; 
2. Silicon substrates (1 x 1 cm; Wafernet GmbH, Eching, Germany) were coated with a 50 nm thick 
titanium layer, using the RF magnetron sputter technique. The titanium sputtering process 
(duration 5 min., pressure ~5 x 10-4 mbar) was performed with the silicon substrates attached 
to a rotating sample holder. Titanium-sputtered silicon substrates were used for XPS, contact 
angle measurements, and AFM; 
3. Disc-shaped titanium substrates (12 mm diameter, 2 mm thickness; commercially-pure 
titanium, as-machined) were used to determine the incorporation of radiolabeled DNA into 
each double-layer. 
Quartz substrates were cleaned in Piranha solution (H2O2 (30% aqueous solution) / H2SO4 – 3:7 v/v) to 
completely remove all traces of organic materials at the surface, and increase the hydrophilicity of the 
surface. (caution: Piranha solution is an extremely corrosive mixture). Subsequently, the substrates were 
thoroughly rinsed with ultra-pure water from a Millipore system (resistivity ≥ 18.2 MΩ⋅cm; Millipore 
B.V., Amsterdam, the Netherlands) and dried using a pressurized air stream. 
Figure 1: Molecular structure of (A) poly(allylamine 
hydrochloride) (PAH) and (B) poly-D-lysine (PDL). 
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Titanium-sputtered silicon substrates and titanium discs were cleaned ultrasonically using consecutively 
nitric acid (10% v/v), acetone, and isopropanol. Between each cleaning step, the substrates were rinsed 
with ultra-pure water. After the last cleaning step, the substrates were dried in air. 
 
Generation of multilayered DNA-coatings 
Multilayered DNA-coatings were generated using the ESA technique, as described by Luo et al. 17 with 
few modifications. The cleaned substrates were immersed in an aqueous solution of either PDL (0.1 
mg/ml) or PAH (1 mg/ml) for 30 minutes, allowing sufficient time for the adsorption of the first cationic 
polyelectrolyte layer onto the substrates. Subsequently, the substrates were washed in ultra-pure water 
(5 minutes, continuous water flow) and dried using a pressurized air stream. Thereafter, the substrates 
were alternately immersed in an anionic aqueous DNA solution (1 mg/ml) and the respective cationic 
polyelectrolyte solution for 7 minutes each, with intermediate washing in ultra-pure water (5 minutes, 
continuous water flow) and drying using a pressurized air stream. The build-up of the multilayered 
DNA-coatings was continued until a total of 5 double-layers was reached. These were designated either 
[PDL/DNA]5 or [PAH/DNA]5) (the denotation of coatings is restricted to indicating the number of double-
layers, i.e. ½ represents only the cationic part of the double-layer). 
 
Characterization 
UV-Vis spectrophotometry 
The progressive build-up of the multilayered DNA-coatings onto quartz substrates was monitored using 
a Shimadzu multi-spec UV-Vis spectrophotometer (Shimadzu Germany, Duisburg, Germany), equipped 
with a diode-array detector. Measurements were taken after each successive layer. Growth of the 
multilayered DNA-coatings was studied via the incremental increase at 260 nm, the absorbance 
maximum of the nucleic base chromophores. All measurements were replicated in a separate second 
run. 
 
Atomic Force Microscopy (AFM) 
The morphology of non-coated titanium-sputtered silicon, partial ([PDL/DNA]½ and [PAH/DNA]½; 
[PDL/DNA]2 and [PAH/DNA]2; [PDL/DNA]3½ and [PAH/DNA]3½ ) and complete ([PDL/DNA]5 and 
[PAH/DNA]5) multilayered DNA-coatings was analyzed using a Nanoscope IIIa AFM set-up (Digital 
Instruments, Buffalo, NY, USA). All scans were made in contact mode, using a Si3N4-tip. Typical scan sizes 
were between 0.5 x 0.5 µm2 and 5 x 5 µm2. To detect potential damaging effects of the probe to the 
multilayered DNA-coatings, scans of the samples were always made with increasing scan size. Image 
analysis software (WSxM free software, downloadable at http://www.nanotec.es) was used to generate 
micrographs and quantitatively compare surface roughness, using Root-Mean-Square (RMS) 
calculations, a roughness denotation based on the standard deviations of the z-value (vertical 
direction). 
 
X-ray photospectroscopy (XPS) 
XPS measurements were performed using a non-monochromized VG-Escalab 200 spectrometer 
equipped with an aluminum anode (Al KR; 1486.6 eV) operating at 510 VA with a background pressure 
of 2 x 10-9 mbar. Spectra were acquired at 0° and 60° with respect to the surface normal, after the 
adsorption of 1, 3½, and 5 double-layers of [PDL/DNA] or [PAH/DNA] onto titanium-sputtered silicon 
substrates. As a reference, the spectrum of a dropcast (pure) DNA film was included. The (IP2p / IN1s) (ratio 
of integrated intensities) of the experimental substrates were used to calculate the fraction of DNA 
(ҳDNA) within the top (5 - 10 nm) of the measured sample, according to Formula 1: 
(1)   _1
2
1
2 

=
DNAsNI
pPI
DNAxsNI
pPI
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As the stoichiometric carbon/nitrogen ratios for DNA, PDL, and PAH are similar, no extra correction was 
necessary. 
 
Contact Angle measurements 
The progressive build-up of the multilayered DNA-coatings on quartz and titanium-sputtered silicon 
substrates was monitored using contact angle measurements on a Drop Shape Analysis System DSA10 
(Krüss GmbH, Hamburg, Germany). Four measurements per substrate were taken using the sessile drop 
method. All measurements were replicated in a separate second run. 
 
Fourier transform infrared spectroscopy (FTIR) 
Infrared spectra of the multilayered DNA-coatings on quartz substrates were obtained using Fourier 
transform infrared spectroscopy (Perkin Elmer Instruments, Bucks, England, UK). The infrared spectrum 
of DNA (as sodium salt) was obtained using the KBr-pellet method (0.4 % w/w DNA in KBr).  
 
Build-up of multilayered DNA-coatings with radiolabeled DNA 
The amount of DNA immobilized into the multilayered coatings was determined using radiolabeled 
DNA. In brief, DNA was radiolabeled using 32P-postlabeling through the T4-kinase enzyme. Non-bound 
label was removed via 2 successive filtrations using Sephadex®-50 columns. The efficiency of labeling 
was 34%. Radiolabeled DNA was added to an aqueous DNA solution with a final concentration of 1 
mg/ml. Concentrations of the aqueous solutions of the cationic polyelectrolytes were as described 
above. Multilayered coatings were fabricated as described above onto disc-shaped glass and titanium 
substrates. After the completion of 1, 2, 3, 4, and 5 double-layers, substrates were taken out of the 
fabrication process, immersed in scintillation fluid, and counted using a liquid scintillation counter. For 
comparison, samples containing 100 (l of the initial aqueous DNA solution (1 mg/ml) were counted. All 
experimental and control samples were present in 3-fold. 
 
Biological assessment 
Mutagenicity assay 
The mutagenicity of the chemicals used to build up the multilayered DNA-coatings was assessed using 
the Muta-ChromoplateTM basic kit (version 3.1; Environmental Biodetection Products Inc., Brampton, 
Ontario, Canada), according to the instructions of the manufacturer. This kit is based on the most 
generally used and validated bacterial reverse-mutation test, known as the ‘Ames Test’. Briefly, a 
mutant strain of Salmonella typhimurium (TA100), carrying a mutation in the operon coding for 
histidine biosynthesis, was exposed to 2 concentrations of the chemicals used for the build up of the 
multilayered DNA-coatings (DNA and PAH: 250 and 2500 µg/ml; PDL: 25 and 250 µg/ml). After an 
incubation period of five days at 37°C, the number of positive wells for each condition was recorded and 
scored against the results of the background (negative control). Sodium azide (NaN3; 5 µg/ml), a direct-
acting mutagen, was used as a positive control. 
 
Cell culture and seeding 
Biological experiments were performed using DNA-coatings generated on disc-shaped titanium 
substrates and non-coated titanium control substrates. All substrates were sterilized using a UV-
irradiation treatment (254 nm; 4 hrs). 
Rat dermal fibroblasts (RDF) were obtained from the ventral skin of male Wistar rats, using a standard 
procedure as described previously [25], after which cells were cryo-preserved. Before the initiation of an 
experiment, cells were thawed and cultured in culture medium (α-MEM (Gibco), supplemented with 
10% v/v fetal calf serum (FCS) and gentamicin (50 µg/ml)). All assays were performed with cells of the 
4th or 5th culture passage. Prior to the assays, cells were detached using trypsin/EDTA (0.25% w/v 
trypsin/0.02% EDTA) and concentrated by centrifugation at 1500 rpm for 5 min. Subsequently, cells 
were resuspended in culture medium and counted using a Coulter® counter (Beckman Coulter Inc., 
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Fullerton, CA, USA). For all in vitro assays, cells were seeded at 1 x 104 cells/cm2 into 24-well plates 
(Greiner Bio-One BV, Alphen aan de Rijn, the Netherlands). 
 
Cell proliferation 
At 1, 3, 7, and 10 days after seeding, the medium was aspirated and the cell layer was washed twice 
with PBS. Subsequently, substrates with attached cells were transferred into fresh wells and incubated 
with 0.5 ml trypsin/EDTA. After detachment of the cells, 0.5 ml culture medium was added. The cell 
suspension was diluted using Coulter® Isotone II diluent (Beckman Coulter Inc.) and cell numbers were 
counted using a Coulter® counter. The experiment was performed 3 times, with at each time point 3 
samples per condition (n=3). 
 
Cell viability 
Cell viability was assessed using a commercially available cytotoxicity assay, according to the 
instructions of the manufacturer (Promega Corporation, Madison, WI, USA). The test is based on the 
conversion of a tetrazolium salt ([3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide], MTT) 
into a formazan product. Briefly, at 3 days after cell seeding on the experimental substrates, 150 µl dye 
solution was added to each well, and cells were incubated at 37 °C for 4 hours. Subsequently, 1 ml of 
solubilization/stop solution was added to each well, and the cells were incubated for another hour (at 
room temperature). Finally, the contents of the wells were mixed thoroughly using a pipette and the 
absorbance at 570 nm wavelength was read using a spectrophotometer. Measured absorbance values 
were corrected for cell numbers using parallel samples, from which the cell number was determined 
using a Coulter® counter. Normalization of the data was performed to the results of the non-coated 
control substrates. 
 
Cell morphology 
To study cell morphology, cell cultured on the experimental substrates for 3 days were washed twice 
with PBS. Subsequently, cell fixation was carried out for 15 min. in 2% glutaraldehyde in 0.1 M sodium 
cacodylate buffered solution. Then, samples were rinsed twice with cacodylate buffered solution and 
dehydrated using a graded series of ethanol. Finally, samples were dried using with tetramethylsilane. 
The samples were sputter coated with gold, and examined using a JEOL 6310 SEM. 
 
Statistical analysis 
Statistical analyses were performed using GraphPad Instat, version 3.0 (GraphPad Software, San Diego, 
CA, USA). Statistical comparisons for RMS-values within one type of coating were performed using an 
ANOVA-test, combined with a post-hoc Tukey-Kramer Multiple Comparisons Test. Statistical 
comparisons between the two types of coatings were performed using an unpaired t-test. The results of 
the biological assays were analyzed using an unpaired t-test. 
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III RESULTS 
Characterization 
UV-Vis photospectrometry 
The build-up of multilayered DNA-coatings on quartz substrates via UV-Vis spectrophotometry could be 
easily monitored using the nucleic base chromophores in DNA (absorbance maximum at 260 nm). As 
illustrated in Figure 2 (A and B), both multilayered DNA-coatings showed an increase in UV-absorbance 
spectrum with every successively added double-layer. The UV-absorbance of [PDL/DNA] double-layers 
was higher compared to that of [PAH/DNA] double-layers. When peak values at 260 nm were plotted 
against the number of double-layers (Figures 3A and 3B), a linear increase with every added double-
layer became apparent for both types of coatings (Figures 3A en 3B). 
Atomic Force Microscopy 
The surface morphology of partial and complete multilayered DNA-coatings on titanium-sputtered 
silicon substrates was studied using AFM. The forces of the cantilever on the coatings during contact 
mode scanning were well below the threshold causing damage to the coatings, as evidenced by the 
absence of damage on AFM-images with increasing scan size. 
Figure 4 shows the AFM height images of (partial and complete) multilayered DNA-coatings of both 
[PDL/DNA] (Figure 4A-E) and [PAH/DNA] (Figure 4F-J) double-layers. For both types of coating, the AFM 
height images showed an optical increase in surface roughness. Further analysis of the surface 
roughness using RMS-values of both types of multilayered DNA-coatings showed significant increases 
with every step (i.e. 1½ double-layer) from [PDL/DNA]1/2 and [PAH/DNA]2 during the build-up of the 
coatings (Table 1). Furthermore, RMS-values of [PDL/DNA]-coatings were significantly lower than those 
of equivalent [PAH/DNA]-coatings after the deposition of 2 double-layers. 
 
Figure 2: UV-absorption spectra of (A) [PDL/DNA]-
multilayer coatings, and (B) [PAH/DNA]-multilayer 
coatings. The UV-absorption spectra were monitored 
using quartz substrates after the deposition of 0 (bl), 1 
(a), 2 (b), 3 (c), 4 (d), and 5 (e) double-layers. 
 
 
Figure 3: Plots of the absorbance at 260 nm (A260) against 
the number of (A) [PDL/DNA]-double-layers, and (B) 
[PAH/DNA]-double-layers. 
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TABLE 1: DETERMINATION OF SURFACE ROUGHNESS (RMS (IN NM)  ± STANDARD DEVIATION) 
*Asterisk indicates significantly increased surface roughness (p<0.05) compared to previous (partial) coating. 
 
Typical differences in surface morphology between the two types of coatings included the spatial 
distribution of elevations, as well as their average height. Whereas [PDL/DNA]5 showed a relatively 
homogenous morphological appearance with equally-spaced elevations of relatively low height 
(average 6 nm), [PAH/DNA]5 showed randomly-distributed elevations of relatively large height (average 
14 nm). To further illustrate these differences, 3D-image reconstructions of both complete multilayered 
DNA-coatings are presented in Figure 5. 
(Partial) coating [PDL/DNA] [PAH/DNA] 
Control (Titanium-sputtered silicon) 1.64 ± 0.03 1.64 ± 0.03 
[double-layer]½ 1.68 ± 0.27 1.99 ± 0.10 
[double-layer]2 2.40 ± 0.11* 1.96 ± 0.11 
[double-layer]3½ 3.16 ± 0.17* 4.58 ± 0.96* 
[double-layer]5 5.49 ± 0.57* 8.32 ± 1.70* 
Figure 4: AFM height images of several stages during the build-up of a [PDL/DNA]5 (A-E) and [PAH/DNA]5 multilayered 
coating on titanium-sputtered silicon substrates. Images were taken after the adsorption of 0 (A and F), ½ (B and G), 2 (C 
and H), 3½ (D and I), and 5 (E and J) double-layers. 
Figure 5: Three-dimensional images of the morphology 
of a [PDL/DNA]5 and [PAH/DNA]5 multilayered coating 
on titanium-sputtered silicon substrates. 
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X-ray photospectroscopy (XPS) 
The XPS spectra of DNA (dropcast) and 1, 3½ , and 5 double-layers of [PDL/DNA] or [PAH/DNA] on 
titanium-sputtered silicon substrates are presented in Figure 6. The XPS spectrum of DNA (dropcast) 
showed the presence of magnesium (Mg), probably as a cationic counter ion, whereas almost no 
sodium (Na) or potassium (K) peaks could be detected. Correspondingly, XPS spectra of DNA-terminated 
[PDL/DNA]-coatings showed the presence of Mg-peaks. However, DNA-terminated [PAH/DNA]-coatings 
did not show the presence of Mg-peaks, nor did coatings terminated with a cationic layer (PDL or PAH). 
Furthermore, a distinct difference was observed regarding the presence of titanium (Ti) peaks. Whereas 
partial and complete [PAH/DNA]-coatings showed the presence of Ti-peaks, equivalent [PDL/DNA]-
coatings did not. 
No angle dependency was observed regarding the phosphorus/nitrogen ratio (IP2p / IN1s) for the 
(dropcast) DNA film, as expected from a one-component film. Interestingly, (partial) [PDL/DNA]- and 
[PAH/DNA]-coatings also showed no angle dependency, implying a homogeneous distribution of DNA 
in the surface region of the coatings. 
The amount of DNA in the top (5 - 10 nm) of the multilayered coatings was calculated using Formula 1 
(see Materials & Methods section). Table 2 demonstrates that [PDL/DNA]-coatings display a higher DNA 
content in the DNA-terminated layers compared to [PAH/DNA]-coatings.  
 
Contact angle measurements 
Regardless of the substrate used (either quartz or titanium-sputtered silicon), the contact angles 
demonstrated to be higher after the adsorption of the positively-charged polymer (either PDL or PAH) 
than after the adsorption of the negatively-charged DNA (data not shown). When the build-up of both 
types of multilayered DNA-coatings progressed, the alternating behavior of the contact angles became 
more pronounced. 
 
Fourier transform infrared spectroscopy (FTIR)  
DNA exhibited its characteristic bands of base-pairs at 1602 cm-1 (adenine), 1650 cm-1 (thymine), 1684 
cm-1 (guanine), and 1481 cm-1 (cytosine) 25. For characterization, however, spectra with minimum 
wavelengths of 1250 cm-1 were used, since PDL and PAH do not have characteristic infrared spectral 
criterions below this wavelength. 
Infrared spectral criterions of the DNA double helical structure can be observed in the 1250 – 950 cm-1 
sugar-phosphate backbone vibration range (Figure 7; upper line). DNA showed its characteristic 
Figure 6: XPS spectra of dropcast DNA film and 
indicated number of double-layers for (A) [PDL/DNA] 
or (B) [PAH/DNA]. Scaling of the spectra is adjusted for 
constant integrated intensity of Phosphorus 2p 
emissions (not shown). 
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absorption bands at 1235, 1088, 1063, and 963 cm-1, which can be assigned to the antisymmetric 
stretching of the phosphate groups (νas 1235 cm-1) 26, the symmetric stretching vibrations of the 
phosphate groups (νs 1088 & 1063 cm-1) 18;19, and the CC stretching of the backbone (963 cm-1) 26, 
respectively. 
Both the [PDL/DNA]5 (Figure 7; middle line) and [PAH/DNA]5 (Figure 7; lower line) multilayered coatings 
showed the characteristic infrared absorption band at 1088 cm-1, corresponding with the νs band. 
Furthermore, a frequency shift of the νas absorption band is visible for [PDL/DNA]5 (1235 Æ 1213 cm-1) 
and for [PAH/DNA]5 (1235 Æ 1224 cm-1). 
DNA immobilization during the build-up of multilayered coatings 
The amount of DNA (µg/substrate) immobilized into the multilayered DNA-coatings was analyzed using 
radiolabeled DNA. In Figure 8, the progressive immobilization of DNA into multilayered DNA-coatings 
titanium is represented. Results of the DNA-immobilization into multilayered DNA-coatings on glass 
substrates were also performed (data not shown). Whereas on glass substrates the amount of DNA 
immobilized in the first double-layer is higher for [PDL/DNA]-coatings than for [PAH/DNA]-coatings (33 
vs. 20 µg/substrate, respectively), an equal amount of DNA (~20 µg/substrate) is immobilized into the 
first double-layer of both types of multilayered DNA-coatings on titanium substrates. After the 
generation of the first double-layer, both types of multilayered DNA-coatings immobilize a constant 
amount of DNA with each successively-adsorbed double-layer, irrespective of the substrate material (i.e. 
glass or titanium) onto which the multilayers are adsorbed. The amount of DNA immobilized into the 
multilayered DNA-coatings is approximately 9-10 µg DNA per double-layer (≈ 3 µg/cm2). 
 
 
 
Figure 7: FTIR-spectra of DNA (upper line), 
[PDL/DNA]5 (middle line), and [PAH/DNA]5 (bottom 
line). Both types of multilayered DNA-coatings were 
build-up on quartz substrates. 
Figure 8: Immobilization of DNA 
into each double-layer during the 
build-up of [PDL/DNA]5 and 
[PAH/DNA]5 coatings on titanium 
substrates. Measurements were 
performed using radiolabeled DNA. 
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Biological assessment 
Mutagenicity assay 
Incubation of a mutant strain of Salmonella typhimurium (TA100) in selected concentrations of DNA (250 
and 2500 µg/ml), PDL (25 and 250 µg/ml), or PAH (250 and 2500 µg/ml) did not show a significant 
increase in reverse-mutation (p>0.05; data not shown). Negative and positive controls showed a limited 
and an intensive increase in reverse-mutation, respectively. 
 
Cell proliferation and viability 
The results of a representative cell proliferation assay are presented in Figure 9. Compared to non-
coated control substrates, significantly higher cell numbers (p<0.05) were observed at almost every 
assayed time point on both types of multilayered DNA-coatings. No differences in cell proliferation 
between the two types of multilayered DNA-coatings were observed. 
To assess potential effects of multilayered DNA-coatings on cell viability, the mitochondrial redox 
activity was assessed using a MTT-based assay. Neither of the two types of multilayered DNA-coatings 
significantly decreased mitochondrial redox activity of RDF cells after 3 days of culture (data not shown).  
 
Cell morphology 
The morphological appearance of the primary fibroblast cells, cultured on both types of multilayered 
DNA-coatings and non-coated titanium controls, was evaluated using scanning electron microscopy. 
Figure 10 presents representative images of these cells after a 3-day culture period. Although the native 
roughness of the as-machined titanium substrates does not allow a clear observation of completely 
spread cells, it becomes apparent from slightly elevated cells that both types of multilayered DNA-
coatings do not alter the morphological appearance of the cells compared to non-coated titanium 
controls. In general, all cells had a typical fibroblast appearance with several (short) cellular extensions. 
Figure 9: Proliferation of RDF cells on non-
coated titanium controls, [PDL/DNA]5-, and 
[PAH/DNA]5-coated titanium substrates. 
Results are shown as mean ± SD. Asterisks 
indicate significant difference compared to 
non-coated control (p<0.05). 
 
Figure 10: SEM images showing the morphology of RDF cells on (A) non-coated titanium controls, (B) [PDL/DNA]5-, and (C) 
[PAH/DNA]5-coated titanium substrates after 3 days of cell culture. Note the presence of multiple cellular extensions 
(arrowheads) of the fibroblasts on all types of substrates. 
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IV DISCUSSION 
The aim of this study was to fabricate and characterize multilayered DNA-coatings, generated via the 
ESA-technique. The choice of DNA as the anionic building block relates to the structural properties of 
the DNA-molecule and their potential beneficial effects in implantology rather than to the encoded 
genetic information. As the cationic building blocks, either PDL or PAH was used. 
Many researchers utilize a polyelectrolyte, which under neutral acidity is extremely charged (e.g. 
poly(ethyleneimine), PEI; or poly(styrenesulfonate), PSS) as the primary layer(s) onto the substrate of 
desire 15;19;20;22;27-31. This is done to achieve optimal coverage of the oppositely-charged substrate. 
However, other researchers do not indicate this necessity 17;32-35. To avoid potential detrimental effects 
of PEI on cellular behavior 27, and because the build-up of PEMs is well-acceptable without using 
extremely-charged polyelectrolytes as a primary layer, the use of polyelectrolytes for our two types of 
multilayered DNA-coatings was limited to the functional anionic polyelectrolyte DNA, and one specific 
cationic polyelectrolyte (either PDL or PAH). 
The build-up of multilayered DNA-coatings has been demonstrated to be dependent on the type of 
cationic polyelectrolyte used. Linear build-up regimes have been demonstrated for PAH-containing 
coatings 14;21;36, whereas exponential build-up regimes were found for PLL-containing coatings 35;37. 
Although the driving force for both growth regimes is essentially similar (i.e. the charge 
overcompensation with each deposited polyionic layer), the diffusive behavior of PLL throughout the 
coatings allows an exponential build-up, proportional to the amount of PLL that diffuses out of the 
coating during immersion in a polyanionic solution 37;38. However, based on both the UV-
spectrophotometry results and the results of the immobilization of radiolabeled DNA in our study, we 
conclude that the build-up regime for both our [PDL/DNA]5 and [PAH/DNA]5 coatings is linear, with 
typical incremental increases with each successively adsorbed double-layer of approximately 10 µg 
DNA on titanium substrates, respectively. Interestingly, a substrate-dependent difference in the amount 
of DNA immobilized in the first double-layer was found for multilayered DNA-coatings. Probably, these 
differences relate to the amount of cationic polyelectrolyte adsorbed in the primary adsorption layer 
and the inherent specific affinity of the used cationic polyelectrolytes for each type of substrate.  
The structure of the DNA after immobilization into either the [PDL/DNA]5 or [PAH/DNA]5 coating 
remains unclear. The shift of the νas band from 1235 to 1213 cm-1 for [PDL/DNA]5 coatings and from 
1235 to 1224 cm-1 for [PAH/DNA]-coatings may reflect a change in the conformation from A to Z-form 
and from A to B-form, respectively 26. Shifts of the νas band after complexation of DNA with cationic 
polyelectrolytes or ions have been observed frequently 18;19;39, and are explained by the interaction of 
the anionic phosphate groups of the DNA-molecules with cationic counterparts. Additionally, the 
relative humidity of multilayered DNA-coatings is an important factor determining the precise location 
of characteristic bands 19. Nevertheless, the results of the FTIR spectroscopy clearly indicate the presence 
of double-helical DNA within both types of multilayered DNA-coating, as evidenced by the presence of 
the characteristic absorption band at 1088 cm-1 19. The biological relevance of DNA structure in the 
coatings remains to be determined. 
AFM images of both types of multilayered DNA-coatings clearly demonstrate a nanoscale roughness for 
both [PDL/DNA]5 and [PAH/DNA]5. The difference in RMS-roughness calculation between equal 
numbers of  [PDL/DNA]- and [PAH/DNA]-double-layers most probably also relates to the adsorption of 
the first cationic polyelectrolyte layer. The more homogenous [PDL/DNA]5-coating (RMS = 5.49 nm) 
reflects a uniform adsorption of the primary PDL-layer, whereas for the [PAH/DNA]5-coating (RMS = 8.32 
nm) randomly-distributed elevations suggest a heterogeneous adsorption of the primary PAH-layer. 
This is further evidenced by the results of the contact angle measurements, which show a more 
pronounced alternating behavior after the adsorption of several double-layers. 
XPS-data corroborate with the results of the AFM-measurements. The build-up of [PDL/DNA]-coatings is 
more homogeneously than that of [PAH/DNA]-coatings, reflected by the presence of Ti-peaks and the 
absence of Mg-peaks in the latter coatings. A less homogeneous DNA incorporation and/or an irregular 
build-up regime of the multilayer structure for [PAH/DNA]-coatings might explain these results. 
II Fabrication, Characterization, and Biological Assessment of Multilayered DNA-coatings for Biomaterial Purposes 
 39
Additionally, the absence of Mg-peaks in the DNA-terminated [PAH/DNA]-coatings might be an 
indication that in this case all counter ions of the DNA are exchanged by the positively-charged PAH-
component, resulting in a decreased three-dimensional structure of the DNA-molecules. Hence, Ti-
peaks might be present in [PAH/DNA]-coatings due to the limited thickness of these coatings. The 
absence of angle-dependent differences in the P/N-ratios for both types of coatings indicates a 
homogeneous distribution of the molecules in the top (5 - 10 nm) of the coatings. Therefore, the layers 
can be regarded as not completely separated, but partly mixed. This mixed character of PEMs has been 
described previously 14. 
The mutagenicity assay demonstrated that the materials used to generate both types of multilayered 
DNA-coatings are non-mutagenic. Further biological assessment revealed that fibroblast cell 
proliferation was increased on both types of multilayered DNA-coatings compared to non-coated 
titanium controls. Although the reason remains unclear, the increased surface roughness 40-43 or an 
altered protein adsorption profile on both types of multilayered DNA-coatings might affect fibroblast 
cell proliferation. Nevertheless, we attribute the elevated cell growth to the presence of a multilayered 
DNA-coating, and not for instance to DNA release from the layers. In view of the studies performed by 
Kitamura et al. 44, who demonstrated that the addition of DNA to the culture medium significantly 
decreases the proliferation of fibroblast cells, this furthermore indicates the stability of the multilayered 
DNA-coatings. The metabolic activity of the fibroblast cells cultured on both types of multilayered DNA-
coatings was not affected, indicating that both types of multilayered DNA-coatings are cytocompatible.  
 
CONCLUSION 
In conclusion, this study demonstrates the feasibility of the ESA-technique to fabricate multilayered 
DNA-coatings. UV-vis spectrophotometry, AFM, and contact angle measurements clearly indicated the 
progressive build-up of both [PDL/DNA]- and [PAH/DNA]-multilayers. Furthermore, AFM and XPS data 
showed a more uniform build-up and morphology of [PDL/DNA]-coatings compared to [PAH/DNA]-
coatings. The DNA-immobilization into both types of multilayered DNA-coatings was linear, and 
approximated 3 µg/cm2 into each double-layer, irrespective of cationic polyelectrolyte and substrate 
material. The surface morphology of both types of multilayered DNA-coatings showed elevations in the 
nanoscale range. Biological assessment demonstrated an increased proliferation of primary fibroblasts 
on both types of multilayered DNA-coatings compared to non-coated titanium controls. Cell viability 
and morphology were unaffected by the presence of either type of multilayered DNA-coating. Further 
biocompatibility and functionalization of the coatings produced here, will be assessed in subsequent 
cell culture and animal-implantation studies. 
 
V ACKNOWLEDGEMENTS 
We thank Dr. Bas Feddes (Dept. Peridodontology & Biomaterials, UMC St Radboud, Nijmegen) and Dr. 
Gerald Verhaegh for their help with the AFM analyses and the radiolabeled DNA-experiments, 
respectively. AFM imaging was performed in collaboration with the Microscopical Imaging Center of the 
Nijmegen Center for Molecular Life Sciences (NCMLS). Mr. Maichel van Riel (Control Laboratory, Central 
Animal Facility, Radboud University Nijmegen Medical Centre) is acknowledged for his assistance with 
performing the mutagenicity assay. This study was financially supported by the Dutch Technology 
Foundation STW, grant # NKG.5758. 
 
 
II Fabrication, Characterization, and Biological Assessment of Mulitlayered DNA-coatings for Biomaterial Purposes 
 40
VI REFERENCES 
 
 1.  Kasemo, B. and J. Gold. 1999. Implant surfaces and interface processes. Adv Dent Res 13:8-20. 
 2.  Castner D.G.  and Ratner B.D. 2002. Biomedical surface science: Foundations to frontiers. Surf Sci 500:28-60. 
 3.  Krieg, A. M. 2000. Immune effects and mechanisms of action of CpG motifs. Vaccine 19:618-22. 
 4.  Stryer, L. 1995. Biochemistry. W.H. Freeman and Company, New York, USA. 
 5.  Krieg, A. M., A. K. Yi, S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. A. Koretzky, and D. M. Klinman. 1995. 
CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546-9. 
 6.  McMichael, A. J. 1992. Antigens and MHC systems. In Oxford textbook of pathology. J. O. D. McGee, P. G. Isaacson, and 
N. A. Wright, eds. Oxford University Press, Oxford, UK. 
 7.  Werner, M. H. , A. M. Gronenborn, and G. M. Clore. 1996. Intercalation, DNA kinking, and the control of transcription. 
Science 271:778-84. 
 8.  Wilson, W. D.  1996. Reversible interactions of nucleic acids with small molecules. In Nucleic acids in chemistry and 
biology. G. M. Blackburn and M. J. Gait, eds. Oxford University Press, Oxford, UK. 
 9.  Tretinnikov, O. N., K. Kato, and Y. Ikada. 1994. In vitro hydroxyapatite deposition onto a film surface-grated with 
organophosphate polymer . J Biomed Mater Res 28:1365-73. 
 10.  Kamei, S., N. Tomita, S. Tamai, K. Kato, and Y. Ikada. 1997. Histologic and mechanical evaluation for bone bonding of 
polymer surfaces grafted with a phosphate-containing polymer. J Biomed Mater Res 37:384-93. 
 11.  Yamada, M., K. Kato, M. Nomizu, N. Sakairi, K. Ohkawa, H. Yamamoto, and N. Nishi. 2002. Preparation and 
characterization of DNA films induced by UV irradiation. Chemistry 8:1407-12. 
 12.  Inoue, Y., T. Fukushima, T. Hayakawa, H. Takeuchi, H. Kaminishi, K. Miyazaki, and Y. Okahata. 2003. Antibacterial 
characteristics of newly developed amphiphilic lipids and DNA-lipid complexes against bacteria. J Biomed Mater Res 
65A:203-8. 
 13.  Fukushima, T., Y. Inoue, T. Hayakawa, K. Taniguchi, K. Miyazaki, and Y. Okahata. 2001. Preparation of and tissue 
response to DNA-lipid films. J Dent Res 80:1772-6. 
 14.  Decher G. Fuzzy Nanoassemblies: Toward Layered Polymeric Multicomposites. Science 277, 1232-1237. 97.  
 15.  Pei, R., X. Cui, X. Yang, and E. Wang. 2001. Assembly of alternating polycation and DNA multilayer films by 
electrostatic layer-by-layer adsorption. Biomacromolecules 2:463-8. 
 16.  Sastry, M., M. Rao, and K. N. Ganesh. 2002. Electrostatic assembly of nanoparticles and biomacromolecules. Acc Chem 
Res 35:847-55. 
 17.  Luo, L., J. Liu, Z. Wang, X. Yang, S. Dong, and E. Wang. 2001. Fabrication of layer-by-layer deposited multilayer films 
containing DNA and its interaction with methyl green. Biophys Chem 94:11-22. 
 18.  Zhou, Y. and Y. Li. 2004. Studies of interaction between poly(allylamine hydrochloride) and double helix DNA by 
spectral methods. Biophys Chem 107:273-81. 
 19.  Sukhorukov, G. B., M. M. Montrel, A. I. Petrov, L. I. Shabarchina, and B. I. Sukhorukov. 1996. Multilayer films containing 
immobilized nucleic acids. Their structure and possibilities in biosensor applications. Biosens Bioelectron 11:913-22. 
 20.  Sukhorukov G.B. , Mohwald H. , Decher G. , and Lvov Y.M. Assembly of polyelectrolyte multilayer films by 
consecutively alternating adsorption of polynucleotides and polycations. Thin Solid Films 284-285, 220-223. 96.  
 21.  Lvov Y. , Decher G. , and Sukhorukov G. Assembly of thin films by means of successive deposition of alternate layers of 
DNA and Poly(allylamine). Macromolecules 26, 5396-5399. 93.  
 22.  Chen X. , Lang J. , and Liu M. Layer-by-layer assembly of DNA-dye complex films. Thin Solid Films 409, 227-232. 2002.  
 23.  Hill, I. R., M. C. Garnett, F. Bignotti, and S. S. Davis. 2001. Determination of protection from serum nuclease activity by 
II Fabrication, Characterization, and Biological Assessment of Multilayered DNA-coatings for Biomaterial Purposes 
 41
DNA-polyelectrolyte complexes using an electrophoretic method. Anal Biochem 291:62-8. 
 24.  Schonhoff M. Layered polyelectrolyte complexes: physics of formation and molecular properties. J Phys: Condens 
Matter 15, R1781-R1808. 2003.  
 25.  Liu, W., Sun, S., Cao, Z., Zhang, X., Yao, K., Lu, W. W., and Luk, K. D. K. An investigation on the physicochemical 
properties of chitosan/DNA polyelectrolyte complexes. Biomaterials .  
 26.  Banyay, M., Sarkar, M., and Graslund, A. A library of IR bands of nucleic acids in solution. Biophys Chem 104(2), 477-
488. 2003.  
 27.  Tryoen-Toth, P., D. Vautier, Y. Haikel, J. C. Voegel, P. Schaaf, J. Chluba, and J. Ogier. 2002. Viability, adhesion, and bone 
phenotype of osteoblast-like cells on polyelectrolyte multilayer films. J Biomed Mater Res 60:657-67. 
 28.  Serrano, M. C., R. Pagani, M. Vallet-Regi, J. Pena, A. Ramila, I. Izquierdo, and M. T. Portoles. 2004. In vitro 
biocompatibility assessment of poly(epsilon-caprolactone) films using L929 mouse fibroblasts. Biomaterials 25:5603-
11. 
 29.  Zhu, H., J. Ji, and J. Shen. 2004. Construction of multilayer coating onto poly-(DL-lactide) to promote 
cytocompatibility. Biomaterials 25:109-17. 
 30.  Boura, C., P. Menu, E. Payan, C. Picart, J. C. Voegel, S. Muller, and J. F. Stoltz. 2003. Endothelial cells grown on thin 
polyelectrolyte mutlilayered films: an evaluation of a new versatile surface modification. Biomaterials 24:3521-30. 
 31.  Tedeschi, C., H. Mohwald, and S. Kirstein. 2001. Polarity of layer-by-layer deposited polyelectrolyte films as 
determined by pyrene fluorescence. J Am Chem Soc 123:954-60. 
 32.  Richert, L., F. Boulmedais, P. Lavalle, J. Mutterer, E. Ferreux, G. Decher, P. Schaaf, J. C. Voegel, and C. Picart. 2004. 
Improvement of stability and cell adhesion properties of polyelectrolyte multilayer films by chemical cross-linking. 
Biomacromolecules 5:284-94. 
 33.  Richert, L., P. Lavalle, D. Vautier, B. Senger, J. F. Stoltz, P. Schaaf, J. C. Voegel, and C. Picart. 2002. Cell interactions with 
polyelectrolyte multilayer films. Biomacromolecules 3:1170-8. 
 34.  Shi, X., Sanedrin, R. J., and Zhou, F. Structural characterization of multilayered DNA and polylysine composite films: 
influence of ionic strength of DNA solutions on the extent of DNA incorporation. J Phys Chem B 106, 1173-1180. 2002.  
 35.  Picart, C., Lavalle, Ph., Hubert, P., Cuisinier, F. J. G., Decher, G., Schaaf, P., and Voegel, J.-C. Buildup mechanism for 
poly(L-lysine)/Hyaluronic acid films onto a solid surface. Langmuir 17, 7414-7424. 2001.  
 36.  Decher, G., Hong, J. D., and Schmitt, J. Buildup of ultrathin multilayer films by a self-assembly process: III. 
Consecutively alternating adsorption of anionic an cationic polyelectrolytes on charged surfaces. Thin Solid Films 210-
211, 831-835. 92.  
 37.  Picart, C., J. Mutterer, L. Richert, Y. Luo, G. D. Prestwich, P. Schaaf, J. C. Voegel, and P. Lavalle. 2002. Molecular basis for 
the explanation of the exponential growth of polyelectrolyte multilayers. Proc Natl Acad Sci U S A 99:12531-5. 
 38.  Mendez Garza, J., Schaaf, P., Muller, S., Ball, V., Stoltz, J-F., Voegel, J-C., and Lavalle, P. Multicompartment Films Made 
of Alternate Polyelectrolyte Multilayers of Exponential and Linear Growth. Langmuir 20, 7298-7302. 2004.  
 39.  Zhou, Y. and Li, Y. Layer-by-Layer Self-Assembly of Multilayer Films Containing DNA and Eu3+: Their Characteristics 
and Interactions with Small Molecules. Langmuir 20, 7208-7214. 2004.  
 40.  Flemming, R. G., C. J. Murphy, G. A. Abrams, S. L. Goodman, and P. F. Nealey. 1999. Effects of synthetic micro- and 
nano-structured surfaces on cell behavior. Biomaterials 20:573-88. 
 41.  Thapa, A., D. C. Miller, T. J. Webster, and K. M. Haberstroh. 2003. Nano-structured polymers enhance bladder smooth 
muscle cell function. Biomaterials 24:2915-26. 
 42.  Zhang, R. and P. X. Ma. 2000. Synthetic nano-fibrillar extracellular matrices with predesigned macroporous 
architectures. J Biomed Mater Res 52:430-8. 
 43.  Teixeira, A. I., G. A. Abrams, P. J. Bertics, C. J. Murphy, and P. F. Nealey. 2003. Epithelial contact guidance on well-
defined micro- and nanostructured substrates. J Cell Sci 116:1881-92. 
 
II Fabrication, Characterization, and Biological Assessment of Mulitlayered DNA-coatings for Biomaterial Purposes 
 42
 44.  Kitamura, H., N. Takemoto, M. Mizuno, Y. Kuboki, N. Sakairi, and N. Nishi. 1997. Suppression for the proliferation of 
fibroblasts by external DNA. Int J Biol Macromol 21:337-40. 
 
III Cyto- and Histocompatibility of Multilayered DNA-coatings on Titanium 
 43
 
 
 
 
 
 
 
3 
 
CYTO- AND HISTOCOMPATIBILITY  
OF 
MULTILAYERED DNA-COATINGS ON TITANIUM 
 
 
JJJP van den Beucken, XF Walboomers, MRJ Vos, NAJM Sommerdijk, RJM Nolte, JA Jansen 
 
J Biomed Mater Res 77A (2006);202 – 211 
 
 
III Cyto- and Histocompatibility of Multilayered DNA-coatings on Titanium 
 44
I INTRODUCTION 
The control over cellular and tissue interactions with biomaterial surfaces is gaining importance. 
Currently, we observe an increase in the use of implants and prostheses. Moreover, the implants are 
placed more frequently in ageing patients suffering from all kinds of health problems, including 
metabolic disorders, vascular diseases, and diabetes. A frequently observed side-effect of such 
conditions is the interference with the healing response around implants 1. Additionally, age-related 
delayed wound healing in senile recipients of implants might aggravate wound healing responses 
around implants 2. Therefore, implant surfaces that evoke a controlled cellular and tissue response gain 
importance. 
Titanium and its alloys are widely applied materials for the generation of implants. Especially for 
orthopedic and dental applications 3;4, titanium (or its alloys) is the material of choice due to its 
biomechanical properties. Also for soft tissue implants, titanium is used for the production of 
pacemakers and the anchorage of percutaneous devices 5;6. 
A recently introduced idea to improve implant performance is the use of deoxyribonucleic acid (DNA) to 
coat implants. Due to the homogeneity of this molecule in vertebrate species, DNA can be regarded as 
non- or low immunogenic 7-9. Furthermore, its capacity to incorporate other substances (e.g. cytokines, 
growth factors, and antibiotics) turns DNA into a potential drug-delivery vehicle. Finally, the high 
phosphate content in the DNA backbone might facilitate the deposition of calciumphosphates 10;11. 
Together, these properties give DNA high potential as a versatile implant coating material that (a) 
reduces adverse immunological responses, (b) allows functionalization with desired substances and 
subsequent modulation of tissue responses, and (c) is applicable in both soft and hard tissues. 
Recently, the fabrication and characterization of multilayered DNA-coatings for biomaterial purposes 
was reported 12. These coatings were fabricated using the so-called  electrostatic self-assembly (ESA) 
technique 13, which allows the build-up of a layered coating via the alternate adsorption of cationic 
polyelectrolytes (poly-D-lysine, PDL; poly(allylamine) hydrochloride, PAH) and anionic DNA. The 
fabricated multilayered DNA-coatings, consisting of 5 double-layers, were shown to have a nano-rough 
surface morphology and incorporated approximately 15 µg DNA/cm2. Additionally, an Ames test-based 
assay demonstrated that the materials used to build up the multilayered DNA-coatings were non-
mutagenic.  
In view of the proposed beneficial properties of DNA, a first step towards the use of DNA as an implant 
coating material is to evaluate cell and tissue responses to non-functionalized, multilayered DNA-
coatings. Therefore, the aim of this study was to evaluate the cyto- and histocompatibility of non-
functionalized multilayered DNA-coatings on titanium. First, in vitro assays with primary fibroblasts 
were used to study cell proliferation and viability. Secondly, the soft tissue reaction to multilayered 
DNA-coatings was assessed when implanted subcutaneously in rats. 
  
II MATERIALS & METHODS 
Materials 
Polyanionic DNA (± 300 bp/molecule; sodium salt) was kindly provided by Nichiro Corporation 
(Kawasaki-shi, Kanagawa prefecture, Japan). Potential protein impurities in the DNA were checked 
using the BCA protein assay (Pierce, Rockford, Illinois, USA) and measured to be below 0.20% w/w (data 
not shown). Polycationic polyelectrolytes poly(allylamine hydrochloride) (PAH; MW ~70000) and poly-
D-lysine (PDL; MW 30000 – 70000) were purchased from Sigma (Sigma-Aldrich Chemie B.V., 
Zwijndrecht, the Netherlands). All materials were used without further purification. 
 
Substrate preparation and cleaning 
Titanium substrates were used for the build-up of multilayered DNA-coatings. For the in vitro-
experiments, disc-shaped titanium substrates (12 mm diameter; commercially-pure titanium, as-
machined) were used. For the in vivo-experiments, we used cylindrical titanium substrates (14 mm 
height, 4 mm diameter; commercially-pure titanium, as-machined). The surface roughness (Ra) of the 
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as-machined titanium was 0.3 µm, as determined using a universal surface tester (UST; Innowep, 
Wurzburg, Germany). Titanium substrates were cleaned ultrasonically using consecutively nitric acid 
(10% v/v), acetone, and isopropanol. Between each cleaning step, the substrates were rinsed with ultra-
pure water. After the last cleaning step, the substrates were dried to air. After cleaning, prepared 
substrates were either directly sterilized (to serve as non-coated controls) or processed for DNA-coating. 
 
Generation of multilayered DNA-coatings 
Multilayered DNA-coatings were generated using the ESA technique, as described by Van den Beucken 
et al. 12. Briefly, the cleaned substrates were immersed in an aqueous solution of either PDL (0.1 mg/ml) 
or PAH (1 mg/ml) for 30 minutes, allowing sufficient time for the adsorption of the first cationic 
polyelectrolyte layer onto the substrates. Subsequently, the substrates were washed in ultra-pure water 
(5 minutes, continuous water flow) and dried using a pressurized air stream. Thereafter, the substrates 
were alternately immersed in an anionic aqueous DNA solution (1 mg/ml) and the respective cationic 
polyelectrolyte solution for 7 minutes each, with intermediate washing in ultra-pure water (5 minutes, 
continuous water flow) and drying using a pressurized air stream. The build-up of the multilayered 
DNA-coatings was continued until a total of 5 double-layers were reached. These were designated 
either [PDL/DNA]5 or [PAH/DNA]5 (the number indicates the number of double-layers). 
 
Substrate sterilization 
All substrates, coated with either type of multilayered DNA-coating or non-coated control substrates, 
were sterilized using a UV-irradiation treatment (254 nm; 4 hrs). 
 
In vitro experiments 
Cell culture and seeding 
Rat dermal fibroblasts (RDF) were obtained from the ventral skin of male Wistar rats, using a standard 
procedure as described previously 14, after which cells were cryo-preserved. Before the initiation of an 
experiment, cells were thawed and cultured in culture medium (α-MEM (Gibco), supplemented with 
10% (v/v) fetal calf serum (FCS) and gentamycin (50 µg/ml)). All assays were performed with cells of the 
4th or 5th culture passage. 
Prior to the assays, cells were detached using trypsin/EDTA (0.25% w/v trypsin/0.02% EDTA) and 
concentrated by centrifugation at 1500 rpm for 5 min. Subsequently, cells were resuspended in culture 
medium and counted using a Coulter® counter (Beckman Coulter Inc., Fullerton, CA, USA). For all in vitro 
assays, cells were seeded at 1 x 104 cells/substrate into 24 well plates (Greiner Bio-One BV, Alphen aan 
de Rijn, the Netherlands). 
 
Live/dead assay 
To further study cell viability and cytotoxicity, cells cultured on the experimental substrates for 3 days 
were conducted in a Live/Dead® assay (Molecular Probes, Inc., Eugene, OR, USA), according to the 
instructions of the manufacturer. Briefly, cells were washed twice with PBS. Subsequently, cells were 
incubated in appropriate amounts of fluorescent dye for 45 min. at 37°C. Then, cells were rinsed twice 
with PBS and visualized using a fluorescence microscope (Leica Microsystems AG, Wetzlar, Germany), 
equipped with a digital camera. 
 
Cell viability 
Cell viability was assessed using a commercially available cytotoxicity assay, according to the 
instructions of the manufacturer (Promega Corporation, Madison, WI, USA). The test is based on the 
conversion of a tetrazolium salt ([3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide], MTT) 
into a formazan product. Briefly, at 3 days after cell seeding on the experimental substrates (3 substrates 
per condition; n=3), 150 µl dye solution was added to each well, and cells were incubated at 37 °C for 4 
hours. Subsequently, 1 ml of solubilization/stop solution was added to each well, and cells were 
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incubated for another hour (at room temperature). Finally, the contents of the wells were mixed 
thoroughly using a pipette and the absorbance at 570 nm wavelength was read using a 
spectrophotometer. Measured absorbance values were corrected for cell numbers, using parallel 
samples, from which the cell number was determined using a Coulter® Counter. Normalization of the 
data was performed to the results of the non-coated control substrates. 
 
Cell proliferation 
At 1, 3, 7, and 10 days after seeding, the medium was aspirated and the cell layer was washed twice 
with PBS. Subsequently, substrates with attached cells were transferred into fresh wells and incubated 
with 0.5 ml trypsin/EDTA. After detachment of the cells, 0.5 ml culture medium was added. The cell 
suspension was diluted using Coulter® Isotone II diluent (Beckman Coulter Inc., Fullerton, CA, USA) and 
cell numbers were counted using a Coulter® counter. A total of 3 independent runs were performed, in 
which at each time point, 3 substrates per condition were used (n=3). 
 
In vivo experiment 
Animals and implantation procedure 
For implantation, male Wistar rats of 200-250 grams were used. The animals were housed in the central 
animal facility at the Radboud University Nijmegen Medical Center (Nijmegen, the Netherlands), 
observing all national guidelines for care and use of laboratory animals. The animals received chow and 
water ad libitum. Prior to the implantation procedure, approval was acquired from the Ethical 
Committee for animal experiments at the Radboud University Nijmegen. 
The implantation procedure was performed under general anesthesia of O2, N2O, and isoflurane. The 
dorsal skin was shaved and disinfected using iodine. On each side of the vertebral column, paravertebral 
incisions of approximately 10 mm were made. Lateral to these incisions, subcutaneous pockets were 
created by blunt dissection with scissors. After insertion of the implants, the wounds were closed using 
skin staples (Agraves®, InstruVet C.V., Cuijk, the Netherlands). A total of 48 implants (16 non-coated 
controls, 16 [PDL/DNA]5, and 16 [PAH/DNA]5) were distributed over 24 animals (2 implants per animal) 
according to a Latin Square randomization scheme. 
 
Implant retrieval and histological preparations 
After each implantation period (either 4 or 12 weeks), tissue-covered titanium implants were retrieved. 
The specimens were fixed in 4% buffered paraformaldehyde for 20 hours. Subsequently, the specimens 
were divided in two groups. In the first group, the implants were removed from the tissue capsule 
through an apical incision using tweezers. The separated tissue capsules were embedded in paraffin, 
after which 6 µm sections were cut in a transversal direction using a Leica RM 2165 Microtome (Leica 
Microsystems, Rijswijk, the Netherlands). The sections were cut from at least  three arbitrary regions 
perpendicular to the long axis of the tissue capsule (paraffin sections). Paraffin sections were stained 
with haematoxylin/eosin. To detect potential tissue remains on the implant surface, the implants were 
dehydrated in a graded series of ethanol, air dried, sputter-coated with gold, and investigated by SEM 
directly afterwards excision. 
In the second group, the specimens (implants including surrounding tissues) were dehydrated in 
ethanol, and embedded in methylmethacrylate (MMA). After polymerization, thin transversal sections 
(10 µm thickness) were prepared with a modified diamond blade sawing microtome technique 15(MMA-
sections). The MMA-sections were stained with methylene blue and basic fuchsin. 
 
Immunohistochemistry 
For the detection of myofibroblasts, also immunohistochemistry was performed on the paraffin-
embedded sections for α-smooth muscle actin (α-SMA). Deparaffinated sections were treated with 3% 
H2O2 in PBS for 20 minutes to block endogenous peroxidase and rinsed in PBS at room temperature. 
Subsequently, the tissue sections were fixed with 4% Formalin and blocked with 5% BSA (Sigma) in PBS. 
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Then, tissue sections were incubated with monoclonal IgG2a mouse anti α-SMA (Sigma), 1:1600 for 1 
hour. After washing with PBS, the tissue sections were incubated with biotinylated donkey anti-mouse 
secondary antibody (Jackson Laboratories, West Grove, PA), 1:500 for 1 hour. After another washing 
step with PBS, staining was performed with a biotin-streptavidin detection system (Vectra elite kit; 
Vector Laboratories, Burlingame, CA) for 45 minutes. Positive controls (blood vessel walls) and negative 
controls (1% BSA in PBS) were included. 
 
TABLE 1: HISTOLOGICAL GRADING SCALE FOR CAPSULE QUALITY 
Histological capsule quality score 
Capsule tissue is fibrous, not dense, resembling connective or fat tissue in the non-injured regions 4 
Capsule tissue is fibrous but immature, showing fibroblasts and little collagen 3 
Capsule tissue is granulous and dense, containing both fibroblasts and many inflammatory cells 2 
Capsule tissue consists of masses of inflammatory cells with little or no signs of connective tissue organization 1 
Cannot be evaluated because of infection or other factors not necessarily related to the material 0 
TABLE 2: HISTOLOGICAL GRADING SCALE FOR CAPSULE THICKNESS 
Histological capsule thickness score 
1 – 4 fibroblasts 4 
5 – 9 fibroblasts 3 
10 – 30 fibroblasts 2 
> 30 fibroblasts 1 
Not applicable 0 
 
Histological evaluation 
Histological evaluation on all sections was performed using a light microscope (Leica Microsystems AG, 
Wetzlar, Germany). For the analyses of haematoxylin/eosin stained sections (paraffin excluding 
implants), a refined histomorphometric grading scale was used (Tables 1 & 2) 16. Three observers 
independently scored a total of 3 paraffin sections per retrieved specimen. 
 
Statistical analysis 
Statistical analysis on the data of the in vitro experiments was performed using a one-way ANOVA and a 
post-hoc Tukey’s Studentized Range Test. The histomorphometrical data of the in vivo experiment were 
processed in a two-way ANOVA and a post-hoc Tukey’s Studentized Range Test. Data shown represent 
means ± SD. Calculations were performed in GraphPad Instat, Version 3.05 (GraphPad Software, San 
Diego, CA, USA). 
 
III RESULTS 
In vitro experiments 
Live/Dead assay 
Generally, the primary RDF cells, cultured on both types of multilayered DNA-coatings and non-coated 
controls, demonstrated high numbers of live (green) cells and hardly any dead (red) cells were observed 
(Figure 1). No apparent difference in the number of dead (red) cells was observed between non-coated 
control samples and either type of multilayered DNA-coatings. On the other hand, an apparent higher 
number of live (green) cells were observed on both types of multilayered DNA-coatings compared to 
non-coated control samples. 
 
Cell viability 
To assess potential effects of multilayered DNA-coatings on cell viability, the mitochondrial activity was 
measured using a MTT-based assay. The capacity of the mitochondrial enzyme succinate 
dehydrogenase to reduce MTT is a measure to evaluate the metabolic activity of cells, as this enzyme is 
centrally involved in both oxidative phosphorylation and the tricarboxylic acid cycle 17. In Figure 2, the 
normalized results of the MTT-based assay after 3 days of cell culture are presented, in which the 
normalized values are corrected for cell number. Neither type of multilayered DNA-coatings decreased 
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mitochondrial redox activity of RDF cells (after 3 days of culture) compared to non-coated controls 
(p>0.05). 
 
Cell proliferation 
The results of a representative proliferation experiment are presented in Figure 3. Proliferation of 
primary rat dermal fibroblasts (RDFs) was monitored on non-coated controls, [PDL/DNA]5-coated, and 
[PAH/DNA]5-coated titanium substrates. Compared to non-coated control titanium substrates, 
significantly higher cell numbers (p<0.05) were observed at almost every assayed time point on both 
types of multilayered DNA-coatings, corresponding with the results of the Live/Dead assay. No statistical 
significant differences (p>0.05) were found between the cell numbers on the [PDL/DNA]5- and 
[PAH/DNA]5-coated substrates. 
 
Figure 1(left): Representative fluorescence images of RDF cells, cultured for 
3 days on (A) non-coated control substrates, (B) [PDL/DNA]5, and (C) 
{PAH/DNA]5 fabricated on titanium substrates (original magnification 
20x). 
 
Figure 2 (top):Viability of RDF cells on multilayered DNA-coatings 
fabricated on  titanium substrates. 
 
Figure 3: Proliferation of rat dermal 
fibroblast (RDF) cells on non-coated control 
substrates (white bars), [PDL/DNA]5 (grey 
bars), and [PAH/DNA]5 (black bars) 
fabricated on titanium substrates. Results 
are shown as means ± SD of triplicate wells 
for one representative experiment out of 
three. (*), significantly different from non-
coated control substrates, p < 0.01. (**), 
significantly different from non-coated 
control substrates, p < 0.001. (#), 
significantly different from [PDL/DNA]5-
coated substrates, p < 0.01. 
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In vivo experiment 
General observations 
During the experiment, none of the 24 experimental animals showed any clinical signs of illness. 
Furthermore, none of the experimental animals showed wound complications after implantation. All 48 
implants could be retrieved after the intended implantation periods. At implant retrieval, no 
macroscopic signs of inflammation or adverse tissue reactions could be observed. All implants were 
surrounded by a semi-transparent fibrous capsule. 
 
SEM observation of excised implants 
At each time point (4 and 12 weeks) after fixation of the retrieved specimens, implants were excised 
from the surrounding capsule tissue and prepared for scanning electron microscopic examination. The 
excised implants were only scarcely covered with biological compounds, which were not identifiable as 
cellular material (Figure 4) but as a proteinaceous-like deposits. No apparent differences in coverage 
with biological compounds were observed between non-coated titanium control implants and implants 
coated with either [PDL/DNA]5 or [PAH/DNA]5. 
Figure 4: Representative electron microscopy images of an excised (A) non-coated control implant, (B) [PDL/DNA]5, 
and (C) [PAH/DNA]5, after 12 weeks of implantation. 
 
Figure 5: Light microscopic images of tissue capsule 
surrounding titanium control implants (A and D), 
[PDL/DNA]5- (B and E), and [PAH/DNA]5-coated 
titanium implants after implantation periods of 4 (A, 
B, and C) and 12 weeks (D, E, and F). 
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Descriptive histological evaluation 
Gross evaluation of the sections of the implant surrounding tissue capsules after four weeks of 
implantation revealed a relatively uniform tissue response to all implants (Figure 5 A - C), except for one 
case, in which an inflammatory infiltrate was observed around a titanium control implant. All implants 
were encapsulated in a fibrous layer, consisting of fibrocytes, which could be clearly discerned from the 
original connective tissue. Especially at the implant side of the fibrous capsule, the fibrocytes had a flat 
appearance, indicating a matured capsule formation. The fibrocytes of the fibrous capsule surrounded 
the implants without intervening mono- or multinucleated phagocytotic cells at the implant surface. 
Similarly, after twelve weeks of implantation, all implants were surrounded by a relatively mature 
fibrous capsule without the presence of inflammatory cells at the implant interface (Figure 5 D - F). 
No gross differences in tissue response were observed depending either on implant type (titanium 
control, [PDL/DNA]5- or [PAH/DNA]5-coated titanium) or implantation period (4 or 12 weeks). 
Similarly, after twelve weeks of implantation, all implants were surrounded by a relatively mature 
fibrous capsule without the presence of inflammatory cells at the implant interface (Figure 5 D - F). 
No gross differences in tissue response were observed depending either on implant type (titanium 
control, [PDL/DNA]5- or [PAH/DNA]5-coated titanium) or implantation period (4 or 12 weeks). 
Histomorphometrical evaluation of implant surrounding capsules 
The results of the histomorphometrical analyses are presented in Figure 6 and 7. Regarding capsule 
thickness, no significant implant type-dependent differences (p>0.05) in the number of fibroblast layers 
in the implant surrounding fibrous capsule were observed. The thickness of all fibroblast capsules was in 
the range of 5 – 30 after both implantation periods, regardless of the substrate type. No significant 
differences (p>0.05) in capsule quality were detected, neither dependent on type of implant (i.e.non-
coated control, [PDL/DNA]5, or [PAH/DNA]5) nor on duration of implantation (i.e. 4 or 12 weeks). 
 
Immunohistochemistry 
To visualize the presence of myofibroblasts in the fibrous capsules surrounding the implants, paraffin 
sections were subjected to immunohistochemical techniques using a monoclonal antibody against α-
SMA. Representative pictures of stained sections are presented in Figure 8. Gross evaluation of the α-
SMA stained sections revealed a uniformous staining in the capsules, irrespective of substrate type and 
implantation period. 
 
Figure 6: Histological quality of fibrous tissue capsules 
surrounding titanium control implants (white bars), 
[PDL/DNA]5-coated (grey bars) or [PAH/DNA]5-coated 
implants (black bars). Results represent the means ± SD 
of 4 implants per condition. 
 
Figure 7: Thickness (number of fibroblast layers) of 
fibrous tissue capsules surrounding (A) glass and (B) 
titanium control implants (white bars), or [PDL/DNA]5-
coated (grey bars) or [PAH/DNA]5-coated implants 
(black bars). Results represent the means ± SD of 4 
implants per condition. 
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IV DISCUSSION 
This study was initiated to evaluate the cyto- and histocompatibility of multilayered DNA-coatings. 
Cytocompatibility of multilayered DNA-coatings was studied via in vitro experiments to determine cell 
proliferation and viability. Histocompatibility of multilayered DNA-coatings was evaluated using a rat 
model, in which the specimens were inserted subcutaneously for either 4 or 12 weeks, after which 
capsule quality and thickness were scored histomorphometrically. The results of the in vitro and in vivo 
experiments performed in this study indicated that multilayered DNA-coatings are cytocompatible as 
well as histocompatible. 
A wide variety of polyelectrolytes, including cationic PDL and PAH, but not anionic DNA, have been used 
for the fabrication of polyelectrolyte multilayered coatings with the aim to modulate cell behavior. 
Various in vitro experiments with cells of many different origins, including endothelial 18;19, bone 20, 
neuronal 21;22, and cartilage tissue 23;24, and blood cells 25 have shown that polyelectrolyte multilayered 
coatings are a feasible means to modulate biomaterial surfaces. Although in most of these studies 
established cell lines were used, the in vitro experiments of the current study were performed using 
freshly isolated rat dermal fibroblasts. The difference between these cells and established cell lines is 
that in the latter cells the life-span and proliferative behavior are artificially affected. Although primary 
cell cultures also have drawbacks, including the induction of senescence-associated genetic alterations 
26 after extensive culture generations and occasional variance in behavior partly attributed to donor-
related origins, we assumed that freshly isolated fibroblasts are a more suitable model for evaluating 
cytocompatibility. 
Regarding the sterilization of the substrates for the in vitro and the implants for the in vivo experiments 
in this study, the authors are aware of the effects of UV-light on DNA. However, as the DNA in the 
coatings is immobilized and not applied for its genetic information, potential cross-linking of the DNA is 
not considered as a negative effect on the coatings. Furthermore, previous research has demonstrated 
that the sterilization process does not change the infrared absorption spectra of DNA-coatings 
(unpublished data).  
The in vitro proliferation assay demonstrated that the proliferation of RDF cells was significantly 
increased on both types of multilayered DNA-coatings. This observation, which was confirmed by 
fluorescence microscopy in the Live/Dead assay, might be explained by a number of phenomena. The 
presence of DNA in the outermost layer of both types of multilayered DNA-coatings might directly or via 
the adsorption of proteins influence cell behavior. Direct contact between DNA and fibroblasts via 
supplementation of DNA in the culture medium has been demonstrated to decrease proliferation 27. On 
the other hand, DNA has a high affinity for collagen and affects collagen fibrillogenesis  28. As collagen is 
a major extracellular matrix product produced by fibroblasts 29, the interaction of DNA with collagen 
could affect the cell environment. The increased proliferation  of RDF cells on multilayered DNA-
coatings in this study demonstrates that inhibiting effects on fibroblast proliferation of DNA in solution 
are reversed after immobilization of the DNA to the substrate surface using ESA. 
Figure 8:Representative immunohistochemical staining for α-SMA of the fibrous capsule surrounding (a) non-coated 
control, (b) [PDL/DNA]5, and (c) [PAH/DNA]5 after an implantation period of 12 weeks. I denotes the position of the 
implant. 
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Besides chemical modification of the surface, the fabrication of multilayered DNA-coatings has 
demonstrated to result in increased nanorough surface morphologies 12. The influence of micro- and 
nanoscale topography on cell behavior has been studied intensively in the last few years using many 
different types of features 30-33. Still, considerable debate is ongoing on the true effects of nanoscale 
topography on cell behavior, since results from several different research groups on this subject are not 
of the same tenor. For instance, Thapa et al. demonstrated that the presence of nanotopographical cues 
on polymeric materials induced an increase in the proliferation of bladder smooth muscle cells 31. In 
contrast, Wan et al. demonstrated that nanoscale (and also microscale) topography did not increase 
osteoblast-like cell proliferation, although initial cell adhesion was increased compared to smooth 
control surfaces 34. As both types of multilayered DNA-coatings used in the current study introduce 
nanoscale topography and change the chemical properties of the substrate surface, the cause of the 
increase of RDF cell proliferation cannot be attributed to a single surface property. 
Regarding in vivo experiments, the results in this study are deduced from tissue specimens, from which 
the implants were removed, and that were embedded in paraffin. To ensure that implant removal did 
not affect the interface, the implant surfaces were observed with SEM. Also, intact specimens, 
containing both implant and surrounding fibrous capsule were processed for MMA-embedding. 
However, these latter did not always yield satisfactory staining. Nevertheless, based on morphological 
criteria MMA-embedded specimens demonstrated relatively mature fibrous capsules surrounding all 
types of implants without inflammatory cells at the interface between implant and surrounding tissue 
(data not shown). These observations corroborated with those from the specimens from which the 
implants were excised after implant retrieval. SEM analysis of the excised implants demonstrated only 
limited coverage with proteinaceous deposits that could not be identified as cellular material. Similarly, 
based on morphological criteria the paraffin sections of the remaining fibrous capsule showed no 
infiltration of inflammatory cells. 
No data are available currently on the histocompatibility of polyelectrolyte multilayered coatings. 
However, the use of polyelectrolyte multilayered coatings on tracheal prostheses in rats has been 
described recently 35. Tracheal prostheses coated with poly-lysine and poly-glutamic acid did not 
negatively influence animal survival compared to non-coated prostheses. In the present study, the 
histocompatibility of multilayered DNA-coatings was assessed using histomorphometrical analyses of 
capsule quality and thickness (number of fibroblast layers) after subcutaneous implantation in the backs 
of rats for either 4 or 12 weeks. Additionally, the presence of myofibroblasts in the fibrous capsules was 
evaluated immunohistochemically. 
Histomorphometrically, multilayered DNA-coatings did not affect the quality and thickness of the 
fibrous capsule. Generally, all capsules consisted of fairly mature tissue without any signs of 
inflammatory cell infiltration, and both capsule quality and thickness were not significantly different 
between the two implantation periods (4 and 12 weeks). Similar results were found by Paquay et al., 
who subcutaneously implanted titanium fibre mesh in the back of goats 36. The implantation period of 
the titanium fibre mesh implants ranged from 1 to 6 weeks, after which histological analysis revealed 
that an inflammatory response was present only during the first 2 weeks. From 2 to 6 weeks, no 
difference in tissue response was found, either histologically or histomorphometrically.  
The presence of α-SMA in connective tissue cells has been proposed to be a marker for myofibroblast 
identification 37, but does not imply active contraction. Although these myofibroblasts facilitate wound 
closure, the presence of myofibroblasts in the fibrous capsule surrounding an implant has been related 
to complications with breast prostheses 38;39. In the present study, all fibrous capsules revealed similar 
staining patterns for α-SMA, independent of implant surface and implantation period. The 
independency of α-SMA staining in fibrous capsules on implantation period and implant surface has 
already been demonstrated by Parker et al. 40. These results support our macroscopic observations of 
the specimens at implant retrieval. 
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CONCLUSION 
In conclusion, the results of the present study confirm our hypothesis that multilayered DNA-coatings 
are cyto- and histocompatible. In vitro, multilayered DNA-coatings increased the proliferation rate of 
primary rat fibroblasts, and did not cause a decrease in cell viability. Subcutaneous implantation 
resulted in fibrous capsule formation around all implants, without any signs of severe inflammation or 
disturbed wound healing. The quality and thickness of capsules around implants containing a 
multilayered DNA-coating were comparable to those around non-coated control implants. Furthermore, 
capsule quality and thickness were constant over time, independent of the implant surface and 
implantation period. The cyto- and histocompatibility of multilayered DNA-coatings demonstrated in 
this study allows their use and functionalization with appropriate cytokines to modulate cell and tissue 
responses in dental and medical implantology. 
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I INTRODUCTION 
Due to the ageing of the population in the Western world, biomedical implants are becoming 
increasingly important tools in the practice of medicine. Examples of such implants include joint 
replacements, vascular grafts, pacemakers, and catheters. The insertion of implants into bodily tissues 
evokes a series of responses directed against these foreign objects, which are conjointly known as the 
‘foreign body response’. Prior to the interaction of cells in these responses, an implant is covered with 
proteins, which adsorb on the implant surface from bodily fluids and initiate the cell response. In view of 
this, especially the serum proteins vitronectin and fibronectin have demonstrated to be important for 
cell attachment 1-3. Additionally, upon binding specific epitopes in the extracellular matrix, cell surface 
receptors are known to be involved in the regulation of cell processes including proliferation and 
differentiation 4. The subsequent cell responses consist of a series of chronological, though not 
completely separated, stadia, which are (1) inflammation, (2) tissue repair, and (3) tissue remodeling 5-7.  
To study the biocompatibility of biomaterials, assays in which the behavior of macrophages is examined 
are a useful determinant. In particular biomaterials used in orthopedics and dentistry have been the 
subject of interest in such assays 8-10. The use of macrophages for this purpose is based on their role in 
the foreign body response. By virtue of their capacity to secrete a large array of products, including 
cytokines and growth factors, macrophages orchestrate the activation of numerous cell types 11, and are 
considered key regulators of the intensity and duration of inflammatory responses. During the entire 
foreign body response, macrophages are considered to be the key cell type regulating the duration and 
intensity of the different stadia of the foreign body response 11;12. Permanent activation of macrophages 
during the foreign body response may result in persistent inflammatory reactions, and eventually in the 
fusion of macrophages into so called ‘foreign body giant cells’ (FBGCs) 13. 
Previous work of Brodbeck et al. was focused at the role of biomaterial surface properties on the 
expression of cytokines by leucocytes, amongst which macrophages 14;15. In these studies, cytokines 
were classified according to their role in the foreign body response (Figure 1).  
Recently, the fabrication and characterization of a novel biomaterial coating with deoxyribonucleic acid 
(DNA) as the main constituent was described 16;17. These coatings were fabricated using the electrostatic 
self-assembly (ESA) technique 18, using either poly-D-lysine (PDL) or poly(allylamine hydrochloride) 
(PAH) as the cationic counterpart of anionic DNA. The proposed beneficial effects of these multilayered 
DNA-coatings on tissue responses upon implantation rely on the homogeneity of the DNA molecule in 
vertebrate species 19;20, and the capacity of vertebrate DNA to prevent immunological reactions 21;22. 
Furthermore, the high phosphate amount in DNA and the capacity of DNA to incorporate other 
Figure 1: Cytokine classification 
according to their roles in the 
foreign body response (adapted 
with modifications from 
Brodbeck et al.15). 
 
IV Macrophage Behavior on Multilayered DNA-coatings in vitro 
 59
compounds 23 may favor the deposition of calcium phosphate in a bone environment and allow 
functionalization of multilayered DNA-coatings with appropriate biologically-active compounds 
(growth factors, antibiotics, etc.), respectively. Indeed, previous experiments at our department have 
already demonstrated the histocompatibility of multilayered DNA-coatings 17;24 and the effective 
functionalization of multilayered DNA-coatings with the osteoinductive factor bone morphogenetic 
protein 2 (BMP-2) 25. In view of these properties of DNA, multilayered DNA-coatings could serve as safe 
coatings for both soft and hard tissue implants that can be functionalized with compounds with desired 
biological activity. 
In view of the proposed beneficial effects of DNA, the aim of the current study was to evaluate the effect 
of multilayered DNA-coatings on the behavior of macrophages. First, the gross protein adsorption to 
non-coated controls and the two types of multilayered DNA-coatings was measured. Additionally, two 
murine macrophage cell lines (J774A.1 and RAW264.7) were cultured on two types of multilayered DNA-
coatings ([PDL/DNA]5 and [PAH/DNA]5) for 24 and 48 hours. Non-coated glass substrates served as 
negative controls, whereas stimulation with lipopolysaccharide (LPS) was used as the positive control. 
Macrophage behavior was assessed in terms of proliferation, viability, morphology, and cytokine 
secretion (TNF-α, TGF-β1, IL-10, IL-1β). 
 
II MATERIALS & METHODS 
Materials 
Polyanionic DNA (300 bp/molecule; sodium salt) was kindly provided by the Central Research 
Laboratory of Nichiro Corporation (Kawasaki-shi, Kanagawa prefecture, Japan). Potential protein 
impurities in the DNA were checked using the bicinchoninic acid (BCA) protein assay (Pierce, Rockford, 
IL, US) and measured to be below 0.20% w/w (data not shown). Polycationic polyelectrolytes 
poly(allylamine hydrochloride) (PAH;  MW ~70000) and poly-D-lysine (PDL; MW 30000 - 70000) were 
purchased from Sigma (Sigma-Aldrich Chemie B.V., Zwijndrecht, the Netherlands). Lipopolysaccharide 
(LPS; from E. coli) was purchased from Fluka (Fluka Chemie GmbH, Buchs, Germany). All materials were 
used without further purification. 
 
Substrate preparation and cleaning 
Disc-shaped glass substrates (diameter 12 mm; Waldemar Knittel Glasbearbeitungs GmbH, 
Braunschweig, Germany) were used. Prior to the fabrication of multilayered DNA-coatings, substrates 
were cleaned in Piranha solution (H2O2 / H2SO4 – 3:7 v/v) to completely remove all traces of organic 
materials at the surface, and increase surface hydrophilicity 26. Subsequently, the substrates were 
thoroughly rinsed with ultra-pure water from a Millipore system (resistivity > 15 MΩ·cm; Millipore B.V., 
Amsterdam, the Netherlands) and dried using a pressurized air stream. 
 
Generation of multilayered DNA-coatings 
Multilayered DNA-coatings were generated using the ESA-technique, as described previously by Van 
den Beucken et al. 16. Briefly, the cleaned substrates were immersed in an aqueous solution of either 
PDL (0.1 mg/ml) or PAH (1 mg/ml) for 30 minutes, allowing sufficient time for the adsorption of the first 
cationic polyelectrolyte layer onto the substrates. Subsequently, the substrates were washed in ultra-
pure water (5 minutes, continuous water flow) and dried using a pressurized air stream. Thereafter, the 
substrates were alternately immersed in an anionic aqueous DNA solution (1 mg/ml) and the respective 
cationic polyelectrolyte solution for 7 minutes each, with intermediate washing in ultra-pure water (5 
minutes, continuous water flow) and drying using a pressurized air stream. The build-up of the 
multilayered DNA-coatings was continued until a total of 5 double-layers were reached, which were 
designated either [PDL/DNA]5 or [PAH/DNA]5. 
All substrates, coated with either type of multilayered DNA-coating or non-coated control substrates, 
were sterilized using a UV-irradiation treatment (254 nm; 4 hrs). 
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Protein adsorption 
Protein adsorption to the multilayered DNA-coatings and non-coated glass controls was assessed using 
the BCA protein assay (Pierce Biotechnology, Inc., Rockford, IL, USA), according to the instructions of the 
manufacturer. Briefly, triplicate substrates (n=3) were immersed in 1 ml culture medium (Minimal 
Essential Medium (Gibco®, Invitrogen Corporation, Breda, the Netherlands), supplemented with 10% 
fetal calf serum (FCS; Gibco®) and antibiotics (gentamycin; 50 µg/ml; Gibco®) for incubation periods of 0, 
½, 1, 4, and 24 hours. After each incubation period, substrates were washed three times with PBS, 
transferred into a fresh 24-well plate (Greiner Bio-One). To retrieve adherent proteins, substrates were 
immersed in 1 ml of a 5% sodium dodecyl sulfate (SDS; Sigma-Aldrich Chemie B.V., Zwijndrecht, the 
Netherlands) solution in ultra-pure water. The plate was incubated dynamically at room temperature 
overnight, after which the amount of protein in the SDS-solution was measured as follows: 100 µl of 
sample or standard was added to 100 µl freshly-prepared working solution in a 96-well plate (Greiner 
Bio-One) and incubated at 37°C for two hours. After cooling to room temperature, the plate was read in 
a plate reader at 562 nm. For the standard curve, serial dilutions of bovine serum albumin (BSA) were 
made (0 – 40 µg/ml) in 5% SDS-solution. Obtained values were corrected by subtracting the values 
obtained from substrates that were not immersed in culture medium (incubation period = 0 h). 
 
Cell experiments 
Macrophage cell lines 
The murine macrophage cell lines J774A.1 and RAW264.7 (kindly provided by Dr. F. Wagener, Dept. 
Pharmacology & Toxicology, NCMLS, Radboud University Nijmegen, Nijmegen, the Netherlands) were 
cultured in α-MEM medium in tissue culture polystyrene (TCPS) flasks (75 cm2; Greiner Bio-One B.V., 
Alphen aan de Rijn, the Netherlands). Cells were routinely detached by mechanical force and 
subsequently split in a ratio of 1:5.  
For every assay, cells were seeded at a density of 1 x 105 cells/cm2 and subsequently cultured for 24 and 
48 hours on four types of experimental substrates, which were placed in 24 well plates (Greiner Bio-One 
B.V.): 
1. negative controls (-controls; non-coated glass) 
2. positive controls (+controls; non-coated glass + LPS-stimulation) 
3. [PDL/DNA]5 
4. [PAH/DNA]5 
For positive controls, cells were stimulated with LPS (10 µl of 10 µg/ml in PBS; final concentration 100 
ng/ml) two hours after cell seeding. Negative controls and both types of multilayered DNA-coatings 
were comparatively supplemented with 10 µl PBS. 
 
Cell quantification 
For the determination of cell amounts (n=3 for each experimental condition at each time point), 
substrates with adherent cells were washed twice with PBS. Subsequently, adherent cells were lysed 
through incubation in ultra-pure water, with 3 subsequent repetitive freeze and thaw cycles. Then, the 
amount of cellular protein in the supernatant was quantified using the BCA protein assay (Pierce 
Biotechnology, Inc.), according to the instructions of the manufacturer. Briefly, 100 µl of sample or 
standard was added to 100 µl freshly-prepared working solution in a 96-well plate (Greiner Bio-One 
B.V.) and incubated at 37°C for two hours. After cooling to room temperature, the plate was read in a 
plate reader at 562 nm. For the standard curve, serial dilutions of bovine serum albumin (BSA) were 
made (0.5 – 40 µg/ml) in ultra-pure water. 
 
Cell viability 
Cell viability was assessed using a commercially available cytotoxicity assay, according to the 
instructions of the manufacturer (Promega Corporation, Madison, WI, USA). The test is based on the 
conversion of a tetrazolium salt ([3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide], MTT) 
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into a formazan product. Briefly, at 24 and 48 hours after cell seeding on the experimental substrates (3 
substrates per condition; n=3), 150 µl dye solution was added to each well, and cells were incubated at 
37°C for 4 hours. Subsequently, 1 ml of solubilization/stop solution was added to each well, and cells 
were incubated for another hour (at room temperature). Finally, the contents of the wells were mixed 
thoroughly using a pipette and the absorbance at 570 nm wavelength was read using a 
spectrophotometer. The results are standardized according to the obtained negative control values (% 
of negative control). 
 
Cell morphology 
To study cell morphology, cells cultured on the experimental substrates for 24 and 48 hours were 
washed twice with PBS and subsequently fixed for 15 min. in 2% glutaraldehyde in 0.1 M sodium 
cacodylate buffered solution. Then, samples were rinsed twice with cacodylate buffered solution and 
dehydrated using a graded series of ethanol. Finally, samples were dried with tetramethylsilane. The 
samples were sputter coated with gold and examined using a JEOL 6310 scanning electron microscope 
(SEM) at an acceleration voltage of 10 – 15 kV. 
 
Cytokine secretion 
The secretion of four different cytokines was measured in the media from the cultures for cell 
proliferation and cell morphology, i.e. tumor necrosis factor-alpha (TNF-α), interleukin 1-beta (IL-1β), 
interleukin 10 (IL-10), and transforming growth factor beta-1 (TGF-β1) using commercially available, 
enzyme-linked immunosorbent assay (ELISA) based kits (OptEIATM; BD Biosciences, San Diego, CA, US), 
according to the instructions of the manufacturer. Samples (n=5 for each experimental condition at 
each time point) were collected during preparation of cell quantification assay and cell morphology, 
centrifuged to remove potential cellular material, and stored at -80°C. Relative values of cytokine 
secretion were obtained by dividing the absolute values determined using the ELISA-based kits by the 
cell quantification values (and expressed as pg/ml/µg cellular protein content).  
 
Statistical analyses 
The entire study was performed twice, with independent runs for the cell experiments. Triplicate 
samples were used for each experimental group at each sampling time to determine protein adhesion, 
cell quantification, and cell viability; quintuplicate samples were used for each experimental group at 
each sampling time to determine cytokine secretion. Statistical analyses were performed using 
GraphPad Instat, version 3.0 (Graphpad Software, San Diego, CA, USA). Experimental results were 
analyzed using a one-way ANOVA, combined with a post-hoc Tukey-Kramer Multiple Comparisons Test. 
 
III RESULTS 
Protein adsorption 
Generally, the results (Figure 2) indicated that major protein adsorption occurs within 30 minutes. After 
this initial adsorption, the additional gross protein adsorption was limited for all experimental 
substrates. No statistically significant differences in gross protein adsorption were observed between 
the experimental substrates at each immersion period (p>0.05). 
 
Cell experiments 
Quantification of the cell amount 
The cell amount of both types of macrophages was measured after culture periods of 24 and 48 hours 
on the experimental substrates. The results showed an increase in cellular protein amount from 24 to 48 
hours of culture for both types of macrophage cultures, independent of experimental condition (Figure 
3). No statistically significant differences were observed at each culture period of individual cell lines 
(p>0.05). 
 
 
IV Macrophage Behavior  on Multilayered DNA-coatings in vitro 
 62
Cell viability 
The results of the viability assay are presented in Figure 4. Neither of the two types of multilayered DNA-
coatings affected macrophage cell viability (p>0.05). On the other hand, LPS-stimulation demonstrated 
to significantly decrease cell viability of both RAW264.7 (p<0.05) and J774A.1 (p<0.001) macrophages 
after 48 hours of cell culture compared to negative controls.  
 
Cell morphology 
Both RAW264.7 and J774A.1 macrophages exhibited a typical macrophage-like morphology, indicated 
by the presence of surface ruffles and numerous extending pseudopodia (Figure 5). Both cultures 
consisted of cells with a rounded cell morphology and ones with a more spread morphology. Due to the 
high seeding density, cell-cell contacts were observed in both cultures. No morphological differences 
were observed between macrophages cultured on either type of DNA-coating or positive controls 
compared to negative controls (data not shown). 
 
Cytokine secretion 
The relative secretion of TNF-α is presented in Figure 6. The secretion of TNF-α, IL-1β, IL-10, and TGF-β1 
is summarized in Table 1. 
Figure 2 Gross protein adsorption to non-
coated controls, [PDL/DNA]5, and 
[PAH/DNA]5 after indicated immersion 
periods in cell culture medium. Results 
represent mean + SD of three experimental 
substrates per condition (n=3). 
 
Figure 3 Cellular protein content of 
macrophages after 24 and 48 hours of 
culture on experimental substrates. (A) 
RAW264.7; (B) J774A.1. Results 
represent mean + SD of three 
experimental substrates per condition 
(n=3). 
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TNF-α 
RAW264.7 macrophages cultured on [PDL/DNA]5 showed TNF-α secretion levels comparable to the 
negative controls (p>0.05). On the other hand, RAW264.7 macrophages cultured on [PAH/DNA]5 
showed a significantly decreased TNF-α secretion after both 24 (p<0.05) and 48 hours (p<0.01) of 
culture. Positive controls showed significantly increased levels of TNF-α secretion both after 24 and 48 
hours (p<0.001). 
J774A.1 macrophages cultured on either type of multilayered DNA-coating showed TNF-α secretion 
levels comparable to negative controls after 24 hours of culture. However, after 48 hours of culture, 
significantly decreased levels of TNF-α secretion were observed on both types of multilayered DNA-
Figure  4: Viability of macrophages after 24 
and 48 hours of culture on experimental 
substrates. (A) RAW264.7; (B) J774A.1. 
Results represent mean + SD of three 
experimental substrates per condition 
(n=3). (*, p<0.05; **, p<0.01; ***, 
p<0.001). 
Figure 5: SEM images showing the 
morphology of RAW264.7 on [PDL/DNA]5 
(A-B) and J774A.1 on [PAH/DNA]5 (C-D) 
after 24 hours of culture. 
 
 
IV Macrophage Behavior  on Multilayered DNA-coatings in vitro 
 64
coatings (p<0.001). Positive controls showed significantly increased levels of TNF-α secretion both after 
24 and 48 hours (p<0.001). 
 
IL-1β 
Secretion levels of IL-1β were low for both macrophage cell types under all four experimental 
conditions. RAW264.7 macrophages showed comparable IL-1β secretion levels for all four conditions 
after 24 and 48 hours (p>0.05).  
Similarly, comparable IL-1β secretion levels were observed for J774A.1 macrophages after 24 hours of 
culture (p>0.05). On the other hand, an increased IL-1β secretion was observed for positive controls 
after 48 hours of culture (p<0.05). 
 
IL-10 
RAW264.7 macrophages IL-10 secretion levels were comparable for those cultured on both types of 
multilayered DNA-coatings and negative controls after both 24 and 48 hours (p>0.05). The positive 
controls, however, showed an increased IL-10 secretion both after 24 (p<0.01) and 48 hours (p<0.05). 
Similar IL-10 secretion profiles were observed for J774A.1 macrophages. No significantly different IL-10 
secretion levels were observed for J774A.1 macrophages cultured on either type of multilayered DNA-
TABLE 1: SUMMARY OF MACROPHAGE CYTOKINE SECRETION (PG/ML/µG CELLULAR PROTEIN) ON MULTILAYERED
 DNA-COATINGS  
 (MEAN ± SD; * P<0.05; ** P<0.01; *** P<0.001 COMPARED TO NEGATIVE CONTROLS). 
 
Figure 6: TNF-α secretion of macrophages after 24 and 48 
hours of culture on experimental substrates. (A) 
RAW264.7; (B) J774A.1. Results represent mean + SD of 
five experimental substrates per condition (n=5). 
(*, p<0.05; **, p<0.01; ***, p<0.001). 
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coating (p>0.05), whereas significantly increased levels were observed for positive controls both after 
24 (p<0.001) and 48 hours (p<0.001). 
 
IV DISCUSSION 
A pivotal factor to consider in the development of biomaterials and biomaterial coatings is the 
inflammatory response to these materials. The insertion of implants is followed by protein adsorption 
and subsequent interactions with cellular components of the biological surroundings, in which 
macrophages play a dominant role through the production of a myriad of signaling molecules. Previous 
research aimed at using macrophages (either primary cells or cell lines) as a model system to evaluate 
biomaterial biocompatibility 8-10;27-31 32 33. Additionally, a classification scheme for cytokines was 
developed, in which their classification is based on their role in inflammation and wound healing 14;15. In 
view of this, the present study evaluated (i) gross protein adsorption to, and (ii) in vitro behavior of 
macrophages on novel biomaterial coatings, consisting of poly-D-lysine (PDL) or poly(allylamine 
hydrochloride) (PAH) and DNA, and compared it to negative (non-coated glass) and positive controls 
(non-coated glass + LPS-stimulation). The results demonstrated that protein adsorption was 
comparable for both types of multilayered DNA-coatings and non-coated negative controls. The 
behavior of two murine macrophage cell lines, RAW264.7 and J774A.1, was evaluated in terms of 
proliferation, viability, morphology, and cytokine secretion. Current cell culture experiments 
demonstrated cell line-dependent differences in cell proliferation and cytokine expression. Both 
macrophage cell viability and morphology were not affected by the presence of either type of 
multilayered DNA-coating. Most interesting, a decreased secretion of TNF-α was observed on both 
types of multilayered DNA-coatings, whereas the secretion of IL-1β, IL-10, and TGF-β1 was not affected 
by the presence of either type of multilayered DNA-coating. 
Cell attachment and proliferation depend on the adsorption of serum proteins, which link cells to the 
biomaterial. The adsorption of proteins from complex mixtures (e.g. culture medium, blood, etc.) is a 
dynamic and competitive process. Important proteins promoting cell attachment in this respect are 
vitronectin and fibronectin 1-3, whose interaction with cells is mainly based on the recognition of RGD-
sequences by receptors located on the cell surface 34;35. In addition to cell binding, these receptors also 
mediate signaling, and are involved in regulating cell processes including proliferation and 
differentiation 4. Consequently, variations in the amount and diversity of adsorbed proteins are likely to 
affect macrophage attachment and behavior (viability, cytokine secretion, morphology) in the current 
study. As in the present study cell attachment was enrolled as a parameter, the protein adsorption from 
cell culture medium containing 10% (v/v) bovine serum was not particularized into adsorption of single 
cell-attachment promoting proteins (e.g. vitronectin and fibronectin). Protein adsorption demonstrated 
to be similar for both types of multilayered DNA-coatings and non-coated controls. The combination of 
the gross protein adsorption results and the cell quantification results after 24 hours of culture indicates 
that (i) both types of multilayered DNA-coatings allow protein adsorption, and (ii) the protein 
adsorption to both types of multilayered DNA-coatings does not alter cell attachment compared to non-
coated control substrates. 
In the present study, cell culture experiments were performed using two different types of murine 
macrophage cell lines, i.e. RAW264.7 and J774A.1. Both cell lines are derived from BALB/c mice: 
RAW264.7 macrophages from a virus-induced tumor, J774A.1 macrophages from a reticulum cell 
sarcoma. In addition to these differences, the former cells have a male genotype, whereas the latter 
have a female genotype. Both these cell lines have been used extensively to study the effect of materials 
on macrophage behavior 8;10;27;28;30;31. Additionally, it is the opinion of the authors that data obtained 
from experiments that use cell lines rather than primary cells are eligible for comparison. Nevertheless, 
the authors are aware of the differences between cell lines and primary cells, and the effects these 
differences can have in in vitro cell culture models. 
The results for cell viability on multilayered DNA-coatings corroborate our previously reported cell 
viability data of primary rat dermal fibroblast cultures on multilayered DNA-coatings 17. A decrease in 
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macrophage cell viability due to stimulation with LPS, as observed after 48 hours of culture in the 
present study, has been reported earlier by Li et al. 31. In their study, RAW264.7 positive controls showed 
a decreased cell viability as early as 6 hours post-supplementation. Apparently, the concentration of LPS 
(10 µg/ml vs. 100 ng/ml in the present study) affects cell viability in a temporal fashion. 
Local cytokine production by implant-adherent macrophages is an important issue in the intensity and 
duration of the stages in the foreign body response 11;13. In the classification presented in Figure 1, the 
role of single pro-inflammatory or pro-wound healing cytokines is evident. However, a unique position 
is put aside for IL-10 and IL-1β, as these cytokines have dual roles in the inflammatory and wound 
healing processes. IL-10 is capable of down-regulating the activity of both inflammatory cells 
(lymphocytes and monocytes) and wound healing (fibroblasts), and suppresses cytokine production. On 
the other hand, IL-1β activates those cells and hence is considered to be pro-inflammatory/pro-wound 
healing.  
Previous studies have demonstrated that cytokine expression is affected by biomaterial properties, such 
as surface topography 10 and surface chemistry 14;15. Refai et al. used four surface topographies 
(polished, coarsely blasted, acid etched, and sandblasted + acid etched) of titanium sputter-coated 
epoxy-resin to study the effect of surface topography on macrophage (RAW264.7) activity and secretion 
of pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6). Their experiments demonstrated that rough 
surfaces increased the secretion of TNF-α. Additionally, they observed a synergistic effect of surface 
roughness and LPS-stimulation by the increased secretion of IL-1β, IL-6, and TNF-α. In our experiments, 
the increased surface roughness of multilayered DNA-coatings 16 evidently did not increase cytokine 
secretion. On the contrary, both types of multilayered DNA-coatings had a decreasing effect on TNF-α 
secretion, whereas the secretion of IL-1β, IL-10, and TGF-β1 was not affected. A reason for this 
discrepancy could be the scale of roughness, which was limited to the nanometer range in the current 
study compared to micrometer range differences in the study of Refai et al. 10. 
In view of surface chemistry, Brodbeck et al. demonstrated using an in vitro human monocyte culture 
system that of four types of substrates surfaces (i.e. hydrophobic, hydrophilic, anionic, and cationic), 
those with a hydrophilic or anionic surface promote an anti-inflammatory type of response owing to a 
decreased IL-8 and an increased IL-10 expression 14. Additionally, an in vivo mouse cage implant system 
demonstrated that hydrophilic and anionic surfaces decreased leukocyte adhesion, and that hydrophilic 
surfaces induced a decrease in the expression of both pro-inflammatory (IL-6 and IL-8) and pro-wound 
healing cytokines (IL-10 and TGF-β) by adherent cells. These results corroborate with our observations 
of decreased pro-inflammatory responses on both types of multilayered DNA-coatings, albeit that in our 
experiments TNF-α was used as the cytokine indicative for pro-inflammatory/anti-wound healing 
responses. It is likely that the decreased TNF-α secretion is caused by the increased hydrophilicity of 
multilayered DNA-coatings owing to the deposition of anionic DNA as the top layer in the multilayer 
coatings. 
Although the results of the current study indicate that multilayered DNA-coatings reduce the pro-
inflammatory response of macrophages as reflected by the decreased secretion of TNF-α, it remains 
questionable whether the effects observed with the conditions in the model system in the current study 
(cell density, in vitro setting) can be fully extrapolated to in vivo situations. The decreased secretion of 
TNF-α, although significantly lower compared to negative controls, might not suffice to show clinical 
effects. Additionally, this study only monitored the secretion of a limited number of cytokines by single 
cell types, whereas in clinical situations the balance between many different cytokines and responsive 
cells determines the course of biological processes. Appropriate animal models are required to elucidate 
whether these in vitro indications of beneficial immunological effects of multilayered DNA-coatings can 
have clinical effects on inflammatory and wound healing processes around implants. 
 
CONCLUSION 
The results of the present study demonstrate that multilayered DNA-coatings do not affect gross protein 
adsorption compared to non-coated controls. Cell culture experiments showed that the attachment to, 
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and viability and morphology of two types of macrophages cultured on multilayered DNA-coatings is 
comparable to non-coated controls. Macrophages repeatedly showed decreased secretion levels of TNF-
α on multilayered DNA-coatings, whereas no differences were observed in the secretion of IL-1β, IL-10, 
and TGF-β1. 
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I INTRODUCTION 
The insertion of orthopedic and dental implants to replace malfunctioning articulating joints and lost 
teeth, is a common surgical procedure. For the construction of orthopedic and dental implants, many 
types of metals (or metallic alloys), ceramics, and polymers, or combinations thereof, have been used 1;2. 
In order to remain functional, the material properties must meet the requirements for a given situation. 
For instance, functional orthopedic and dental implants require a tight conjunction with the 
surrounding bone tissue. 
Amongst several other materials, calcium phosphate (CaP) ceramics such as hydroxyapatite (HA), have 
the capacity to form a chemical bond with the bone tissue at the interface and can induce a continuous 
transition from bone tissue to the implant surface 3. In view of this, the formation of bone-like apatite on 
the surface is proposed as the essential requirement for an artificial material to bond to living bone 4. 
However, due to their brittleness, the in vivo use of these so-called ‘bioactive’ materials for mechanically 
loaded applications is limited to coatings on a mechanically stronger implant base material, such as 
titanium. 
The most commonly used methods to provide CaP-coatings on implants, including plasma spraying and 
sputter techniques, have limitations regarding implant geometry and porosity, and the incorporation of 
biologicals. Hence, studies have been undertaken to elucidate the mechanism responsible for the 
apposition of bone tissue to bioactive materials in order to find methods to increase surface bioactivity 
that do not entail these limitations. In view of this, the role of surface functional groups has been 
studied using in vitro experiments with simulated body fluids (SBF), which are solutions that are 
compositionally similar to human blood plasma. Such studies, in  
which in vivo apatite formation can be reproduced 5, indicated that negatively-charged groups, and 
phosphate-containing groups in particular, are the most potent inducers of the CaP nucleation process 
6;7. 
A recently proposed implant coating material with high phosphate content is deoxyribonucleic acid 
(DNA) 8. In addition to the proposed beneficial effects on CaP nucleation, DNA is an immunologically 
interesting material 9-11 and has the capacity to incorporate and bind other compounds 12. In view of 
this, we recently used electrostatic self-assembly (ESA) to fabricate multilayered DNA-coatings 8, 
consisting of either poly-D-lysine (PDL) or poly(allylamine hydrochloride) (PAH) as the cationic 
counterpart of anionic DNA. The buildup of such coatings depends on the adsorption of the first 
polyelectrolyte to a substrate, after which electrostatic forces between oppositely-charged 
polyelectrolytes allow the formation of multilayered coatings. Both types of DNA-coatings were shown 
to contain 15 µg DNA per cm2, as demonstrated using radiolabeled DNA  8. Furthermore, these DNA-
coatings displayed a polycation-dependent surface roughness, as studied using atomic force 
microscopy 8. Finally,  both types of DNA-coatings demonstrated (i) to be cyto- and histocompatible 
13;14, (ii) to decrease the secretion of the major pro-inflammatory cytokine (tumor necrosis factor alpha; 
TNF-α) by macrophages 15, and (iii) to be eligible for functionalization with the osteoinductive factor 
bone morphogenetic protein 2 16. 
In the present study, we aimed at evaluating potential effects of the phosphate groups in both types of 
DNA-coatings on CaP nucleation and growth in SBF immersion experiments. For this purpose, DNA-
coatings were prepared on titanium substrates and immersed in SBF of various compositions. Non-
coated titanium substrates served as controls. After immersion in SBF for 1, 2, and 4 weeks, the surfaces 
of the substrates were evaluated morphologically (scanning electron microscopy, SEM) and chemically 
(X-ray diffraction, XRD; Fourier transform infrared spectroscopy, FTIR; energy dispersive spectroscopy, 
EDS). Subsequently, titanium substrates with or without DNA-coatings and subsequent SBF-immersion 
pretreatment were seeded with primary rat bone marrow-derived osteoblast-like cells to study cell 
proliferation, differentiation, and morphology. 
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II MATERIALS & METHODS 
Materials 
Polyanionic salmon DNA (± 300 bp/molecules; sodium salt) was kindly donated by Nichiro Corporation 
(Kawasaki-city, Kanagawa prefecture, Japan). Potential protein impurities in the DNA were checked 
using the bicinchoninic acid (BCA) protein assay (Pierce, Rockford, IL, USA), and were measured to be 
below 0.20 % w/w (data not shown). Polycationic polyelectrolytes poly-D-lysine (PDL; MW 30000 – 
70000) and poly(allylamine hydrochloride) (PAH; MW ~70000) were purchased from Sigma (Sigma-
Aldrich Chemie B.V., Zwijndrecht, the Netherlands). All materials were used without further purification. 
 
Substrate preparation and cleaning 
Disc-shaped titanium substrates (12 mm diameter; 1.5 mm thickness; commercially-pure titanium 
(cpTi), as-machined) were cleaned ultrasonically using consecutively nitric acid (10% v/v), acetone, and 
isopropanol. After the cleaning steps using nitric acid and acetone, the substrates were thoroughly 
rinsed with ultra-pure water from a Milipore system (Milipore B.V., Amsterdam, the Netherlands). After 
the isoporopanol step, the substrates were air-dried. 
 
Generation of multilayered DNA-coatings 
DNA-coatings were generated using the ESA-technique, as described previously 17. Briefly, the 
substrates were immersed in an aqueous solution of either PDL (0.1 mg/ml) or PAH (1 mg/ml) for 30 
minutes, allowing sufficient time for the adsorption of the first cationic polyelectrolyte layer onto the 
substrates. Subsequently, substrates were washed in ultra-pure water (5 minutes; continuous water 
flow) and dried using a pressurized air stream. Thereafter, substrates were alternately  immersed in an 
anionic aqueous DNA solution (1 mg/ml) and the respective cationic polyelectrolyte solution for 7 
minutes each, with intermediate washing in ultra-pure water and subsequent drying using a 
pressurized air stream to obtain final coating architectures of [PDL/DNA]5 or [PAH/DNA]5 (the number 
indicates the total number of double-layers). 
 
SBF immersion experiments 
Simulated Body Fluid 
The recipe for the preparation of SBF was adopted from Kokubo et al. 18;19. Immersion experiments were 
performed with SBF containing physiological (SBF1) and 2-fold increased calcium- and phosphate-ion 
concentrations (SBF2) compared to human blood serum (Table 1). The pH-value of both solutions was 
set at 7.4 after complete preparation. Immersion studies were performed in 15 ml tubes (Greiner Bio-
One B.V., Alphen aan de Rijn, the Netherlands), using 1 substrate per tube in 4 ml SBF. Tubes were 
placed in a water bath at 37°C under continuous shaking. The SBF solution in the tubes was refreshed on 
a weekly basis. After immersion periods of 1, 2, and 4 weeks, substrates were thoroughly rinsed three 
times with ultra-pure water, and air-dried. 
 
TABLE 1: CONCENTRATIONS OF IONIC SPECIES (MM) IN SIMULATED BODY FLUID (SBF) OF DIFFERENT CA2+ AND PO43- 
 CONCENTRATIONS AND HUMAN BLOOD PLASMA (HBP). 
Species SBF1 SBF2 HBP 
Na+ 142.0 142.0 142.0 
K+ 5.0 7.0 5.0 
Ca2+ 2.5 5.0 2.5 
Mg2+ 1.5 1.5 1.5 
Cl- 148.0 147.0 103.0 
CO32- 4.2 4.2 27.0 
PO43- 1.0 2.0 1.0 
SO42- 0.5 0.5 0.5 
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Evaluation of surface morphology 
After the various SBF immersion periods (1, 2, and 4 weeks), the surface morphology of the substrates 
was examined using scanning electron microscopy (SEM). Therefore, specimens were sputter coated 
with gold and examined using a Jeol 6310 scanning electron microscope at an acceleration voltage of 
10-15 kV. 
 
Surface analysis 
The crystallographic structure of depositions on the substrates was characterized using a Philips thin-
film X-ray diffractometer with CuKα-radiation (PW3710; 40 mV; 30 mA). For analysis, the substrates 
were fixed with the angle of incidence at a position of 2.5° (2θ), while scanning from 24° to 36° (2θ) 
with the solid state detector (step size of 0.02° (2θ); sample time of 25 s/step). Characterization of the 
molecular structure of depositions on the experimental substrates was performed using Fourier 
Transform InfraRed spectroscopy (FTIR; Perkin Elmer Instruments, Zoetermeer, the Netherlands). 
Infrared spectra were recorded in the range from 4000 to 450 cm-1. Energy Dispersive Spectroscopy 
(EDS) was performed using an energy-dispersive X-ray microanalyzer (Voyager), integrated with the 
abovementioned SEM. EDS was carried out at a magnification of 500x at an acceleration voltage of 10-
15 kV to determine the elemental composition of potential depositions. The calcium amount on the 
substrates after immersion in SBF for 1, 2, and 4 weeks was measured using the ortho-cresolphtalein 
(OCPC) method (Sigma) 20. Briefly, the substrates were placed into a fresh 24 wells plate, 1 ml 0.5 N 
acetic acid was added per substrate, and the experimental substrates were incubated overnight on a 
shaking apparatus. For analysis, 300 µl working reagent was added to aliquots of 10 (l sample or 
standard (in duplo) in a 96-wells plate. A standard curve was prepared using serial dilution of CaCl2 (final 
concentrations 0 – 100 µg/ml). The plate was incubated at room temperature for 10 minutes and then 
read in an ELISA reader at 540 nm. 
 
Osteoblast-like cell culture experiments 
Three independent experimental runs of cell culture experiments with osteoblast-like cells were 
performed. For each experimental run, cells were isolated from one individual rat. 
 
Experimental substrates 
For cell culture experiments, seven types of experimental substrates were used: 
1. Ti-[PDL/DNA]5 (no immersion in SBF2) 
2. Ti-[PDL/DNA]5-1w (1 week immersion in SBF2) 
3. Ti-[PDL/DNA]5-2w (2 weeks immersion SBF2) 
4. Ti-[PAH/DNA]5 (no immersion in SBF2) 
5. Ti-[PAH/DNA]5-1w (1 week immersion in SBF2) 
6. Ti-[PAH/DNA]5-2w (2 weeks immersion in SBF2) 
7. non-coated control (titanium discs) 
Prior to use in cell culture experiments, all substrates were sterilized by UV-treatment (254 nm; 4 h.). 
 
Isolation of rat bone marrow cells 
Rat bone marrow (RBM) cells were isolated and cultured using a method adapted from Maniatopoulos 
et al. 21. Briefly, the femora of male Wistar WU rats were extracted, and epiphyses were cut off. RBM cells 
were flushed out of the remaining diaphyses using cell culture medium (α-MEM (Gibco) supplemented 
with 10% fetal calf serum (FCS; Gibco), 50 µg/ml ascorbic acid (Sigma), 10 mM Na-β-glycerophosphate 
(Sigma), 10-8 M dexamethasone (Sigma), and 50 µg/ml gentamycin (Gibco)). RBM cells of two femora 
were cultured under static conditions in cell culture medium in three 75 cm2 culture flasks (Greiner Bio-
One) in a humidified incubator (37°C; 95% air; 5% CO2) for one day, after which the medium was 
refreshed to remove non-adherent cells. Subsequently, the attached cells were pre-cultured for another 
6 days. After the total primary culture of 7 days to obtain osteoblast-like cells, cells were detached using 
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trypsin/EDTA (0.25% w/v trypsin, 0.02% w/v EDTA) and the total cell number was determined using a 
Coulter® counter (Beckman Coulter Inc., Fullerton, CA, USA). Finally, cells were seeded at a density of 1 x 
104 cells/cm2 onto the experimental substrates, which were placed in a 24-wells plate (Greiner Bio-One). 
The cell culture medium was refreshed 1 day after cell seeding, and thereafter 3 times per week. 
 
Cell proliferation 
At 4, 8, 12, and 16 days post-seeding, the medium was removed and the cells were washed with 
phosphate-buffered saline (PBS; pH 7.4) three times. Subsequently, the experimental substrates (n=3 
for each condition at each time point) with attached cells were transferred into fresh 24-well plates, and 
each experimental substrate was immersed in 1 ml ultra-pure water. These samples were frozen and 
thawed for 3 repetitive cycles, after which the proliferation of the cells was analyzed by measuring the 
cellular protein content in the aqueous samples using a micro BCA protein assay (Pierce, Rockford, IL, 
USA) according to the instructions of the manufacturer. 
 
Alkaline phosphatase activity 
The alkaline phosphatase (ALP) activity was measured as a marker for early differentiation of osteoblast-
like cells using the same samples (n=3 for each condition at each time point) as for the proliferation 
assay according to a previously described method 22. A volume of 80 µl of sample or standard and 20 µl 
of buffer solution (5 mM MgCl2, 0.5 M 2-amino-2-methyl-1-propanol) was pipetted into a 96-wells plate 
(Greiner Bio-One) in duplo, and 100 µl of substrate solution (5 mM paranitrophenylphosphate) was 
added per well. Subsequently, the plate was incubated for one hour at 37°C, after which the reaction 
was stopped by adding 100 µl 0.3 M NaOH. Serial dilutions of 4-nitrophenol (final concentrations 0 – 25 
nM) were used for the standard curve. The plate was read in an ELISA reader at 405 nm. 
 
Osteocalcin assay 
To avoid interference of calcium from SBF-pretreated experimental substrates, not calcium deposition 
but the deposition of osteocalcin in the extracellular matrix was used as a marker of late differentiation 
of osteoblast-like cells. The amount of deposited osteocalcin after 8, 16, and 24 of cell culture was 
measured by an enzyme immuno-assay (EIA; Biomedical Technologies, Inc., Stoughton, MA, USA) 
according to the instructions of the manufacturer. Briefly, samples (n=3 for each condition at each time 
point) were collected by scraping the surface of the experimental substrates at indicated time points 
after washing twice with PBS. Samples were stored at -20°C until analyses. For analysis, 100 µl of sample 
was added to the wells (in duplo) and incubated at 4°C for 24 hours. Wells were washed three times 
with 300 µl wash buffer, after which 100 µl osteocalcin antiserum was added to each well. After 1 hour 
incubation at 37°C, wells were washed as before and 100 µl donkey anti-goat IgG-peroxidase was 
added. After incubation for 1 hour at room temperature and subsequent washing as before, 100 µl 
substrate solution (1 volume TMB solution + 1 volume hydrogen peroxidase) was added to each well for 
30 minutes incubation at room temperature. Subsequently, 100 µl stop solution was added to each 
well, and the plate was read at 405 nm within 15 minutes. Standards (0 – 40 ng/ml) were enrolled to 
prepare a standard curve. 
 
Evaluation of cell morphology 
Scanning electron microscopy was performed to evaluate the morphological appearance of the cells. At 
4 and 16 days post-seeding, substrates with attached cells were washed twice with PBS and fixed using 
gluteraldehyde (4% in 0.1 M cacodylate buffer) for 20 minutes. Subsequently, the substrates were 
washed twice with 0.1 M cacodylate buffer and dehydrated in a graded series of ethanol. Finally, the 
substrates were dried with tetramethylsilane, sputter coated with gold and examined using a JEOL 6310 
SEM at an acceleration voltage of 10-15 kV. 
 
 
V Multilayered DNA-coatings: Bioactivity & Osteoblast-like Cells 
 76
Statistical analyses 
All data were obtained from triplicate samples and measured in duplo. Measurements were statistically 
evaluated with Graphpad® Instat 3.05 software (GraphPad Software Inc., San Diego, CA, USA), using a 
one-way ANOVA combined with a post-hoc Tukey–Kramer Multiple Comparisons test. The significance 
level was set at p<0.05. 
 
III RESULTS 
SBF immersion experiments 
Surface morphology 
During all SBF immersion experiments, no homogeneous precipitates were observed in the SBF 
solutions, and no precipitation on the test tubes was observed. Immersion of the experimental 
substrates in SBF1 did not result in the formation of precipitates on any type of substrate used in this 
study. In contrast, immersion experiments with SBF2 resulted in spot-like depositions on all three types 
of substrates (Ti, Ti-[PDL/DNA]5, and Ti-[PAH/DNA]5) after one week. The spots consisted of compact 
spheroids, which in SEM observation exhibited diameters of approximately 5 µm. After two weeks 
immersion in SBF2, the depositions on Ti-[PDL/DNA]5 and Ti had increased in both size and number, 
whereas on Ti-[PAH/DNA]5 the complete surface was covered with a continuous thin layer of deposited 
spheroids (Figure 1). After four weeks of immersion in SBF2, all of the substrates (Ti, Ti-[PDL/DNA]5, and 
Ti-[PAH/DNA]5) were covered with a continuous layer of deposited spheroids. 
 
 
Figure 1: Scanning electron micrographs of Ti, Ti-
[PDL/DNA]5, and Ti-[PAH/DNA]5 substrates after 
immersion in SBF2 for a period of two weeks. 
Images on the left were obtained by tilting the 
samples (approximately 60°). Higher 
magnifications (of non-tilted samples) are 
presented in the right panels. 
 
V Multilayered DNA-coatings: Bioactivity & Osteoblast-like Cells 
 77
Surface analysis 
The XRD analyses revealed that the depositions had a poorly crystalline apatitic nature. Figure 2 
presents the XRD-patterns of the substrates after an immersion period of two weeks in SBF2. Diffraction 
peaks of apatitic calcium phosphate at 2θ = 25.7° (002) and a broad band around 2θ = 32° 23;24 could be 
observed on Ti-[PDL/DNA]5 and especially Ti-[PAH/DNA]5. Additionally, only the Ti-[PAH/DNA]5 
substrates showed an additional apatitic diffraction peak at 2θ = 28.0 (102) 24. On the other hand, 
apatitic diffraction peaks were less intense on Ti, and only broad maxima were observed between 2θ = 
28° and 2θ = 32°. Intensities of apatitic diffraction peaks were higher for Ti-[PAH/DNA]5 as compared to 
both Ti-[PDL/DNA]5 and Ti. After an immersion period of four weeks, all experimental substrates 
exhibited XRD-patterns similar to the one of Ti-[PAH/DNA]5 after only two weeks. 
FTIR-spectra of all experimental samples after one week of immersion in SBF2 consisted of weak 
phosphate absorption bands (data not shown). After two weeks of immersion in SBF2, FTIR-spectra 
showed more pronounced absorption bands on all experimental substrates (Figure 3), although 
substrate-dependent differences in intensity were observed (Ti-[PAH/DNA]5 > Ti-[PDL/DNA]5 > Ti). A 
broad absorption band at 3400 cm-1 (OH-stretching) and a small absorption band at 1646 cm-1 (H2O-
bending) were observed on all experimental substrates. Absorption bands characteristic for phosphate 
were observed at 957 (ν1 PO4-stretching), 1020 (ν3 PO4-stretching), and 1113 cm-1 (ν3 PO4-stretching).  
 
Figure 2: XRD-patterns of Ti, Ti-
[PDL/DNA]5, and Ti-[PAH/DNA]5 
substrates after immersion in 
SBF2 for two weeks. (A: apatite; 
T: titanium) 
 
Figure 3: FTIR-spectra of Ti, Ti-
[PDL/DNA]5, and Ti-[PAH/DNA]5 
substrates after immersion in SBF2 
for two weeks. 
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The incorporation of CO3-ions into the apatitic depositions is reflected by absorption bands at 872 (ν2 
CO3), 1412 (ν3 CO3-stretching B-type), 1451 (ν3 CO3-stretching B-type), and 1544 (ν3 CO3-stretching A-
type) cm-1 25. After a four week immersion period in SBF2, the FTIR-spectra of all experimental substrates 
were similar with absorption bands at identical positions and similar intensities as those of the spectrum 
of Ti-[PAH/DNA]5 after two weeks. 
Using EDS, it was demonstrated that the deposited spheroids contained calcium- as well as phosphorus-
atoms. The calcium/phosphate ratios of the deposited spheroids demonstrated to be in the range of 1.7 
– 2.0.  
The amount of calcium deposited on the experimental substrates during immersion in SBF2 was 
measured using the OCPC-method. The results (Figure 4) showed that a significantly higher amount of 
calcium (p<0.05) was found on Ti-[PAH/DNA]5 after one week compared to Ti. After two weeks, both Ti-
[PDL/DNA]5 and Ti-[PAH/DNA]5 showed significantly higher amounts of calcium (p<0.05) compared to 
Ti. No statistically significant (p>0.05) differences in the amount of deposited calcium were measured 
after an immersion period of 4 weeks. 
Osteoblast-like cell culture experiments 
Three independent runs of cell culture experiments showed similar results. Non-SBF-immersed DNA-
coatings were found to have no effects on osteoblast-like cell proliferation, differentiation, and 
morphology compared to controls. Therefore, only the results of SBF-pretreated DNA-coatings and non-
coated/non-SBF-pretreated controls are described in the following section.  
In Figure 5, the results for osteoblast-like cell proliferation are depicted. All experimental groups 
showed an increase in the cellular protein content between day 4 and 8 after cell seeding. Around day 
12, a maximum was reached in all experimental groups, after which cellular protein content in all 
experimental groups decreased from day 12 to day 16. Compared to controls, significantly decreased 
values were observed for Ti-[PDL/DNA]5-2w (p<0.05) at day 4, and for Ti-[PDL/DNA]5-1w (p<0.05) and 
Ti-[PAH/DNA]5-1w (p<0.05) at day 8. 
Figure 4: Calcium deposition 
on Ti (controls; white bars), Ti-
[PDL/DNA]5 (grey bars), and Ti-
[PAH/DNA]5 (black bars) after 
immersion in SBF2. (* p<0.05 
compared to controls [Ti]) 
 
Figure 5: Cellular protein content of osteoblast-like cells 
after culture on Ti-[PDL/DNA]5-1w, Ti-[PDL/DNA]5-2w, Ti-
[PAH/DNA]5-1w, Ti-[PAH/DNA]5-2w, and controls for 4, 8, 
12, and 16 days. Bars represent mean ± SD of one 
representative experiment out of 3. (* p<0.05 compared 
to controls [Ti]) 
 
Figure 6: Alkaline phosphatase (ALP) activity of 
osteoblast-like cells after culture on Ti-[PDL/DNA]5-1w, Ti-
[PDL/DNA]5-2w, Ti-[PAH/DNA]5-1w, Ti-[PAH/DNA]5-2w, 
and controls for 4, 8, 12, and 16 days. Bars represent 
mean ± SD of one representative experiment out of 3. 
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The results of the ALP activity measurements are depicted in Figure 6, and are indicative for the early 
differentiation of osteoblast-like cells. Similar to the results of cell proliferation, an increase in ALP 
activity was observed for all experimental groups from day 4 to day 8 after cell seeding. All experimental 
groups reached maximal ALP activity around day 12, after which in all groups ALP activity decreased. No 
statistically significant differences were observed compared to controls (p>0.05). 
The deposition of osteocalcin, as a marker of matrix mineralization, was measured on days 8, 16, and 24 
after cell seeding (Figure 7). The deposition of osteocalcin showed an increase in all experimental 
groups from day 8 to day 24 after cells seeding. Compared to controls, significantly increased levels 
were observed for Ti-[PDL/DNA]5-2w at day 16 (p<0.01) and day 24 (p<0.05), and for Ti-[PAH/DNA]5-2w 
at day 24 (p<0.05). 
Examination of the osteoblast-like cell cultures on the experimental substrates using electron 
microscopy indicated that in all experimental groups cells proliferated (Figure 8). No apparent 
microscopic differences were observed after 4 days osteoblast-like cell culture between the 
experimental groups. Generally, after 4 days of culture none of the surfaces of the experimental 
substrates was covered completely with a confluent layer of osteoblast-like cells. Instead, relatively 
large areas of the uncovered substrate surfaces were visible. On SBF-pretreated DNA-coatings, cells 
were positioned on the deposited CaP spheroids and cellular extensions were observed to bridge gaps 
between relatively high CaP spheroids (Figure 8A,D). On control substrates, osteoblast-like cells had a 
flat appearance and were spread out over the surface (Figure 8G). After 16 days of osteoblast-like cell 
culture, cells had formed a cellular multilayer on all experimental substrates. Furthermore, abundant 
formation of extracellular matrix, consisting of collagen fibers and mineralized globules, was observed 
on all experimental substrates. However, on Ti-[PDL/DNA]5-2w, on basis of visual inspection, the 
formation of mineralized globules appeared to be more pronounced than on any of the other 
experimental substrates (Figure 8B,C), which corroborates the results of the osteocalcin deposition. 
 
IV DISCUSSION 
The objective of this study was to detect potential effects of abundant phosphate groups in two types of 
multilayered DNA-coatings on (i) CaP nucleation and growth in SBF immersion experiments, and (ii) the 
behavior of osteoblast-like cells in vitro with or without pretreatment in SBF. It was demonstrated that 
DNA-coatings increase the deposition of CaP spheroids from SBF with doubled concentrations of 
calcium and phosphate ions compared to non-coated titanium controls. Deposited CaP spheroids were 
found to be composed of a poorly crystalline carbonated apatitic nature. Furthermore, cell culture 
experiments with osteoblast-like cells demonstrated that non-SBF-pretreated DNA-coatings did not 
affect cell proliferation, differentiation, and morphology compared to non-coated controls. However, 
two weeks pretreatment of DNA-coatings in SBF appeared to increase osteoblast-like cell 
differentiation, as observed by a decreased proliferation and an increased deposition of osteocalcin in 
the extracellular matrix. The formation of CaP depositions on biomaterials after immersion in SBF is a 
Figure 7: Osteocalcin deposition in 
extracellular matrix by osteoblast-
like cells cultured on Ti-
[PDL/DNA]5-1w, Ti-[PDL/DNA]5-
2w, Ti-[PAH/DNA]5-1w,  Ti-
[PAH/DNA]5-2w, and controls after 
8, 16, and 24 days. Bars represent 
mean ± SD of one representative 
experiment out of 3. (* p<0.05; ** 
p<0.01 compared to controls [Ti]) 
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well defined method to obtain first indications about potential bone bonding properties of 
biomaterials in vivo. Recently, Van der Wal et al. demonstrated that several types of ceramics 
remained inert in SBFx, with x below 1.4 26. Therefore, SBF with two different compositions (SBF1 and 
SBF2) were used in our immersion experiments. Immersion of Ti, Ti-[PDL/DNA]5, and Ti-[PAH/DNA]5 in 
SBF1 did not result in the formation of depositions on any of the substrates, which corroborates with 
the results of Van der Wal 26. However,  immersion of the substrates in SBF2 resulted in substrate-
dependent deposition of apatitic spheroids. At two weeks after immersion, the complete surface of 
Ti-[PAH/DNA]5 was covered with a thin layer of spheroids. In contrast, the deposition of spheroids on 
Ti and Ti-[PDL/DNA]5 was found to be directed away from the substrate surface, resulting in higher 
deposition spots (islands) rather than a complete surface coverage. The amount of calcium deposited 
on the experimental surfaces appeared to be significantly higher on both types of DNA-coatings. 
Together, these results indicate a predisposition of DNA-coatings for the deposition of apatitic 
spheroids and corroborate the results of experiments that demonstrated that phosphate groups at 
the substrate surface are potent inducers of heterogeneous CaP nucleation and growth in SBF 6;7. 
Differences in the amount and morphological appearance of the depositions are probably related to 
(i) differences in surface roughness of both types of DNA-coatings prior to SBF immersion 8, (ii) the 
conformation of DNA-molecules in the coating (Z-conformation in [PDL/DNA]5; B-conformation in 
[PAH/DNA]5 17), and/or the interference of the cationic polyelectrolyte. The influence of surface 
roughness remains speculative as the data on this subject are contradictory. Leitao et al. 
demonstrated that rougher surfaces induce scattered crystal-like depositions, whereas smoother 
surfaces exhibit a more plate-like deposition morphology 27. On the other hand, Barrere et al. 28 
demonstrated that heterogeneous nucleation of CaP on titanium from a supersaturated SBF (SBF5) 
Figure 8: Scanning electron microscopy images of osteoblast-like cell cultures on Ti-[PDL/DNA]5-2w (A,B,C), Ti-[PAH/DNA]5-
2w (D,E,F), and controls (G,H,I) after 4 (A,D,G) and 16 (B,C,E,F,H,I) days post-seeding. 
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was independent of surface roughness, but that rough topography was beneficial for further growth 
and mechanical attachment of the final CaP-coating. In view of DNA-conformation in the DNA-coatings, 
the difference in screw sense between the Z- and the B-form of DNA is accompanied by differences in 
helix diameter and hence the number of base pairs per turn of the helix, which is increased in Z-form 
DNA 29. This results in specific spatial distributions of the phosphate groups in the DNA-molecules. 
Interference of the cationic electrolyte used during the build up of the coatings, either PDL or PAH, in 
terms of blocking phosphate groups in the electrostatically bonded DNA molecules with calcium ions in 
the SBFs is more likely for PDL, as this polymer is capable of diffusing throughout polyelectrolyte 
multilayers 30. However, this property of PDL, which is also the critical factor for exponential growth of 
polyelectrolyte multilayers after the deposition of multiple double-layers, is expected to be of limited 
relevance in the present study, which used linearly-growing DNA-coating consisting of only 5 double-
layers 8.  
The results of the XRD and FTIR measurements corroborate the findings of SEM and calcium deposition. 
The intensities of the absorbance bands were high on Ti-[PAH/DNA]5, intermediate on Ti-[PDL/DNA]5, 
and low on Ti after a two week immersion period in SBF2. The apatitic spheroids deposited on all types 
of substrates contained carbonate ions, which became apparent after two weeks of immersion in SBF2. 
The carbonate ions were incorporated at PO4-sites (B-type substitution), and via hydroxyl substitution 
(A-type substitution). The presence of a mixed-type AB carbonate apatite might further explain the 
increased calcium-to-phosphate ratios compared to those in biological HA (Ca/P = 1.67), measured by 
EDS, as the substitution of phosphate by carbonate results in increased calcium-to-phosphate ratios. 
For cell culture experiments, the choice of experimental groups was based on (i) the effects DNA-
configuration and roughness of non-SBF-immersed DNA-coatings, and (ii) the CaP-coverage and 
roughness of SBF pretreated DNA-coatings. Since an immersion period of 4 weeks resulted in the 
complete coverage of the non-coated control substrates and both types of DNA-coatings, these 
substrates were not enrolled in the cell culture experiments with osteoblast-like cells. 
Cell culture experiments with osteoblast-like cells revealed that non-SBF-immersed DNA-coatings do 
not change osteoblast-like cell behavior. In contrast, previous experiments in our group have 
demonstrated that the proliferation of primary rat dermal fibroblast was increased on both types of 
DNA-coatings compared to non-coated controls 13;14. Apparently, the increased proliferation on DNA-
coatings is cell type-dependent. 
Pretreatment of DNA-coatings in SBF was found to affect osteoblast-like cell differentiation, as 
evidenced by the increased deposition of osteocalcin in the extracellular matrix. It may be argued that 
for proper comparison of osteocalcin deposition levels these data should be corrected for cell amount. 
Unfortunately, prolonged culture of osteoblast-like cells and concomitant differentiation of these cells 
are related to difficulties in retrieving samples for the determination of cell amount 31. On the other 
hand, the data on osteocalcin deposition are supported by the SEM observations, which show more 
pronounced extracellular matrix formation, especially for Ti-[PDL/DNA]5-2w substrates. Furthermore, 
the increase in osteocalcin deposition corroborates with other studies that demonstrated the  cytoactive 
nature of CaP 32;33. 
Unambiguously, the 2-week pretreatment of DNA-coatings in SBF resulted in a complete change in 
surface characteristics from those described in our previous work 8 to a CaP surface as characterized in 
this work. The differences in CaP-coverage and final substrate roughness can explain the observed 
differences in osteocalcin deposition by osteoblast-like cells on the two experimental groups that 
received a 2-week pretreatment and are in line with previously reported effects of surface roughness on 
osteoblast-like cell behavior 34-36. Pretreatment of DNA-coatings in SBF for 1 week resulted in surfaces 
with properties that are a mixture of those of these DNA-coatings 8 and those of coatings with partial 
CaP-coverage. This could be an explanation for the similarities in osteoblast-like cell behavior on 1-week 
pretreated DNA-coatings and that on non-coated controls.  
Although the results of this study can be interpreted as being promising for the in vivo bioactivity of 
DNA-coatings, future animal experiments are necessary to classify DNA-coatings as bioactive. In such in 
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vivo experiments, many important biological processes that affect direct bone-bonding are combined in 
an overlapping sequential fashion, including both non-cellular and cellular interactions. Furthermore, as 
the formation of CaP-depositions was observed to be dependent on the cationic polyelectrolyte used 
for the built up of the DNA-coatings, other cationic counterparts may further enhance the deposition 
process. 
 
CONCLUSION 
This study demonstrates that surface treatment of titanium with DNA-coatings increases its potential to 
nucleate CaP-deposition from SBF. The surface coverage was dependent on the cationic counterpart of 
DNA in the DNA-coating. While [PDL/DNA]5 coatings and non-coated titanium controls showed spot-like 
depositions after two weeks of immersion in SBF2, [PAH/DNA]5 coatings were completely covered by a 
continuous layer of carbonated apatitic spheroids. Non-SBF-pretreated DNA-coatings were found to 
have no effects on osteoblast-like cell behavior. On the other hand, SBF-pretreatment of DNA-coatings 
affected the differentiation of osteoblast-like cells through an increased deposition of osteocalcin. The 
results of this study are indicative for bone-bonding capacities of DNA-coatings. Nevertheless, future 
animal experiments are required to provide conclusive evidence for the bioactivity of DNA-coatings. 
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I INTRODUCTION 
In the field of implantology, control over tissue responses after the insertion of a biomaterial remains a 
challenge. Several approaches to modulate tissue responses have been investigated in the past 
decades, including topographical and/or chemical modulations at the biomaterial surface. Additionally, 
biomaterials have been combined with biologically active factors to induce desired tissue responses in 
the direct vicinity of the implant. 
In the early 90’s, a versatile coating technique has been developed 1, known as layer by layer (LbL) 
assembly or electrostatic self-assembly (ESA). This technique is based on the sequential adsorption of 
oppositely-charged polyelectrolytes into multilayered structures (polyelectrolyte multilayers; PEMs) 2. 
Due to the wide choice of polyelectrolytes, this technique allows the generation of coatings with 
numerous different properties. 
Previously, the application of ESA to fabricate multilayered coatings consisting of DNA and a 
polycationic counterpart has been described 3-8. In our previous work, we fabricated multilayered DNA-
coatings onto glass and titanium substrates consisting of deoxyribonucleic acid (DNA) as the anionic 
polyelectrolyte and either poly-D-lysine (PDL) or poly(allylamine hydrochloride) (PAH) as its cationic 
counterpart 9. In these studies, in particular DNA was chosen not for its genetic information, but for its 
beneficial biomaterial properties, which include non- or low-immunogenicity 10-12, capability to 
incorporate other compounds 13;14, and high phosphate content. In view of these properties, 
multilayered DNA-coatings are known to be cyto- and histocompatible 15, and proposed to be eligible 
for drug-delivery and favorable for the deposition of calciumphosphates in a bony environment. 
Additionally, the complexation of DNA with cationic polyelectrolytes has demonstrated to prevent DNA 
from nucleolytic degradation 16, which is indicative for the stability of multilayered DNA-coatings.  
For drug-delivery purposes, the use of multilayered coatings can be based on functional components of 
the (biodegradable) multilayered structure itself 17-20. On the other hand, functionalization of 
multilayered coatings can be based on the incorporation of biologically active factors within the basic 
multilayer structure. Several reports have already demonstrated this approach for the regulation of 
biological responses, using both in vitro 21-27 and in vivo 28 experiments. In these latter studies, a variety 
of biologically active factors were used, which were embedded through covalent bonding 21;25;27;28, 
adsorption 22, or complexation (with or without chaperone molecules) 23;24;26;29. However, the focus of 
these studies was to evaluate the potential of functionalized multilayered coatings, in which the 
biologically active factor was incorporated at a single location in a multilayer architecture. On the 
contrary, the present study is aimed at the functionalization of multilayered DNA-coatings with the 
osteoinductive factor bone morphogenetic protein 2 (BMP-2) using different loading modalities. 
Clinically, BMP-2 could be used to accelerate the process of osseo-integration of orthopedic and dental 
implants. It is hypothesized that the location of the factor in a multilayered coating influences its release 
profile and affects the behavior of osteoblast-like cells in in vitro experiments. 
The current study focused on three types of functionalization of multilayered DNA-coatings built up 
from either poly-D-lysine (PDL) or poly(allylamine hydrochloride) (PAH) as the cationic component and 
DNA as the anionic component. The amounts of BMP-2 loaded into the multilayered DNA-coatings and 
its subsequent release characteristics were determined using radiolabeled BMP-2. Subsequently, the 
effect of BMP-2 functionalized multilayered DNA-coatings on the in vitro behavior of bone marrow-
derived osteoblast-like cells was evaluated in terms of proliferation, differentiation, mineralization, and 
cell morphology. 
 
II MATERIALS & METHODS 
Materials 
Polyanionic DNA (300 bp/molecule; sodium salt) was kindly provided by the Central Research 
Laboratory of Nichiro Corporation (Kawasaki-shi, Kanagawa prefecture, Japan). Potential protein 
impurities in the DNA were checked using the BCA protein assay (Pierce, Rockford, IL, US) and measured 
to be below 0.20% w/w (data not shown). Polycationic polyelectrolytes poly(allylamine hydrochloride) 
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(PAH;  MW ~70000) and poly-D-lysine (PDL; MW 30,000 – 70,000) were purchased from Sigma (Sigma-
Aldrich Chemie B.V., Zwijndrecht, the Netherlands). Recombinant human bone morphogenetic protein 
2 (rhBMP-2; MW 32,000; in MFR buffer [containing 0.5% sucrose, 2.5% glycine, 30 mM L-glutamic acid, 
0.01% polysorbate 80, pH 4.5]) was generously supplied by Yamanouchi Europe B.V. (Leiderdorp, the 
Netherlands). All materials were used without further purification. 
 
Substrate preparation and cleaning 
Disc-shaped titanium substrates (diameter 12 mm; as machined) were used. Prior to the fabrication of 
multilayered DNA-coatings, substrates were cleaned ultrasonically in nitric acid (10% v/v), acetone, and 
isopropanol, respectively. Subsequently, the substrates were air-dried. 
 
Generation of multilayered DNA-coatings 
Multilayered DNA-coatings were generated using the ESA-technique, as described previously 9. Briefly, 
the cleaned substrates were immersed in an aqueous solution of either PDL (0.1 mg/ml) or PAH (1 
mg/ml) for 30 minutes, allowing sufficient time for the adsorption of the first cationic polyelectrolyte 
layer onto the substrates. Subsequently, the substrates were washed in ultra-pure water (5 minutes, 
continuous water flow) and dried using a pressurized air stream. Thereafter, the substrates were 
alternately immersed in an anionic aqueous DNA solution (1 mg/ml) and the respective cationic 
polyelectrolyte solution for 7 minutes each, with intermediate washing in ultra-pure water (5 minutes, 
continuous water flow) and drying using a pressurized air stream. The build-up of the multilayered 
DNA-coatings was continued until a total of 5 double-layers were reached. These coatings were 
designated either [PDL/DNA]5 or [PAH/DNA]5. 
 
Functionalization of multilayered DNA-coatings 
Multilayered DNA-coatings were functionalized with rhBMP-2 according to three different loading 
modalities (Figure 1). The loading modalities are designated superficial (s), deep (d), and double-layer 
(dl), depending on the location of the BMP-2. During the build-up of the multilayered DNA-coatings, 
rhBMP-2 was loaded at the appropriate location from a rhBMP-2 solution without precipitates (10 µl of 
a 10 µg/ml rhBMP-2 solution in 0.5% (w/v) BSA/PBS) and allowed to adsorb for 7 minutes. Unless the 
rhBMP-2 was applied on top of the multilayered DNA-coatings, substrates were washed in ultra-pure 
water, after which the build up of the coatings was continued as described above. rhBMP-2 applied on 
top of the coatings (in case of s-loading and the final loading step in dl-loading) was allowed to dry at 
room temperature. 
  
 
 
Figure 1: Schematic representation of 
the different loading modalities of 
multilayered DNA-coatings with BMP-
2. Note the difference in BMP-2 (green 
spheres indicate dropcast BMP-2 
without subsequent wash steps; white 
spheres indicate incorporated BMP-2 
with subsequent wash steps during 
build-up of the coatings). 
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Radioiodination of rhBMP-2 
rhBMP-2 was labeled with 125I according to the iodogen method, as described previously 30. Briefly, to a 
500 µl eppendorf vial containing 100 µg iodogen, 10 µl  0.5 M phosphate buffer (pH 7.4), 80 µl 50 mM 
phosphate buffer (pH 7.4), 10 µg rhBMP-2 (in 2.6 µl PBS), and 3 µl 125I (0.3 mCi) were added. The vial 
was incubated at room temperature for 10 minutes. Subsequently, the quench reaction was initiated by 
adding 100 µl of a saturated Tyrosine solution in PBS. Finally, the reaction mixture was eluted with 0.5% 
BSA/PBS on a pre-rinsed disposable Sephadex G25M column (PD-10; Pharmacia, Uppsala, Sweden) to 
separate labeled rhBMP-2 from free 125I. To prevent sticking of the rhBMP-2, pipette tips and vials used 
during the radioiodination procedure were silanized with SigmaCoat® (Sigma). 
The radiochemical purity of the 125I-labeled rhBMP-2 was determined by instant thin-layer 
chromatography (ITLC) on Gelman ITLC-SG strips (Gelman Laboratories, Ann Arbor, MI, USA) with 0.1 M 
citrate, pH 5.0 as the mobile phase. The radiochemical purity of the 125I-labeled rhBMP-2 preparation 
was 97.3%, which indicates that 97.3% of the 125I-label was covalently linked to rhBMP-2. The specific 
activity of the labeled rhBMP-2 was 14.1 µCi/µg. 
 
Determination of rhBMP-2-loading and in vitro rhBMP-2 release 
The amount of rhBMP-2 loaded in the functionalized multilayered DNA-coatings was determined using 
radiolabeled rhBMP-2. Functionalization was performed as described in the section ‘Functionalization of 
multilayered DNA-coatings’, with the exception that radiolabeled rhBMP-2 was used. For each type of 
coating, three substrates (n=3) were coated with a functionalized multilayered DNA-coating. 
The loaded amount of rhBMP-2 was determined by measuring activity of the experimental substrates in 
a shielded well-type gamma counter (Wizard, Pharmacia-LKB, Sweden). The amount of gamma 
radiation from the deep (d-functionalization) and double-layer (dl-functionalization) loaded 
multilayered DNA-coatings was calculated using that of superficially loaded (s-functionalization) 
multilayered DNA-coatings, which was artificially set at 100 ng. 
To study the in vitro release characteristics of rhBMP-2, the substrates modified with a type of 
functionalized multilayered DNA-coating (n=3) were placed separately in 10 ml glass vials containing 4 
ml PBS, and incubated statically at 37°C for up to 8 weeks. At selected time points (4 hours, 1, 7, 14, 22, 
28, 42, and 56 days) the samples were carefully transferred into new vials containing fresh PBS. 
Subsequently, the activity on the substrates was measured in a gamma counter. Standards were 
counted simultaneously to correct for radioactive decay. 
 
In vitro experiments 
Experimental groups 
For cell culture experiments, 7 experimental groups were used, based on coating composition and 
loading modality: 
1. [PDL/DNA]5-s (superficial) 
2. [PDL/DNA]5-d (deep) 
3. [PDL/DNA]5-dl (double-layer) 
4. [PAH/DNA]5-s (superficial) 
5. [PAH/DNA]5-d (deep) 
6. [PAH/DNA]5-dl (double-layer) 
7. control (non-coated titanium) 
The use of a control consisting of non-coated titanium is justified as previous in vitro experiments have 
demonstrated that osteoblast-like cells behave similar on non-coated titanium compared to both 
[PDL/DNA]5 and [PAH/DNA]5 multilayered coatings with respect to cell proliferation, differentiation, 
mineralization, and morphology (unpublished data). 
All substrates, coated with either type of multilayered DNA-coating or non-coated 
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control substrates, were sterilized using a UV-irradiation treatment (254 nm; 4 hrs). The entire cell 
culture experiment was performed in two independent runs, using rat bone marrow cells from one rat 
per experimental run. 
 
Isolation and pre-culture of rat bone marrow cells 
Rat bone marrow (RBM) cells were isolated an cultured according to the method adapted from 
Maniatopoulos et al. 31. Briefly, the femora of male Wistar WU rats were retrieved, cleaned, and 
epiphyses were cut off. The marrow was flushed out of the remaining diaphyses using cell culture 
medium (α-MEM (Gibco) supplemented with 10% fetal calf serum (FCS; Gibco), 50 µg/ml ascorbic acid 
(Sigma), 10 mM Na-β-glycerophosphate (Sigma), 10-8 M dexamethasone (Sigma), and 50 µg/ml 
gentamycin (Gibco)). RBM cells of two femora were cultured under static conditions in cell culture 
medium in three 75 cm2 culture flasks (Greiner Bio-One) for one day, after which the medium was 
refreshed to remove non-adherent cells. Subsequently, the attached cells were pre-cultured for another 
6 days. After the primary culture of 7 days to obtain osteoblast-like cells, cells were detached using 
trypsin/EDTA (0.25% (w/v) trypsin, 0.02% (w/v) EDTA) and the total cell number was determined using a 
Coulter® counter (Beckman Coulter Inc., Fullerton, CA, USA). Finally, cells were seeded at a density of 1 x 
104 cells/cm2 onto the experimental substrates, which were placed in a 24-wells plate (Greiner Bio-One). 
Cell culture medium was refreshed 1 day after cell seeding, and thereafter 3 times per week. 
 
Cell proliferation 
Cell proliferation curves were made based on a total cellular protein measurement. At 4, 8, 12, and 16 
days post-seeding, the medium was removed and the cells were washed with PBS three times. 
Subsequently, the experimental substrates with attached cells were transferred into fresh 24-wells 
plates, and each experimental substrate was immersed in 1 ml ultra-pure water. These samples were 
frozen and thawed for 3 repetitive cycles, after which the cellular protein content in the aqueous 
samples was analyzed using a micro BCA protein assay (Pierce, Rockford, IL, USA) according to the 
instructions of the manufacturer. In each experimental run, three samples per time point for each 
experimental condition (n=3) were used to ensure reproducibility. 
 
Alkaline phosphatase activity 
The alkaline phosphatase (ALP) activity of the osteoblast-like cells was measured as a marker for early 
differentiation of osteoblast-like cells using the aqueous samples of the proliferation assay according to 
a previously described method 32. A volume of 80 µl of sample or standard and 20 µl of buffer solution 
(5 mM MgCl2, 0.5 M 2-amino-2-methyl-1-propanol) was pipetted into a 96-wells plate (Greiner Bio-One) 
in duplo, and 100 µl of substrate solution (5 mM p-nitro-phenyl-phosphate) was added per well. 
Subsequently, the plate was incubated for one hour at 37°C, after which the reaction was stopped by 
adding 100 µl 0.3 M NaOH. Serial dilution of 4-nitrophenol (final concentrations 0 – 25 nM) were used 
for the standard curve. The plate was read in an ELISA reader at 405 nm. In each experimental run, three 
samples per time point for each experimental condition (n=3) were used. 
 
Calcium deposition 
The deposition of calcium was used as a marker of late differentiation of osteoblast-like cells. The 
amount of calcium deposited after 4, 8, 12, 16, and 24 days of cell culture was measured by the 
orthocresolphtalein complexone (OCPC) method (Sigma), as described previously 33. Briefly, the 
experimental substrates were washed twice using PBS, after which 1 ml 0.5 N acetic acid was added. 
After overnight incubation on a shaking apparatus, 300 µl working solution was added to 10 µl sample 
in a 96-wells plate (Greiner Bio-One). Working solution consisted of (a) OCPC solution (80 mg OCPC in 75 
ml milliQ + 0.5 ml 1 M KOH + 0.5 ml 0.5 N acetic acid), (b) 14.8 M ethanolamine/boric acid buffer 
(pH=11), (c) 8-hydroxyquinoline (1 g in 20 ml 95% ethanol), and (d) milliQ, in a ratio of 5:5:2:88 (a:b:c:d). 
A standard curve was generated by preparing serial dilutions of CaCl2 (0 – 100 µg/ml). For each 
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experimental run, the calcium assay was performed using 3 substrates per experimental condition at 
each time point (n=3).  
 
Cell morphology 
Scanning electron microscopy (SEM) was performed to evaluate the morphological appearance of the 
cells. At 4 and 16 days post-seeding, substrates with attached cells were washed twice with PBS and 
fixed using gluteraldehyde (4% in 0.1 M cacodylate buffer) for 20 minutes. Subsequently, the substrates 
were washed twice with 0.1 M cacodylate buffer and dehydrated in a graded series of ethanol. Finally, 
the substrates were dried with tetramethylsilane, sputter coated with gold and examined using a JEOL 
6310 SEM at an acceleration voltage of 10 kV. 
 
Statistical analysis 
Measurements were statistically evaluated with Graphpad® Instat 3.05 software (GraphPad Software 
Inc., San Diego, CA, USA). Data of the in vitro release experiment and the cell culture experiments were 
analyzed using a one-way ANOVA, combined with a post-hoc Tukey-Kramer Multiple Comparisons test. 
The significance level was set at p<0.05. 
 
III RESULTS 
Loading of multilayered DNA-coatings with rhBMP-2 
The amounts of rhBMP-2 loaded into the multilayered DNA-coatings are presented in Figure 2. The 
results demonstrate that the amount of rhBMP-2 incorporated into the differently-loaded multilayered 
DNA-coatings was highest with dl-loading (± 160 ng ≈ 140 ng/cm2), intermediate with s-loading (100 
ng ≈ 88 ng/cm2), and lowest with d-loading (± 15 ng ≈ 13 ng/cm2). No statistically significant 
differences were observed between [PDL/DNA]-based coatings and [PAH/DNA]-based coatings. The 
loading efficiency was 100% for s-loading, 15% for d-loading, and 32% for dl-loading.  
In vitro release of rhBMP-2 from multilayered DNA-coatings 
The in vitro release characteristics of rhBMP-2 from multilayered DNA-coatings were determined using 
radiolabeled rhBMP-2. In Figures 3A and 3B, the cumulative release of rhBMP-2 out of the differently-
loaded multilayered DNA-coatings is depicted. All differently-loaded multilayered DNA-coatings 
revealed an initial burst release within the first 24 hours of incubation in PBS, ranging from 35 to 75% of 
the initially loaded amount rhBMP-2. Proportionally, the burst release was low for d-loaded (47.6% for 
[PDL/DNA]-based and 34.8% for [PAH/DNA]-based multilayered DNA-coatings) and high for both s- and 
dl-loaded multilayered DNA-coatings (>60%). After the burst release, all differently-loaded multilayered 
DNA-coatings showed an incremental sustained release, in which a continuous fraction of 
approximately 6 - 8% of the remaining rhBMP-2 was released in each week (Table 1). After an 
incubation period of 8 weeks, the cumulative rhBMP-2 release of the d-loaded multilayered DNA-
coatings approximated 70%, whereas both the s-loaded and the dl-loaded DNA-coatings released 
Figure 2: Incorporation of 
rhBMP-2 into multilayered 
DNA-coatings. The amount of 
gamma radiation of s-loaded 
coatings was artificially set at 
100 ng, after which d- and dl-
loading were calculated 
accordingly. Results are 
presented as mean + SD (n=3). 
(Loading efficiencies are 100, 
15, and  32% for s-, d-, and dl-
loading, respectively) 
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approximately 85%, cumulatively. Statistical analysis revealed that actual cumulative amounts of 
released rhBMP-2 were highest for dl-loading, intermediate for s-loading, and lowest for d-loading. No 
statistically significant differences were observed between equivalently functionalized coatings based 
on either [PDL/DNA] or [PAH/DNA] regarding release characteristics in percentage terms (p>0.05). 
Osteoblast-like cell behavior on rhBMP-2-loaded multilayered DNA-coatings 
The behavior of osteoblast-like cells on the differently-loaded multilayered DNA-coatings was evaluated 
to detect biological activity of the incorporated rhBMP-2. 
 
Cell proliferation 
The proliferation of osteoblast-like cells, based on total cellular protein content measurements, is 
depicted in Figure 4. Osteoblast-like cells showed a similar proliferation pattern on all types of 
differently-loaded multilayered DNA-coatings and non-coated control substrates. After cell seeding, 
osteoblast-like cells started proliferating, reaching a maximum around day 12, after which a decrease 
was observed. Somewhat lower, but significantly different levels of cellular protein content were 
observed in both types of d-loaded multilayered DNA-coatings on day 12 ([PDL/DNA]5-d vs. control, 
p<0.01; [PAH/DNA]5-d vs. control, p<0.05). After 16 days of osteoblast-like cell culture, no significant 
different levels were observed between both types of d-loaded multilayered DNA-coatings and controls 
(p>0.05). 
Figure 3: In vitro release of rhBMP-2 from differently-loaded multilayered DNA-coatings after immersion in PBS. (A) Release 
characteristics of [PDL/DNA]-based multilayered DNA-coatings; (B) Release characteristics of [PAH/DNA]-based multilayered 
DNA-coatings (s = superficial, d = deep, dl = double-layer). Results are presented as mean± SD (n=3). 
 
Figure 4:Proliferation of bone marrow-derived 
osteoblast-like cells on differently-loaded 
multilayered (A) [PDL/DNA]- and (B) 
[PAH/DNA]-coatings. (* p<0.05; ** p<0.01 
compared to controls) 
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Alkaline phosphatase activity 
Osteoblast-like cells showed a normal ALP-activity expression on all experimental substrates. The ALP-
activity increased on all experimental substrates during the first 12 days of culture, after which a rapid 
decrease in ALP-activity was observed (Figure 5). Significant differences compared to controls (p<0.05) 
were observed on day 12 for both types of d-loaded multilayered DNA-coatings. 
Calcium deposition 
The deposition of a mineralized extracellular matrix by osteoblast-like cells was determined by 
measuring the amounts of calcium deposited on the experimental substrates during cell culture (Figure 
Figure 5: Alkaline phosphatase (ALP) activity 
of bone marrow-derived osteoblast-like cells on 
differently-loaded multilayered (A) [PDL/DNA]- 
and (B)  [PAH/DNA]-coatings. (*p<0.05 
compared to controls) 
 
Figure 6: Mineralization (calcium deposition) 
by bone marrow-derived osteoblast-like cells 
on differently-loaded multilayered (A) 
[PDL/DNA]- and (B) [PAH/DNA]-coatings. 
(* p<0.05; *** p<0.001 compared to controls) 
VI Functionalization of  Multilayered DNA-coatings with BMP-2 
 93
6). An accelerated calcium deposition by osteoblast-like was observed on s- and dl-loaded multilayered 
DNA-coatings compared to non-coated controls. On day 12, osteoblast-like cells on s- and dl-loaded 
multilayered DNA-coatings had deposited significantly increased amounts of calcium compared to non-
coated controls (p<0.001). On the other hand, d-loaded multilayered DNA-coatings demonstrated to 
decrease calcium deposition by osteoblast-like cells. Significantly decreased amounts of deposited 
calcium were observed on these types of functionalized multilayered DNA-coatings on days 16 and 24 
(p<0.001). 
 
Cell morphology 
The morphological appearance of the osteoblast-like cells cultured on the differently-loaded 
multilayered DNA-coatings was evaluated using scanning electron microscopy. At day 4, all differently-
loaded multilayered DNA-coatings and non-coated controls were covered with a layer of osteoblast-like 
cells. No apparent differences in cell morphology were observed. In contrast, at day 16 d-loaded 
multilayered DNA-coatings showed an aberrant morphological appearance of osteoblast-like cells 
compared to all other experimental groups (Figure 7). Many calcified globular accretions associated 
with collagen bundles were present on s-, and dl-loaded multilayered DNA-coatings, and non-coated 
controls. Less characteristics of mineralization were observed on d-loaded multilayered DNA-coatings. 
Figure 7: Scanning electron microscopy 
images of bone marrow-derived 
osteoblast-like cells after 16 days of culture 
on differently-loaded multilayered DNA-
coatings. (A) non-coated control, (B) 
[PAH/DNA]5-s, (C) [PAH/DNA]5-d, and (D) 
[PAH/DNA]5-dl. Note the difference in 
globular accretions at the high 
magnification images (E-H).  
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IV DISCUSSION 
The functionalization of biomaterial coatings with biologically-active factors is of interest, as localized 
drug delivery reduces systemic side effects and increases drug efficiency. In view of this, the 
functionalization of polyelectrolyte multilayers offers increased application due to the possibility of 
generating ESA-based coatings onto many different materials used for both soft and hard tissue 
implants without restrictions regarding geometry. The aim of the current study was to explore the 
potential of multilayered DNA-coatings, based on [PDL/DNA] and [PAH/DNA] double-layers, for 
functionalization with the osteoinductive factor BMP-2. To that end, three different modalities of BMP-
loading were chosen, based on the location of BMP-2 in the multilayered DNA-coating (i.e. superficial, 
deep, and double-layer). The incorporation and release of BMP-2 were quantitatively assessed using 
radiolabeled BMP-2. Additionally, functionalized multilayered DNA-coatings were used in cell culture 
experiments to assess their biological effects on rat bone marrow-derived osteoblast-like cells. The 
results demonstrated the feasibility of multilayered DNA-coatings to be functionalized with BMP-2 
according to all three loading modalities, and that the loading and release characteristics are 
independent of the cationic counterpart of DNA in the multilayered coating (i.e. PDL or PAH). All types 
of functionalized multilayered DNA-coatings showed an initial bulk release within 24 hours followed by 
an incremental sustained release. The in vitro experiments with osteoblast-like cells revealed that the 
loaded BMP-2 remained biologically active. Superficial and double-layer loading resulted in accelerated 
calcium deposition, whereas deep loading decreased the deposition of calcium by osteoblast-like cells. 
The use of multilayered coatings to modulate cell/tissue responses has been described previously and 
was based on the functionality of basic multilayered structure components (i.e. polyelectrolytes) 17-20 or 
additional biologically-active components 21-26;28. In the present study, BMP-2 was incorporated as an 
additional component in multilayered coatings, which consisted of either PDL or PAH as the cationic 
counterpart of anionic DNA. These coatings demonstrated to contain approximately 3 µg DNA per 
double-layer per square centimeter, irrespective of the cationic polyelectrolyte used 9. Recombinant 
human BMP-2 was incorporated after the adsorption of a negatively-charged DNA-layer, as the iso-
electric point of BMP-2 is 8.5, which indicates a positive charge of BMP-2 under physiological conditions 
34. However, due to the presence of (negatively-charged) BSA in the BMP-2 solution, interference of 
electrostatic interactions between the BMP-2 and DNA is likely. Additionally, the interaction of BSA with 
BMP-2 potentially results in the incorporation of BSA-BMP-2 complexes rather than pure BMP-2, which 
could also affect its release.  
Functionalization of multilayered DNA-coatings according to the chosen loading modalities (Figure 1) 
demonstrated that the differently-loaded multilayered DNA-coatings bear the following proportion to 
one another: s + (4 * d) = dl. From this proportion it becomes evident that constant amounts of BMP-2 of 
approximately 15 ng can be incorporated into the coatings after a DNA-layer in case of subsequent 
wash steps. Additionally, this proportion indicates that the build-up of the multilayered DNA-coatings is 
not affected by the incorporation of factor. In view of this, the continuous build-up of multilayered 
coatings with adsorbed factors has already been demonstrated previously using Optical Waveguide 
Lightmode Spectrometry 22. Calculations on the loading of multilayered DNA-coatings correspond to a 
BMP-2 incorporation of ~13 ng/cm2 (1 µg DNA immobilizes ~4.5 ng BMP-2), which are well in line with 
incorporation efficiencies of other factors into other types of multilayers. For instance, brain-derived 
neurotrophic factor (BDNF) could be incorporated through adsorption to an amount of 96.4 ng/cm2 into 
[PSS/PAH]-based multilayers 22. Similarly, the chemorepulsive protein Semaphorin 3A could be 
incorporated to an amount of 25.4 ng/cm2 into identical multilayer structures 22. Both BDNF and 
Semophorin 3A were adsorbed after polystyrene sulphonate in [PSS/PAH]-based multilayers. Although 
these studies as well as the present study show loading efficiencies of tens of nanograms per square 
centimeter, it has to be emphasized that due to differences in properties of the multilayer components, 
the factors used for functionalization, and the conditions during multilayer build-up (e.g. salt 
concentration, pH, etc.), the actual loading efficiency through adsorption is likely to be influenced. 
Additionally, an increase in the amount of functionalization factor can be achieved using several 
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approaches. The most feasible one is to increase the number of double-layers in a multilayer structure, 
which will increase the total amount of biologically-active factor and has been demonstrated to be 
effective 35. Another approach is the complexation of the biologically-active factor with chaperone 
molecules. This method has demonstrated to be applicable for anti-inflammatory agents, including 
piroxicam 23 and a lipid A-antagonist 24, and increases the loading efficiency without affecting the 
biological activity of the factor. Other approaches include covalent bonding of factors to 
polyelectrolytes 21;25;28 prior to the generation of multilayered structures. Although this last method 
seems preferable in terms of controlling the loaded amount of factor, the biological activity of the factor 
might be affected by covalent bonding. For instance, covalent bonding might change the native 
structure of the factor, which impairs the availability of functional epitopes for cell surface receptors. 
Additionally, covalent bonding only allows release of the factor in case of degradation of the 
multilayered coating, which might limit its availability in the peri-implant surroundings. This has been 
demonstrated previously by Jessel et al. 21, who showed a reduced biological activity of a covalently-
bound factor underneath poly-D-lysine-containing compared to biodegradable poly-L-lysine-
containing double-layers. Consequently, covalent bonding of factors in an effort to introduce biological 
activity into multilayered coatings is only functional if (i) the polyelectrolytes are biodegradable, (ii) the 
factor is located such, that it is available for cells via cellular membrane extension, or (iii) a combination 
of both. 
For bone tissue engineering approaches, in which BMP-2 is the most powerful osteoinductive factor to 
be used 36, it is important to tailor the availability of the osteoinductive factor in such a way that the 
behavior of mesenchymal stem cells is controlled in terms of migration, differentiation, and secretion of 
extracellular matrix. The current study showed that the BMP-2 release pattern of the differently-loaded 
multilayered DNA-coatings consisted of two phases: (i) a bulk release of 35 – 75% within 24 hours, and 
(ii) an incremental sustained release of approximately 6 – 8% of the remaining BMP-2 weekly for (at 
least) 8 weeks. The bulk release might be due to differences in the composition of the solutions used 
during multilayer build-up and the release medium, which contained ionic species that are likely to 
affect electrostatic interactions. Bulk release was lowest for both types of d-loaded multilayered DNA-
coatings. This is most likely due to the absence of dropcast BMP-2 on top of these multilayered DNA-
coatings and increased interactions of BMP-2 with the polyelectrolytes in the coating. Different BMP-2 
release profiles have been reported by others using different carriers. For instance, ceramics have 
demonstrated to bind BMP-2 with high affinity, resulting in a limited release 37;38. On the other hand, 
biodegradable scaffolds consisting of either polycaprolactone (PCL) or a composite of PCL with calcium 
phosphate showed BMP-2 release profiles in which 100% release was established within 3 weeks 39. The 
specific requirements for BMP-2 to be effective in vivo, however, remain unclear, since both release 
profiles induced osteogenic differentiation in vivo and in vitro, respectively.  
The bioactivity of the BMP-2 loaded into the multilayered DNA-coatings was assessed using an in vitro 
cell culture model with rat bone marrow-derived osteoblasts. The results indicate the presence of a 
threshold for the osteoinductive capacity of BMP-2, as only functionalized multilayered DNA-coatings 
containing relatively high amounts of BMP-2 (s- and dl-loaded coatings) accelerated the deposition of 
calcium by osteoblast-like cells. Although the actual comparative fraction of biologically-active BMP-2 
under the different loading modalities is unknown, these results corroborate those obtained by Van den 
Dolder et al. 40 and Vehof et al. 41. In their studies, in which rat bone marrow-derived osteoblast-like cells 
were cultured in medium to which 0, 10, 100, or 1000 ng/ml BMP-2 was supplemented, effects of the 
supplemented BMP-2 became apparent from 100 ng/ml. A remarkable difference, however, is the 
altered behavior of osteoblast-like cells at low BMP-2 concentrations. Whereas the supplementation of 
10 ng/ml BMP-2 to the culture medium did not affect osteoblast-like cell behavior in terms of 
proliferation and ALP expression 40;41, in our study osteoblast-like cells on d-loaded multilayered DNA-
coatings proliferated and differentiated to a lesser extent compared to the control substrates. 
Additionally, the deposition of calcium was significantly decreased compared to controls. Although no 
elusive explanation is available currently for this observation in osteoblast-like cell cultures with sub-
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treshold BMP-2 concentrations, it can be speculated that the amount and the temporal and spatial 
availability of factor are causal issues in the ultimate effect of factors.  
 
CONCLUSION 
This study demonstrates the feasibility of multilayered DNA-coatings to be functionalized by 
embedding BMP-2 according to three different loading modalities: superficial (s), deep (d), and double-
layer (dl). BMP-2 was incorporated proportionally into the multilayered DNA-coatings as: s + (4 * d) = dl. 
The release profiles of all differently-loaded multilayered DNA-coatings showed an initial burst release, 
followed by a sustained release of the remaining BMP-2 for (at least) 8 weeks. In vitro culture 
experiments with rat bone marrow-derived osteoblast-like cells demonstrated that the loaded factor 
remained biologically active, as an accelerated calcium deposition was observed on s- and dl-loaded 
multilayered DNA-coatings, without affecting cell proliferation. In contrast, d-loaded multilayered DNA-
coatings influenced the behavior of osteoblast-like cells by decreasing the deposition of calcium. 
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I INTRODUCTION 
An important physiological aspect in the healing around biomaterials is vascular development. For 
tissue engineering matrices, particularly those that are pre-seeded with cells, fast development of a 
vascular network is required for tissue ingrowth and cell survival, respectively. Also for solid devices, 
such as subcutaneously implantable biosensors, the development of a contiguous vascular network is 
important for their functionality 1;2. For instance, previous studies have demonstrated that the 
responsiveness of implanted biosensors to fluctuations of analytes in the interstitial fluid is diminished 
by the formation of a largely avascular fibrous tissue capsule and the resulting increased diffusion 
distance between sensor and blood supply to the sensor surrounding tissue 1;2. Furthermore, Gerritsen 
et al. showed that inflammatory cells as well as low molecular weight serum components influence the 
performance of amperometric glucose sensors 3. The basis for these findings was the secretion of 
enzymes by stimulated granulocytes, which consumed the hydrogen peroxide formed by the oxidation 
of glucose, and both the formation of a diffusional barrier for glucose and the inhibition of glucose 
oxidase activity by serum components. Consequently, the authors of these publications suggested that 
biosensor functionality is likely to improve if (i) the vascularity in the direct vicinity of the device is 
increased, and (ii) inflammatory responses to the device are minimal. 
The development of the vasculature depends on two processes, e.g. vasculogenesis and angiogenesis, 
which are responsible for de novo vessel formation and sprouting from already existing vessels, 
respectively 4. Therapeutical modulation of vascular supply, however, is limited to angiogenesis, since 
vasculogenesis is believed to occur only during early embryogenesis. Angiogenesis is a complex process, 
which involves subtle interactions of cells, extracellular matrix components, and regulatory molecules. 
Decisive steps in this process are the localized proteolytic degradation of the subendothelial basement 
membrane, migration of endothelial cells, the formation of sprouts, extracellular matrix remodeling, 
and the formation of anastomoses, which all together precede the establishment of blood flow 5. 
Potentially, the delivery of growth factors with pro-angiogenic action is a powerful tool in the control 
over vascular development. A widely used pro-angiogenic growth factor in tissue engineering is 
vascular endothelial growth factor (VEGF) 6. VEGF affects endothelial cells through positive effects on 
proliferation, migration, tubule formation, survival, and integrin expression 7. 
In order to increase vascularity around subcutaneously implanted biosensors, we hypothesized that 
VEGF-functionalization of DNA-based coatings could be beneficial. These coatings, whose generation is 
based on the layer-by-layer (LbL) deposition of either cationic poly-D-lysine (PDL) or poly(allylamine 
hydrochloride) (PAH) with anionic DNA 8, were demonstrated to be fully histocompatible upon 
subcutaneous implantation showing no adverse reactions in terms of inflammation and wound healing 
9;10. Furthermore, it was shown that these DNA-based are eligible for functionalization with the osteo-
inductive factor bone morphogenetic protein 2 (BMP-2) using different loading modalities, and that this 
factor retained its biological activity 11. Another important feature of the fabrication method of these 
DNA-based coatings is its simplicity, which allows a wide variability of substrate materials (e.g. ceramics, 
metals, and polymers) with almost unrestricted substrate geometry 12. 
In view of the described disadvantageous effects of lack of vascularity on biosensor functionality, we 
hypothesized that VEGF-functionalization of DNA-based coatings would be beneficial for the 
vascularization of the peri-implant tissue. Consequently, the aim of this study was to evaluate the effect 
of VEGF-functionalized DNA-based coatings on (i) endothelial cell behavior in vitro, and (ii) vascular 
development in vivo. Therefore, [PDL/DNA]5-coatings on glass substrates were functionalized with a low 
(25 ng) or a high (250 ng) amount of VEGF to study dosage-dependent effects. These VEGF-
functionalized DNA-based coatings, as well as non-functionalized coatings and non-coated controls, 
were enrolled in an in vitro experiment to study the proliferation, migration, and morphology of 
endothelial cells. Additionally, these four types of substrates were implanted in the backs of rats in an in 
vivo animal model to study vascular development in the direct vicinity of the implants. 
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II MATERIALS & METHODS 
Materials 
Polyanionic salmon DNA (± 300 bp/molecules; sodium salt) was kindly provided by Nichiro Corporation 
(Kawasaki-city, Kanagawa prefecture, Japan). Potential protein impurities in the DNA were checked 
using the bicinchoninic acid (BCA) protein assay (Pierce, Rockford, IL, USA), and were measured to be 
below 0.20 % w/w (data not shown). Polycationic polyelectrolyte poly-D-lysine (PDL; MW 30000 – 
70000) was purchased from Sigma (Sigma-Aldrich Chemie B.V., Zwijndrecht, the Netherlands). All 
materials were used without further purification. 
 
Substrate preparation and cleaning 
Disc-shaped glass substrates (12 mm diameter; 1.5 mm thickness; Waldemar-Knittel Glasbearbeitung 
GmbH, Braunschweig, Germany) were cleaned in Piranha solution (H2O2 (30% aqueous solution) / H2SO4 
– 3:7 v/v) to completely remove all traces of organic materials at the surface, and to increase the 
wettability of the surface. Subsequently, the substrates were thoroughly rinsed with ultra-pure water 
from a Millipore system (resistivity ≥ 18.2 MW×cm; Millipore B.V., Amsterdam, the Netherlands) and 
dried using a pressurized air stream. 
 
Generation of multilayered DNA-coatings 
DNA-coatings were generated using the layer-by-layer (LbL) deposition, as described previously 8. 
Briefly, the substrates were immersed in an aqueous solution of PDL (0.1 mg/ml) for 30 minutes, 
allowing sufficient time for the adsorption of the first cationic polyelectrolyte layer onto the substrates. 
Subsequently, substrates were washed in ultra-pure water (5 minutes; continuous water flow) and dried 
using a pressurized air stream. Thereafter, substrates were alternately immersed in an anionic aqueous 
DNA solution (1 mg/ml) and the PDL solution for 7 minutes each, with intermediate washing in ultra-
pure water and subsequent drying using a pressurized air stream to obtain final coating architecture of 
[PDL/DNA]5 (the number indicates the total number of double-layers). 
 
Experimental groups: 
Non-coated substrates and [PDL/DNA]5-coated substrates were sterilized using a UV-treatment (254 
nm; 4h). Subsequent, VEGF-functionalization of [PDL/DNA]5-coated substrates was carried out as 
described below. The experimental groups used in this study were: 
1. controls (non-coated glass substrates) 
2. [PDL/DNA]5 (glass substrates with a [PDL/DNA]5-coating) 
3. [PDL/DNA]5-VEGF25 ([PDL/DNA]5-coated glass substrates with 25 ng VEGF) 
4. [PDL/DNA]5-VEGF250 ([PDL/DNA]5-coated glass substrates with 250 ng VEGF) 
 
Functionalization with VEGF: 
Recombinant rat VEGF (rrVEGF164; 164 amino acids; Dept. Biochemistry, Radboud University Nijmegen 
Medical Center, Nijmegen, the Netherlands) was serially diluted in phosphate-buffered saline (PBS), 
after which amounts of either 25 or 250 ng VEGF were administered in 10 µl aliquots on the sterilized 
[PDL/DNA]5-coated substrates. Due to the iso-electric point of VEGF (pI 8.5)13, this factor will be 
positively-charged at neutral pH and show similar interaction with the negatively-charged DNA top-
layer in the multilayered structure as observed previously for BMP-211. The solvent was evaporated 
during incubation at 37°C. 
 
In vitro experiments 
Cell culture and seeding 
Human umbilical vein endothelial cells (HUVEC; PromoCell GmbH, Heidelberg, Germany) were 
expanded in growth medium, containing basic fibroblast growth factor (1 ng/ml), endothelial cell 
growth supplement/heparin (0.4% v/v), epidermal growth factor (0.1 ng/ml), hydrocortisone (1 µg/ml), 
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phenol red (0,62 ng/ml), and fetal calf serum (2% v/v) (GM; PromoCell GmbH, Heidelberg, Germany). To 
increase cell attachment, prior to cell seeding, the experimental substrates were incubated for 1 hour at 
37°C in assay medium (AM; alpha-Minimal Essential Medium (α-MEM; Gibco), supplemented with 10% 
v/v fetal calf serum (FCS) and gentamycin (50 µg/ml)). For each experimental run, cells were seeded at a 
density of 20 x 103 cells/cm2 and maintained in AM to exclude potential effects of factors supplemented 
in GM. Medium was refreshed at 1 day after cell seeding, and thereafter 3 times per week. 
 
Proliferation of endothelial cells 
At selective time points after cell seeding (1, 4, 7, and 10 days post-seeding), cells were trypsinized and 
counted using a Coulter® counter. Data were obtained from two independent experimental runs, with in 
each run triplicate samples for each condition (n=3) at each time point. 
 
Morphology of endothelial cells 
Parallel to the proliferation assays, two independent runs to study endothelial cell morphology were 
carried out. In each of these runs, two experimental samples for each condition at each time point (n=2) 
were seeded with HUVECs at a density of 20 x 103 cells/cm2 and incubated for 3 and 10 days. After these 
culture periods, cell layers were washed twice with PBS, fixed with 2% gluteraldehyde, and dehydrated 
in a graded series of ethanol. Finally, cell layers were dried using tetramethylsilane (TMS), sputter-
coated with gold, and morphologically examined using a scanning electron microscope (JEOL 6310 
SEM). 
 
Migration of endothelial cells 
The migrational behavior of endothelial cells (HUVEC) was assessed in one experimental run using a 
commercially available in vitro endothelial cell migration assay platform (BD BioCoatTM Angiogenesis 
System: Endothelial Cell Migration; BD Biosciences, Bedford MA, US), according to the instructions of the 
manufacturer. The assay measures the migration of cells (located in an insert) through a microporous 
membrane towards medium (with or without supplement) in the well. Briefly, [PDL/DNA]5-VEGF25 and 
[PDL/DNA]5-VEGF250 experimental substrates (n=3) were placed in a 24-well plate, and incubated with 
1 ml AM for 1, 4, 7, 10, and 14 days. At each time point, the medium was collected, after which fresh 
medium was added to each experimental substrate for subsequent VEGF release. Collected medium was 
stored at -80°C until use in the migration kit. For the assay, 225 µl collected medium was added in 
duplicate in a 96-well plate. Subsequently, HUVECs were added to each insert (25 x 103 cells in 75 µl α-
MEM 2% BSA), whose content is separated from the well volume by a fluorescence blocking 
microporous (3 µm) PET membrane. The migration of HUVECs was quantified using post-labeling of the 
cells with Calcein-AM, and subsequent fluorescence-measurements (excitation 485 nm, emission 530 
nm)  of the PET membrane after 22 hours of incubation. For comparison, the migration of endothelial 
cells towards medium with known amounts of VEGF (standards; range 0 – 250 ng/ml) was measured. 
Data were corrected for fluorescence-values of blanks (inserts without endothelial cells) and expressed 
as fold migration, which is set at 1 for the lowest VEGF-concentration of the standard. 
 
In vivo experiment 
Animals and implantation procedure 
For implantation, male Wistar rats of 200-250 g were used. The animals were housed in the central 
animal facility at the Radboud University Nijmegen Medical Center (Nijmegen, the Netherlands), 
observing all national guidelines for care and use of laboratory animals. The animals received chow and 
water ad libitum. Prior to the implantation procedure, approval was acquired from the Ethical 
Committee for animal experiments at the Radboud University Nijmegen (KUNDEC #2003-14). 
Surgery was performed under general inhalation anesthesia with nitrous oxide, oxygen, and isoflurane. 
The animals were immobilized and placed in a ventral position. Subsequently, the dorsal skin of the 
animals was shaved, washed and disinfected with povidone-iodine. On each side of the vertebral 
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column, 2 paravertebral incisions were made (~ 10 mm), after which a subcutaneous pocket was 
created using blunt dissection with scissors lateral to each incision. The insertion of substrates was 
performed such, that the VEGF-functionalized side faced the dorsal skin. After insertion of an implant, 
the skin was closed using skin staples (Agraves®; InstruVet C.V., Cuijk, the Netherlands). A total of 64 
implants (16 implants of each group) were distributed over 16 rats (4 implants per rat) according to a 
Latin square randomization scheme. 
 
Implant retrieval and histological preparations 
At the end of each implantation period (either 1 or 3 weeks), 8 rats were sacrificed using CO2-suffication. 
Subsequently, tissue-covered specimens (n=8 for each implant type and implantation period) were 
collected, the implants excised from the tissue capsule and checked for potential tissue remains using 
SEM as described previously 9;10, and the implant-surrounding tissue processed for embedding in 
paraffin. Paraffin sections were analyzed histologically (haematoxylin/eosin-staining) to obtain 
complete descriptions of the observed thin sections. 
 
Immunohistochemistry 
Parallel to haematoxylin/eosin-staining, paraffin sections were used for immunohistochemical staining 
using an anti-alpha smooth muscle actin (anti-αSMA) antibody. Amongst other tissues, α-SMA is 
present in blood vessel walls 14 and myofibroblasts 15, and its expression was used to determine the 
total number of blood vessels in the peri-implant area. Deparaffinated sections were treated with 3% 
H2O2 in phosphate-buffered saline solution (PBS) for 20 min to block endogenous peroxidase, fixed with 
Figure 1: Schematic overview of histomorphometric 
parameters in immunohistochemically (anti-αSMA) 
stained sections. (A) Representative image showing 
the original location of the implant (I), the 
surrounding fibrous capsule (Cap), the connective 
tissue (C), and muscle tissue (M). (B) Qwin Pro-image 
analysis software was used to indicate the region of 
interest (ROI), after which the number of positively-
stained vascular structures within the ROI was 
counted. 
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4% formalin and blocked with 5% BSA (Sigma), incubated with monoclonal IgG2a mouse anti-αSMA 
(1:1600; Sigma), thereafter incubated with biotinylated donkey anti-mouse secondary antibody (1:500; 
Jackson Laboratories, West Grove, PA, USA). Staining was performed with a biotin-streptavidin 
detection system (Vectra Elite kit; Vector Laboratories, Burlingame, CA, USA) for 45 min. Positive 
controls (rat brain tissue sections with positive staining in previous immunohistochemical procedures) 
and negative controls (1% BSA in PBS) were included. 
 
Histological and histomorphometrical evaluation 
A light microscope (Leica Microsystems AG, Wetzlar, Germany) was used for histological evaluation of 
the haematoxylin/eosin-stained sections. Immunohistochemically (anti-αSMA) stained sections were 
used for histomorphometrical evaluation of the number of blood vessels per area. Computer-based 
image analysis techniques (Leica Qwin Pro-image analysis software; Leica, Wetzlar, Germany) were used 
to determine the following parameters in digital images of immunohistochemically stained sections: 
 - region of interest (ROI): the connective tissue area at the dorsal site of the implant 
  (i.e. excluding muscle and fat tissue) in a digital image of approximately 700 x 560 µm 
  (original magnification 20x; see Figure 1). 
 - number of blood vessels (BV): number of positively-stained vascular structures (blood 
  vessels) within the ROI 
The values obtained with these parameters were used to determine the vascularization (vessel density, 
VD): 
 
 (1) VD = BV/ROI 
 
For each implant surrounding tissue section, VD was determined by averaging the numbers of counted 
vascular structures per ROI of three digital images (at 20x magnification) per tissue section. A total of 
eight averages VDs (n=8) were obtained for each group at each time period. 
 
Statistical analysis 
All measurements were statistically evaluated using GraphPad Instat software (version 3.05; GraphPad 
Instat, San Diego, CA, USA). Statistical analysis was performed using a one-way ANOVA with a post-hoc 
Tukey-Kramer Multiple Comparisons test for cell proliferation, migration, and vascularization at 
individual implantation periods. Vascularization for individual groups and pooled groups at different 
implantation periods was assessed using an unpaired t-test. A probability (p) value smaller than 0.05 
was considered statistically significant. 
 
III RESULTS 
In vitro experiments 
Proliferation of endothelial cells 
The two independent runs of endothelial cell proliferation showed comparable results. The results of 
one of these runs are presented in Figure 2. Initial cell numbers (on day 1) showed that comparable 
numbers of endothelial cells attached to the experimental substrates after cell seeding. From day 4, 7, 
and 10, however, endothelial cells on both [PDL/DNA]5-VEGF25 and [PDL/DNA]5-VEGF250 showed 
statistically significant increased cell numbers compared to controls and [PDL/DNA]5 (p<0.05, p<0.01, 
and p<0.001 for days 4, 7, and 10, respectively). Whereas cell numbers on [PDL/DNA]5-VEGF25 and 
[PDL/DNA]5-VEGF250 increased in time, those on controls and [PDL/DNA]5 were constant in time and 
did not differ statistically from each other (p>0.05). Furthermore, no statistically significant differences 
were found between [PDL/DNA]5-VEGF25 and [PDL/DNA]5-VEGF250 at individual time points (p>0.05).  
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Morphology of endothelial cells 
The morphological appearance of the endothelial cells (HUVECs) on the experimental substrates was 
evaluated using scanning electron microscopy. In Figure 3, representative images of endothelial cells 
cultured for 4 days on control and [PDL/DNA]5-VEGF250 substrates are depicted. Endothelial cells 
showed a similar morphology on all types of experimental substrates. The cells exhibited a flat 
appearance and had several cellular extensions. After both 4 and 10 days of cell culture, an optically 
increased number of cells were observed on [PDL/DNA]5-VEGF25 and [PDL/DNA]5-VEGF250 compared 
to controls and [PDL/DNA]5. 
Migration of endothelial cells 
An in vitro migration assay was used to study the effect of VEGF-release from VEGF-functionalized DNA-
based coatings on endothelial cell migration. The migration of endothelial cells towards a concentration 
gradient of VEGF-standards (rrVEGF164 in AM; range 0 – 250 ng/ml) is depicted in Figure 4 (inset), and 
was used to obtain information on the VEGF-release from VEGF-functionalized DNA-based coatings. The 
results show that VEGF significantly increased endothelial cell migration at concentrations ranging from 
1.25 – 100 ng/ml (p<0.05). In contrast, a VEGF-concentration of 250 ng/ml demonstrated to have no 
effect on endothelial cell migration. 
Collected medium from the incubation of [PDL/DNA]5-VEGF25 and [PDL/DNA]5-VEGF250 experimental 
substrates showed that these media also increased endothelial cell migration (Figure 4). The increased 
effect on endothelial cell migration was observed in medium that had been collected from 1 to at least 
14 days after initiation of incubation. No statistically significant differences were observed between 
media collected from [PDL/DNA]5-VEGF25 and [PDL/DNA]5-VEGF250 experimental substrates (p>0.05). 
 
Figure 2: Proliferation of endothelial cells 
(HUVECs) on experimental substrates. 
Results are shown as means ± SD of 
triplicate samples for one representative 
experiment out of two. (*) p<0.05 
compared to controls, (**) p<0.01 
compared to controls, (***) p<0.001 
compared to controls. 
 
Figure 3: Morphology of endothelial cells (HUVECs) after culture on experimental substrates after 4 days. Representative SEM 
images of endothelial cells (HUVECs) on (A) control and (B) [PDL/DNA]5-VEGF250 substrates, showing a flat morphology of 
endothelial cells with several cellular extensions. 
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In vivo experiment 
General observations 
All 16 rats in the animal experiment remained in good health during the implantation periods and did 
not show any wound complications after surgery. At 1 week after implantation, a total of 32 implants 
were retrieved. At retrieval, all subcutaneous implants were surrounded by a thin fibrous capsule. None 
of the implant sites showed macroscopic signs of inflammation or adverse tissue reaction. Similarly, at 3 
weeks after implantation, another 32 implants were retrieved, which were all surrounded by a thin 
fibrous capsule and devoid of any macroscopic signs of inflammation or adverse tissue reactions. 
 
Descriptive histological evaluation 
Scanning electron microscopic examination of the excised implants showed that implants were scarcely 
covered with proteinaceous-like deposits, which were not identifiable as cellular material (data not 
shown). Gross evaluation of the haematoxylin/eosin-stained sections of the implant surrounding tissue 
capsules after 1 week of subcutaneous implantation revealed a relatively uniform tissue response to all 
implants (Figure 5). Tissue at the dorsal side of the implants consisted of a fibrous capsule, connective 
tissue, muscle tissue, and the dermis. Occasionally, fat tissue was observed in the vicinity of the 
implants. The fibrous capsule was immature, reflected by the absence of flat fibrocytes at the implant 
side of the capsule. Little or no inflammatory cells could be observed at the interface implant/capsule or 
in the direct vicinity of the implants. 
After 3 weeks of subcutaneous implantation, a tissue response similar to that after 1 week was observed 
for all implants. However, the fibrous tissue capsules had matured, as indicated by the presence of 
fibrocytes with a flat appearance within the tissue capsules (Figure 5 A&B). The thickness of the fibrous 
capsules was within the range of 5 – 30 fibroblasts, independent of implant type. No gross differences in 
tissue response were observed depending on implant type. 
 
Histomorphometrical evaluation of vascularization at the dorsal site of the implant 
For the evaluation of the vascularization of the connective tissue at the dorsal site of the implants, 
paraffin sections were subjected to immunohistochemical techniques using a monoclonal antibody 
Figure 4: Migration of endothelial cells (HUVECs) in response to rrVEGF164 release from VEGF-functionalized experimental 
substrates ([PDL/DNA]5-VEGF25 and [PDL/DNA]5-VEGF250). Inset shows migration effects of different concentrations of VEGF 
(rrVEGF164; range 0 – 250 ng/ml; *p<0.05 compared to 0 ng/ml).  
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against αSMA. Representative images of the stained sections are presented in Figure 6 C&D. Positive 
staining was observed for vascular structures and fibrous capsules. A difference was observed in 
immunohistochemical staining of fibrous capsules after 1 and 3 weeks of implantation, with increased 
staining in the more mature fibrous capsules at 3 weeks after implantation. 
Histomorphometrically, the vascularity in the tissue at the dorsal site of the implant was calculated by 
determining the region of interest (ROI) and the number of positively-stained vascular structures (blood 
vessels) within this ROI. The histomorphometrical results are presented in Table 1. The average ROI of 
the digitally imaged area in all experimental groups ranged from 0.25 – 0.28 mm2. Vascularization 
(vessel density VD; # vascular structures/ mm2 ROI) of the analyzed areas showed a tendency to increase 
in both groups of VEGF-functionalized DNA-based coatings. However, no statistically significant 
differences between the individual experimental groups at individual implantation periods were found 
(p>0.05). On the other hand, pooled data of VEGF-functionalized experimental implants ([PDL/DNA]5-
VEGF25 + [PDL/DNA]5-VEGF250) and non-functionalized implants (controls + [PDL/DNA]5) showed a 
significantly increased vascularization in the peri-implant tissue of VEGF-functionalized implants 
(p<0.05). Vascularization in the peri-implant tissue was in the range of 102 – 155 and 66 – 142 vascular 
structures per mm2 at 1 and 3 weeks after subcutaneous implantation, respectively. No statistically 
significant differences were found for individual experimental groups at different implantation periods, 
except for [PDL/DNA]5, which showed decreased vascularization after 3 weeks compared to after 1 
week. 
Figure 5: Representative histological sections (haematoxylin/eosin-staining) of implant-surrounding tissue at 1 week after 
subcutaneous implantation in the back of rats. (A&B) Overview showing the fibrous tissue capsule with connective tissue, 
a muscle layer, and dermis at the dorsal side of the implant. (C&D) Magnification of A&B showing the thin fibrous capsule 
and connective tissue at the dorsal side of the implant. 
 
 
VII In Vitro and In Vivo Effects of DNA-based Coatings Functionalized with VEGF 
 108
IV DISCUSSION 
This study was initiated to study the effect of functionalization of a DNA-based coating with the pro-
angiogenic factor VEGF on (i) endothelial cell behavior in vitro, and (ii) vascularization of the peri-
implant tissue in vivo. In vitro, the effects of DNA-based coatings with low (25 ng) and high (250 ng) 
amounts of VEGF on endothelial cell proliferation, morphology, and migration were evaluated and 
compared to non-coated controls and non-functionalized DNA-based coatings. In vivo, these four types 
of substrates were implanted subcutaneously in the back of rats. After implantation periods of 1 and 3 
weeks, the vascularization in the direct vicinity of the implants was determined. The results of the in 
vitro experiments indicate that the pro-angiogenic factor VEGF remains biologically active within the 
functionalized DNA-based coatings, as reflected by an increasing effect of functionalized DNA-based 
coatings on endothelial cell proliferation and migration compared to non-coated controls and non-
functionalized DNA-base coatings. Furthermore, an increased vascularization of the peri-implant tissue 
surrounding VEGF-functionalized DNA-based coatings was observed in vivo. 
In an attempt to optimize the functionality of biosensors, this study was a first exploration for the use of 
DNA-based coatings for this purpose in view of their feasibility to be functionalized with desired factors 
11. Consequently, this study focused on functionalization of DNA-based coatings with the pro-
angiogenic factor VEGF, and experiments were aimed at elucidating in vitro effects on endothelial cells 
and in vivo effects on implant site vascularization. The type of DNA-based coating was limited to only 
[PDL/DNA]5, although the fabrication and characterization of different types of DNA-based coatings 
Figure 6: Representative histological sections of implant-surrounding tissue at 3 weeks after subcutaneous implantation in 
the back of rats. (A&B) Haematoxylin/eosin staining showing the fibrous tissue capsule with connective tissue at the dorsal 
side of the implant. (C&D) Immunohistochemical staining (anti-αSMA) showing the blood vessels in the connective tissue 
at the dorsal side of the implant. 
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have been described previously 8. The choice for one single type of DNA-based coatings is justified as 
previous experiments have demonstrated that cellular and histological responses to different types of 
DNA-based coatings were found to be similar 8-10;16. The amount of VEGF needed for biological activity 
in vitro and in vivo appears to be unclear. Amounts as low as 10 ng have shown biological effects in vitro 
17, whereas others used micrograms to induce biological effects of VEGF. 18;19. It is likely that the amount 
needed for biological effects on vascular development are dependent on issues including type of VEGF, 
release profile, and animal model. For our experiments, as a first approach, two amounts (i.e. 25 and 250 
ng) were chosen with a 10-fold difference. 
 
TABLE 1: HISTOMORPHOMETRICAL ANALYSIS OF VASCULARIZATION AT THE DORSAL SITE OF  SUBCUTANEOUSLY-INSERTED 
 IMPLANTS (MEANS ± SD FOR N=8; *P<0.05).  
The increased proliferation of endothelial cells on VEGF-functionalized DNA-based coatings in the in 
vitro experiments demonstrates that the pro-angiogenic factor VEGF remains biologically active. Similar 
results were recently found for the osteo-inductive factor bone morphogenetic protein 2, which was 
superficially loaded onto DNA-based coatings and accelerated the differentiation of osteoblast-like cells 
11. Furthermore, our proliferation experiments demonstrated that the presence of VEGF is a prerequisite 
for endothelial cells (HUVECs) to proliferate, since cells cultured on controls and DNA-based coatings did 
not proliferate. Additionally, no negative effects of DNA-based coatings on endothelial cells were 
observed, which corroborates observations of others using polyelectrolyte multilayers as a substrate for 
endothelial cells 20;21. 
The efficacy of biomaterial devices in combination with growth factors depends partly on the 
availability of the growth factors for sensible cells. For instance, a minimal release of BMP-2 from a 
porous calcium phosphate scaffold appeared to be sufficient for enhanced bone formation 22. However, 
for our purpose an increasing effect of VEGF on the vascularity in the peri-implant area in our in vivo 
experiment is likely to be dependent on release of the factor from the DNA-based coating. Additionally, 
the increased effect on the proliferation of endothelial cells observed on VEGF-functionalized DNA-
based coatings does not necessitate factor release, as also bound factor might be available for adherent 
cells. In view of this, the results of the migration assay indicate a continuous release of VEGF from VEGF-
functionalized DNA-based coatings. Although this assay does not provide detailed information on exact 
amounts of VEGF released at each incubation period, it shows that released amounts are sufficient for 
the chemotaxis of endothelial cells. On the basis of the release profiles of BMP-2 from [PDL/DNA]5 
coatings and the comparable iso-electric point and molecular weight of BMP-2 and VEGF 13, it can be 
speculated that VEGF release profiles also show an initial burst release followed by a sustained release 
for several weeks. This would indicate that the initial VEGF burst release would approximate 17 and 170 
ng for DNA-based coatings functionalized with 25 and 250 ng VEGF, respectively. The subsequent 
sustained VEGF release would then approximate 0,5 and 5 ng per week, respectively. Although the exact 
released amounts are not clear, the amounts released in the collected release media apparently are 
sufficient for an effect on endothelial cell migration. 
Several animal models to study angiogenesis have been described in detail, including dorsal skinfold 
chambers 23 and ear pinnae 24. However, these models have limitations regarding implant size 25, which 
impedes their use for our implants. Additionally, since the focus of our study was monitor vascularity 
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effects of the peri-implant tissue of subcutaneous implants, we used a simplistic subcutaneous 
implantation model in rats. Inevitably, also this simplistic approach for the detection of effects on 
vascularization has several drawbacks. For instance, the confinement of the area for evaluation of the 
effects of VEGF on vascularization was difficult to standardize. In contrast to previous studies, in which 
vascularization was determined in porous implants 26;27, the use of solid implants is associated with 
concessions in peri-implant area. Standardization of the peri-implant area was further hampered by the 
excision of the implants, allowing deformations of the fibrous capsule and surrounding tissue during 
subsequent histological processing. Nevertheless, the approach used in this study allows the 
comparison of vessel density in the peri-implant area, in which the maximum distance of vessels to the 
implant surface approximates 600 µm (image height of αSMA-stained sections ≈ 650 µm). The results 
show no significant effects of individual VEGF-functionalized DNA-based coatings on peri-implant vessel 
density. However, in comparison to controls and non-functionalized DNA-base coatings, a significant 
increase in peri-implant vascularity was observed in VEGF-functionalized DNA-based coatings. Further, a 
significant decrease in vascularity from 1 to 3 weeks after implantation was observed in tissue 
surrounding non-functionalized DNA-based coatings. This observation might be related to effect of 
DNA-based coatings on fibroblasts 9;10, which form the fibrous capsule, and subsequent intercellular 
signaling between fibroblasts and cells in their surroundings. However, the actual cause for this 
observation remains unclear and should be addressed in future experiments.  
Although the functionalization of DNA-based coatings in this study was restricted to one single 
angiogenic factor, considerable debate is ongoing on the necessity for combined growth factor delivery 
for angiogenesis and vessel maturation. Indeed, synergistic effects of combined administration of VEGF 
and basic fibroblast growth factor (bFGF) have been demonstrated on collateral circulation in a hind 
limb ischemia model 28. Additionally, Peattie et al. demonstrated enhancement of angiogenic responses 
in a murine ear pinnea model by dual delivery of VEGF and keratinocyte growth factor (KGF) 29. Such 
combined delivery vehicles could also be fabricated using DNA-based coatings, since the mechanism of 
fabrication has been demonstrated to be applicable for compartmentalization of such polyelectrolyte 
multilayers 30, which would allow temporal control over growth factor release. 
 
CONCLUSION 
This study demonstrates that the functionalization of DNA-based coatings with the pro-angiogenic 
factor VEGF results in an increased proliferation and migration of endothelial cells in vitro, indicating 
that the VEGF retained its biological activity. In an in vivo implantation experiment in rats, increased 
vascularization of the peri-implant tissue surrounding VEGF-functionalized DNA-based coatings was 
observed. 
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I SUMMARY AND ADDRESS TO THE AIMS 
The growing world population in combination with the increasing life-expectancy make that the 
application of medical and dental implants will expand. The proper integration of these artificial devices 
relies greatly on the medical condition of the patient, the properties of the biomaterial device, and the 
interaction of the adjacent tissue with the biomaterial surface. Important biological and material 
aspects in the interaction of living tissue with artificial devices are described in the literature review as 
presented in chapter 1. Here it is described that improvements in the longevity of artificial devices are 
often sought in surface modifications and include topographical as well as chemical alterations. It needs 
to be emphasized that changes in surface chemistry commonly bring along changes in surface 
topography. Nevertheless, surface modification has demonstrated to be a powerful tool in controlling 
the processes at the interface between biomaterial and living tissue. In view of this, the general aim of 
the research described in this thesis was to evaluate the use of deoxyribonucleic acid (DNA) as a 
biomaterial coating. Irrespective of its genetic information, the structural properties of the vertebrate 
DNA molecule suggest that it can have beneficial effects on cell and tissue response with respect to 
immunology, drug-delivery, and apposition of bone mineral. The research on this subject was gradually 
approached, using experimental studies to answer specific research questions. 
 
• Fabrication and characterization of DNA-based coatings 
The initial research was focused on the fabrication of DNA-based coatings and their characterization. 
The use of DNA as a coating material is hampered by its water solubility and degradation by abundantly 
present nucleolytic enzymes. Chapter 2 describes the fabrication of multilayered DNA-coatings using 
electrostatic self-assembly (ESA). This technique is based on the alternate deposition of cationic and 
anionic polyelectrolytes, by which a multilayered coating is fabricated. With the use of either poly-D-
lysine (PDL) or poly(allylamine hydrochloride) (PAH) as the cationic component and DNA as the anionic 
counterpart, multilayered coatings consisting of 5 double-layers were fabricated on glass and titanium 
(assigned as [PDL/DNA]5 and [PAH/DNA]5). A progressive build up of both coatings was demonstrated 
from contact angle measurements, UV-measurements, and atomic force microscopy. Furthermore, a 
linear increase in the incorporation of DNA into the multilayered coatings was observed during build up, 
approximating 3 µg/cm2 into each double-layer. Additionally, monitoring the surface morphology of 
the coatings by atomic force microscopy showed that the roughness of the coatings increased during 
build up. Finally, the coating constituents were checked for mutagenicity, and demonstrated to have no 
mutagenic effects on a mutant strain of Salmonella typhimurium. These results showed that with the 
ESA-technique it is feasible to fabricate DNA-coatings on glass and titanium whose constituents are 
safe. 
 
• Cyto- and histological responses to DNA-based coatings 
In chapter 3, cell and soft tissue responses to DNA-based coatings were evaluated and compared to 
non-coated controls. In vitro cell culture experiments with primary rat dermal fibroblasts demonstrated 
that both types of DNA-coatings ([PDL/DNA]5 and [PAH/DNA]5) did not affect cell viability and 
morphology compared to non-coated controls. However, cell proliferation on both types of DNA-
coatings was increased compared to non-coated controls. Using an in vivo animal model, coated 
implants and non-coated controls were implanted subcutaneously for four and twelve weeks in the 
backs of rats. DNA-coatings demonstrated to induce no adverse reactions in terms of inflammation and 
wound healing. Furthermore, histological analysis showed that the soft tissue response to DNA-coated 
implants was similar to that of non-coated controls. The results of these studies demonstrated that 
DNA-coatings are cyto- as well as histocompatible. 
 
• In vitro macrophage response to DNA-based coatings 
Macrophages are regarded as the pivotal cell type in wound healing processes, including inflammation, 
tissue repair, and tissue remodeling. During these biological processes, macrophages orchestrate the 
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intensity and duration of these phases by producing a myriad of signaling molecules that control the 
behavior of other cell types involved in these processes. In chapter 4, the behavior of macrophages 
cultured on DNA-based coatings is described. To study macrophage behavior, two murine macrophage 
cell lines were used to evaluate cell attachment, viability, morphology, and cytokine secretion. For 
cytokine secretion, a group of four cytokines was selected, whose individual mode of action can be 
classified as pro- or anti-inflammatory, pro- or anti-wound healing, or a combination of these. Culture of 
macrophages on DNA-based coatings demonstrated to have no effect on cell attachment, viability, and 
morphology. However, a substrate-dependent cytokine secretion profile was observed, which showed 
that on DNA-based coatings the secretion of the major pro-inflammatory cytokine TNF-α was 
decreased. This observation indicates that the use of DNA-based coatings can decrease the 
inflammatory response and hence accelerate the total wound healing processes. 
 
• Effect of DNA-based coatings on the deposition of calcium phosphate and the behavior of 
bone-forming cells 
In addition to the beneficial low immunogenic properties of DNA-based coatings described above, it 
was hypothesized that the high phosphate content in the DNA-molecule could be beneficial for the 
deposition of calcium phosphate. It is known that for bone implants the direct apposition of bone tissue 
to the implant surface (without an intervening soft tissue capsule) is a prerequisite for fixation, and that 
the deposition of calcium phosphate from simulated body fluids is indicative for this property called 
bioactivity. Consequently, chapter 5 describes in vitro immersion studies of DNA-based coatings in 
simulated body fluids, and the effect of DNA-based coatings on the behavior of bone-forming cells. 
These studies demonstrated that DNA-based coatings favored the deposition of calcium phosphate over 
non-coated titanium controls. Additionally, cell culture experiments with rat bone marrow-derived 
osteoblast-like cells showed that DNA-based coatings did not affect cell behavior. On the other hand, 
pre-treatment of DNA-based coatings in simulated body fluid affected cell differentiation, evidenced by 
an increased deposition of osteocalcin. These studies are indicative for bone-bonding capacities of DNA-
based coatings, but conclusive evidence for the bioactivity of DNA-based coatings needs to be provided 
by in vivo animal experiments. 
 
• Functionalization of DNA-based coatings with the osteoinductive factor BMP-2 
Control over the behavior of cells and tissues in the direct vicinity of an implant is auxiliary to increase 
implant functionality. Powerful tools in this respect are factors that exhibit biological activity, such as 
growth factors and cytokines. In chapter 6, the functionalization of DNA-based coatings with the 
osteoinductive factor bone morphogenetic protein 2 (BMP-2) was assessed using three different loading 
modalities. Experiments with radiolabeled BMP-2 demonstrated the feasibility of  DNA-based coatings 
to be functionalized with BMP-2 and showed a release pattern consisting of an initial burst release 
within 1 day followed by a sustained release up to 8 weeks. Additional cell culture experiments with rat 
bone marrow-derived osteoblast-like cells demonstrated that the incorporated factor remained 
biologically active, as evidenced by an accelerated mineralization of the extracellular matrix. From these 
experiments, it was concluded that DNA-based coatings are eligible for functionalization with 
biologically-active compounds, and hence can modulate cell response. 
 
• Angiogenic response to VEGF-functionalized DNA-based coatings 
Vascularization is regarded as an important issue in wound healing and essential for tissue ingrowth 
into porous tissue engineering matrices. Furthermore, the functionality of subcutaneously implanted 
biosensors is known to be dependent on peri-implant vascularization. In view of this, chapter 7 
describes a first exploration of the use of DNA-based coatings for optimization of peri-implant 
vascularization through their functionalization with the pro-angiogenic factor vascular endothelial 
growth factor (VEGF). In vitro, VEGF-functionalized DNA-based coatings demonstrated to increase the 
proliferation of endothelial cells. Additionally, released VEGF from these coatings was found to enhance 
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the migration of endothelial cells. In an in vivo animal model, subcutaneously implanted VEGF-
functionalized DNA-based coatings showed to increase peri-implant vascularization. This study 
demonstrated that the functionalization of DNA-based coatings with biologically-active compounds is 
an effective means to modulate tissue response in vivo. 
 
II CLOSING REMARKS & FUTURE PERSPECTIVES 
The experiments described in this thesis concern the use of DNA as a coating material for implants. The 
idea to use DNA for this purpose arose from the structural properties of the DNA-molecule, which were 
hypothesized to beneficially affect several aspects of the biological processes that occur after the 
insertion of an implant. The homogeneity of DNA in vertebrate species rendered this material 
interesting from an immunological point of view. For hard tissue implants, the high phosphate content 
in DNA was hypothesized to facilitate the apposition of bone tissue. Additionally, the capacity of DNA to 
bind other compounds was hypothesized to allow the modulation of cell and tissue responses through 
drug-delivery at the site of implantation. 
The first issue to address in this research was the fabrication of a coating containing DNA. Within the 
limited number of methods to fabricate DNA-based coatings, we have chosen for electrostatic self-
assembly. This technique is inexpensive and simple, and has the advantage that it is applicable on many 
different materials without limitations regarding implant geometry. Although in our experiments all 
coatings were applied manually, several automated systems for the fabrication of coatings through 
electrostatic self-assembly are already commercially available. In view of the simplicity of the technique, 
the use of automated systems could rapidly upscale coating production for commercial exploitation. 
For the fabrication of DNA-based coatings in our research, the number of double-layers (either 
[PDL/DNA] or [PAH/DNA]) used was limited to 5, since coating characterization methods indicated that 
5 double-layers was sufficient to reach surface coverage. However, in view of the loading of DNA-based 
coatings, the number of double-layers could be increased to enlarge the total amount of biologically-
active compound loaded into the DNA-based coatings. A point of concern remains the loading 
efficiency, which is relatively low due to necessary wash steps in case of non-terminal loading. An 
additional issue is the use of effective dosages (amount and release) of biologically-active compounds. 
Although a lot of effort has been put in elucidating application-dependent standards, more work needs 
to be done to unravel the requirements to optimize, both from a clinical and a cost-effective point of 
view, the use of biologically-active compounds in implantology. 
In view of the eventual utilization of DNA-based coatings in a clinical setting, the first steps have been 
taken towards specific applications. In continuation of the results of the VEGF-functionalized DNA-based 
coatings on peri-implant tissue vascularization, the application of such coatings to optimize 
subcutaneously implanted biosensors (more specifically glucose-sensors) is currently under 
investigation. Furthermore, self-standing DNA-based films, consisting of DNA and chitosan, are being 
explored for their effects on the prevention of post-surgical adhesions. 
A final issue in view of the eventual application of DNA-based coatings/material is the load enfolded in 
the abbreviation DNA. Although nature has provided us with many unique materials, including proteins, 
sugars, fats, and DNA, the latter rouses people to reluctance and anxiousness. To abandon or minimize 
such feelings, the general knowledge of people on DNA and its application(s) should be enlarged to give 
DNA a more common image. 
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I SAMENVATTING EN EVALUATIE VAN DE DOELSTELLINGEN 
Door de groei van de wereldbevolking en de toegenomen levensverwachting zal het toepassen van 
medische en tandheelkundige implantaten expanderen. Een adequate integratie van dit soort artificiele 
lichaamsdelen is afhankelijk van de medische conditie van de patient, de eigenschappen van het 
artificiele lichaamsdeel en de interactie van aangrenzend weefsel met het oppervlak van het 
implantaat. Belangrijke aspecten op het gebied van biologie en materiaalkunde in de interactie tussen 
levend weefsel en het oppervlak van biomaterialen staan beschreven in hoofdstuk 1. Dit hoofdstuk 
toont dat verbeteringen ter verlenging van de levensduur van kunstmatige lichaamsdelen vaak gezocht 
worden in oppervlakte-modificaties, welke zowel topografische als chemische veranderingen behelsen. 
Het dient te worden benadrukt dat chemische veranderingen veelal samengaan met veranderingen in 
oppervlakte-topografie. Niettemin, modificaties aan het implantaat-oppervlak hebben bewezen een 
krachtig middel te zijn om een bepaalde mate van controle op de processen op het scheidingsvlak 
tussen biomateriaal en levend weefsel uit te oefenen. Met dit in het achterhoofd was het algemene doel 
van het onderzoek beschreven in het onderhavige proefschrift de toepassing van deoxyribonucleine 
zuur (DNA) als coatings voor biomaterialen. Afgezien van de genetische informatie beschikt DNA van 
gewervelde organismen over een aantal structurele eigenschappen, welke mogelijk heilzame effecten 
zouden kunnen bewerkstelligen op de cel- en weefselreactie. Deze eigenschappen bieden 
mogelijkheden ten aanzien van ontstekingsreacties, drug-delivery en de afzetting van botmineraal. Het 
onderzoek naar deze mogelijkheden werd trapsgewijs aangepakt via meerdere experimentele studies 
ter beantwoording van specifieke onderzoeksvragen.   
 
• Productie en karakterisering van DNA-coatings 
Het initiele onderzoek was gericht op de productie van DNA-coatings en hun karakterisering. Het 
gebruik van DNA als coatingmateriaal wordt bemoeilijkt de oplosbaarheid van DNA in water en het 
gevaar van degradatie door door specifieke enzymes. Hoofdstuk 2 beschrijft de productie-methode van 
gelaagde DNA-coatings middels electrostatic self-assembly (ESA). Deze techniek is gebaseerd op de 
beurtelingse afzetting van positief en negatief geladen polyelectrolyten, hetgeen leidt tot een gelaagde 
coating. Door gebruik te maken van poly-D-lysine (PDL) of poly(allylamine hydrochloride) (PAH) als 
positief polyelectrolyte en DNA als negatieve tegenhanger, werden gelaagde coatings bestaande uit 5 
dubbellagen gemaakt op glas en titanium (aangegeven als [PDL/DNA]5 en [PAH/DNA]5). Door het 
meten van contacthoeken en UV-absorptie, en analyse middels atomic force microscopy werd 
aangetoond dat deze gelaagde coatings een progressieve opbouw vertonen. Verder werd aangetoond 
dat de incorporatie van DNA in deze gelaagde coatings een lineair verband vertoont met het aantal 
dubbellagen, overeenkomend met circa 3 µg/cm2 in elke dubbellaag. Voorts werd middels atomic force 
microscopy aangetoond dat de ruwheid van de gelaagde coatings toenam gedurende hun opbouw. 
Tenslotte werden de bestanddelen van de gelaagde coatings onderzocht op mutageniteit middels een 
standaard mutageniteitstest, hetgeen toonde dat deze geen mutagene effecten op een stam van 
Salmonella typhimurium hebben. Samenvattend hebben deze experimenten bewezen dat middels ESA 
veilige, gelaagde coatings met DNA kunnen worden gemaakt op glas en titanium.  
 
• Cel- en weefselreactie op DNA-coatings 
In Hoofdstuk 3 wordt de evaluatie van de zacht weefsel reactie op DNA-coatings beschreven en 
vergeleken met de reactie op ongecoate implantaten. Met behulp van in vitro celkweek experimenten 
met primaire fibroblasten werd aangetoond dat zowel [PDL/DNA]5 als [PAH/DNA]5 geen effect hebben 
op de levensvatbaarheid en morphologie van de cellen. Echter, op beide types DNA-coatings werd een 
vernelde groei van de primaire fibroblasten waargenomen vergeleken met de controles. In een in vivo 
diermodel werden implantaten met een DNA-coating en ongecoate controles onderhuids ingebracht in 
ratten. Na een periodes van 4 en 12 weken werden geen ongunstige weefselreacties waargenomen, 
zoals ontstekingsreacties of aangetaste wondgenezing. Deze observaties werden later ondersteund 
door de resultaten van de histologische analyse, waarin verder geen verschillen werden waargenomen 
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tussen de zacht weefsel reactie tegen implantaten mét of zonder DNA-coating. Op basis van deze 
resultaten werd geconcludeerd dat DNA-coatings zowel cel- als weefselcompatibel zijn. 
 
• In vitro reactie van macrofagen op DNA-coatings 
Macrofagen worden beschouwd als het belangrijkste celtype in de processen rond wondgenezing, zoals 
de ontstekingsreactie, weefselherstel, en weefsel remodeling. Tijdens het verloop van deze processen, 
bepalen macrofagen de intensiteit en duur van deze fases van de wondgenezing door hun productie 
van talloze signaalmoleculen, welke de activiteit van andere betrokken celtypen controleren. In 
hoofdstuk 4 wordt het gedrag van macrofagen op beide types DNA-coatings beschreven. Hiertoe zijn 2 
muizen-macrofaag cellijnen gebruikt, waarvan celhechting, levensvatbaarheid, morfologie en cytokine 
secretie zijn onderzocht na kweek op beide types DNA-coatings. De onderzochte cytokines werden 
geselcteerd op basis van hun rol in ontstekingsprocessen en wondgenezing. Beide types DNA-coatings 
bleken geen effect te hebben op celhechting, levensvatbaarheid en morfologie vergeleken met 
ongecoate controles. Wel werd een substraat-afhankelijke secretie van de geselecteerde cytokines 
waargenomen. Meest opvallend was hierbij dat op beide types DNA-coatings de secretie van TNF-α, het 
belangrijkste cytokine in ontstekingsreacties, verlaagd was. Deze waarneming duidt op een effect tot 
verlaging van de ontstekingsreactie door DNA-coatings, hetgeen zou kunnen leiden tot versnelde 
wondgenezing. 
 
• Effect van DNA-coatings op de afzetting van calcium fosfaat en het gedrag van 
botvormende cellen 
Naast de eerder beschreven gunstige effecten van DNA-coatings op ontstekingscellen, was een van de 
hyptheses dat gezien het hoge fosfaat-gehalte in DNA, dit materiaal de afzetting van calcium fosfaat 
positief zou kunnen beïnvloeden. Het is bekend dat voor bot-implantaten de directe afzetting van 
botmineraal (zonder een tussenliggende laag van zacht weefsel) een voorwaarde is voor stabiele fixatie, 
en dat de afzetting van calcium fosfaat vanuit lichaamsvloeistof-simulerende oplossingen indicatief is 
voor deze eigenschap, genaamd bioactiviteit, van materialen. Derhalve zijn experimenten uitgevoerd 
met lichaamsvloeistof-simulerende oplossingen en botvormende cellen, welke beschreven zijn in 
hoofdstuk 5. Deze experimenten tonen dat de afzetting van calcium fosfaat versneld plaatsvindt op 
beide types DNA-coatings in vergelijking met ongecoate titanium controles. Verder werd geen effect 
van DNA-coatings op het gedrag van (voorlopers van) botvormende cellen waargenomen. Echter, door 
gecoate substraten te incuberen in lichaamsvloeistof-simulerende oplossingen, en deze te vergelijken 
met ongecoate titanium controles, werd aangetoond dat deze voorbehandeling de ontwikkeling van 
botvormende cellen uit deze voorlopercellen stimuleert, blijkend uit een verhoogde depositie van het 
matrix-eiwit osteocalcine. Deze experimenten zijn indicatief voor de bot-bindende capaciteit van DNA-
coatings, maar dienen te worden ondersteund door in vivo dier-experimenten om eensluidende 
uitspraken over de bioactiviteit van DNA-coatings te kunnen doen. 
 
• Functionaliseren van DNA-coatings met de osteoinductieve factor BMP-2 
Een bepaalde mate van controle op het gedrag van cellen en weefsels in de directe omgeving van een 
implantaat zou substantieel kunnen bijdragen aan de functionaliteit van het betreffende implantaat. In 
dit opzicht vormen stoffen met een bepaalde biologische activiteit, zoals groeifactoren en cytokines, 
een krachtig hulpmiddel. In hoofdstuk 6 wordt de functionalisatie van DNA-coatings met de osteo-
inductieve factor bone morphogenetic protein 2 (BMP-2; induceert de ontwikkeling van botvormende 
cellen uit voorlopers) beschreven, waarbij drie verschillende varianten van gefunctionaliseerde DNA-
coatings werden vergeleken. Door BMP-2 radio-actief te labelen kon worden aangetoond dat DNA-
coatings inderdaad te functionaliseren zijn met BMP-2, en dat het BMP-2 uit deze DNA-coatings 
vrijkomt via een initiële plotsklapse afgifte binnen een dag gevolgd door een geleidelijke afgifte 
gedurende minimaal acht weken. Daarnaast lieten celkweek experimenten met (voorlopers van) 
botvormende cellen zien dat het BMP-2 in de DNA-coatings zijn biologische activiteit behoudt, blijkend 
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uit een versnelde mineralisatie van de, door deze cellen gevormde, extracellulaire matrix. Op basis van 
deze resultaten werd geconcludeerd dat DNA-coatings te functionaliseren zijn met biologisch-aciteve 
stoffen, en op deze manier het gedrag van cellen kunnen beïnvloeden. 
 
• Effect van VEGF-gefunctionaliseerde DNA-coatings op de ontwikkeling van bloedvaten 
De ontwikkeling en aanwezigheid van bloedvaten wordt gezien als een belangrijk aspect van 
wondgenezing, en is essentieel voor het ingroeien van weefsel in poreuze tissue engineering 
constructen. Voorts is ook de functionaliteit van onderhuids geplaatste biosensoren afhankelijk van de 
ontwikkeling van bloedvaten in de directe nabijheid. Met dit in het achterhoofd beschrijft hoofdstuk 7 
de eerste stappen richting de toepassing van DNA-coatings ter optimalisatie van de 
bloedvatontwikkeling middels functionalisatie met de bloedvatontwikkeling-stimulerende stof vascular 
endothelial growth factor (VEGF). Door gebruik te maken van celkweek-modellen werd aangetoond dat 
functionalisatie van DNA-coatings de groei van bloedvatcellen versnelt. Daarnaast was uit de DNA-
coatings vrijgekomen VEGF in staat om de mobiliteit van bloedvatcellen te vergroten. Met behulp van 
een diermodel, waarbij implantaten onderhuids werden geplaatst, werd aangetoond dat de 
ontwikkeling van bloedvaten in de directe omgeving van het implantaat werd gestimuleerd door 
functionalisatie van DNA-coatings met VEGF. Dit experiment laat zien dat functionalisatie van DNA-
coatings een effectieve manier is om de weefselreactie te sturen. 
 
II AFSLUITENDE OPMERKINGEN & TOEKOMSTVISIE 
De experimenten beschreven in dit proefschrift zijn gerelateerd aan het gebruik van DNA als 
coatingsmateriaal voor implantaten. Het idee om DNA voor dit doel te gebruiken kwam voort uit de 
structurele eigenschappen van DNA, waarvan verondersteld werd dat deze een gunstige bijdrage 
kunnen leveren ten aanzien van verschillende aspecten van de biologische processen die plaatsvinden 
na het plaatsen van een implantaat. Vanwege de homogeniteit van DNA binnen gwervelde organismen 
is dit materiaal interessant vanuit immunologisch oogpunt. Daarnaast zou het hoge gehalte aan fosfaat 
in het DNA gunstig kunnen zijn voor de afzetting van botmineraal op bot-implantaten. Tenslotte werd 
aangenomen dat de capaciteit van DNA om andere stoffen te binden aangewend zou kunnen worden 
om middels drug-delivery het gedrag van cellen en weefsels te kunnen beïnvloeden. 
Het eerste dat gedaan moest worden om het onderzoek naar DNA-coatings voor implantaten van de 
grond te kunnen krijgen, was het maken van DNA-coatings. Binnen de beperkte mogelijkheden om 
coatings met DNA te kunnen maken, hebben we gekozen voor electrostatic self-assembly (ESA). Dit is 
een goedkope en eenvoudige methode, en heeft als voordeel dat het toepasbaar is op vele materialen 
zonder beperking ten opzichte van de vorm van het implantaat. Hoewel voor onze experimenten alle 
DNA-coatings handmatig gemaakt zijn, had dit ook gedaan kunnen worden middels commercieel 
verkrijgbare, geautomatiseerde systemen. Gezien de eenvoud van deze methode, zou het gebruik van 
geautomatiseerde systemen eventuele commerciële uitbuiting kunnen doen versnellen. 
In het in dit proefschrift beschreven onderzoek is gebruik gemaakt van DNA-coatings bestaande uit 5 
dubbellagen (hetzij [PDL/DNA] of [PAH/DNA]) omdat de karakterisering van deze DNA-coatings 
aantoonde dat dit aantal dubbellagen voldoende was om het oppervlak van een substraat te bedekken. 
Voor het functionaliseren van DNA-coatings kan echter het aantal dubbellagen eenvoudig verhoogd 
worden, waardoor er meer biologisch-actieve stof in de DNA-coatings kan worden opgenomen. Een 
aandachtspunt hierbij blijft de opname-efficiëntie van de stof in de DNA-coatings, welke relatief laag is 
vanwege de benodigde wasstappen bij het functionaliseren van andere dubbellagen dan de laatste. 
Daarbij komt ook nog het belang van het gebruik van effectieve doseringen (hoeveelheid en afgifte-
patroon) van de ingebrachte biologisch-actieve stof. Hoewel reeds veel energie is gestoken in het 
vinden van toepassingsafhankelijke standaarden voor effectiviteit van dit soort stoffen, is nog altijd 
meer onderzoek noodzakelijk om de vereisten op te helderen, zowel vanuit klinisch als financieel 
oogpunt, ten aanzien van het gebruik van biologisch-actieve stoffen in de implantologie. 
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Momenteel zijn de eerste stappen gezet om de resultaten van het in dit proefschrift beschreven 
onderzoek klinisch te toetsen. Aan de hand van de resultaten van het experiment waarin DNA-coatings 
werden gefunctionaliseerd met VEGF ten behoeve van het stimuleren van de ontwikkeling van 
bloedvaten rond een implantaat, is onderzoek naar de toepassing van DNA-coatings voor onderhuids 
geplaatste biosensoren (zoals een glucose-sensor voor diabetici) gepland. Daarnaast is een onderzoek 
gestart naar het gebruik van vliesjes bestaande uit DNA en chitosan, ter preventie van post-operatieve 
verklevingen. 
Een laatste punt ten aanzien van het gebruik van op DNA gebaseerde coatings en materialen is de 
lading die de afkorting DNA met zich meedraagt. Hoewel ‘moedertje Natuur’ ons vele unieke materialen 
heeft gegeven, zoals eiwitten, suikers, vetten, en ook DNA, roept voornamelijk DNA nog altijd 
terughoudendheid en angst op bij mensen. Om dit gevoel uit te roeien of te minimaliseren dient de 
kennis van mensen over DNA en de bijbehorende toepassingen ervan te worden vergroot, waardoor het 
image van DNA minder abnormaal wordt. 
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Bij de start van het onderzoeksproject, dat als basis diende voor dit proefschrift, was mij niet duidelijk 
hoe groot de betrokkenheid van mensen zou zijn bij de totstandkoming van het uiteindelijke 
proefschrift. De lijst van mensen, welke hieronder bedankt worden voor hun bijdrage, is al aardig qua 
omvang, maar waarschijnlijk niet volledig. Ontbreken in onderstaand overzicht wil echter zeker niet 
zeggen dat de geleverde bijdrage niet gewaardeerd is… 
Allereerst wil ik benadrukken dat ik een prima tijd heb gehad op de afdeling Parodontologie & 
Biomaterialen, zowel inhoudelijk als sociaal. Meteen vanaf het begin was de sfeer prima, en ondanks 
meerdere veranderingen in het personeelsbestand bleef deze uitstekend. Het type onderzoek dat 
gedaan wordt, is boeiend en blijft toenemen in belang door vraag van de samenleving, waardoor de 
link met het praktisch nut duidelijk in zicht blijft. 
 
Prof. dr. JA Jansen – Beste John, ongelooflijk bedankt voor alles wat je me geleerd hebt. Dat dit verder 
gaat dan zuiver inhoudelijke kennis op het gebied van implantologie moge duidelijk zijn! 
Bewonderenswaardig is de wijze waarop je overzicht houdt op vrijwel al het relevante op 
wetenschappelijk gebied, en zeker hoe je dit weet te vertalen naar gebruik in eigen onderzoekslijnen. 
Wat me echter het meest heeft weten te raken, is de open manier van communiceren, het doelgericht 
werken, en je snelheid van werken. Dit werd vooral duidelijk tijdens onze eerste (hoofdstuk 1) en laatste 
publicatie (hoofdstuk 7) in dit project. Door jouw openheid zijn we er uiteindelijk ‘samen’ achter 
gekomen hoe we de proof konden openen, en door jouw snelheid van werken (de turbo erop!) hebben 
we razendsnel het laatste manuscript kunnen indienen. Uit dit alles blijkt dat je gedreven en doelgericht 
bent, zonder te vergeten met beide benen op de grond te blijven staan. Dit was al een voorbeeld voor 
me en zal dat ook blijven. Bedankt!!! 
Prof. dr. RJM Nolte – Beste Roeland, inspirerend was de wijze waarop je tijdens gezamenlijke 
bijeenkomsten van de leden van het DNA-project altijd op zoek was naar oplossingen voor problemen 
bij lopende zaken. Mijn waardering is groot voor je immer optimistische visie en oplossingsgerichte 
bijdrage aan dit proefschrift. Het meest zal me bijblijven de charme waarmee je sturend optreedt: dat is 
een buitengewoon bijzondere kwaliteit! 
Dr. XF Walboomers – Beste Frank, met plezier denk ik terug aan onze samenwerking. Ik waardeer de  
mate van vrijheid en vertrouwen, welke je me gaf in je dagelijkse begeleiding. Naast je inhoudelijke 
kennis ben je een persoon met een fantastische humor. De meest eenvoudige opmerking van jou kan 
voldoende zijn voor een halve dag plezier voor mij! Ook ons bezoek aan het domein van ‘the King’ was 
een hoogtepunt. Ik heb zelden een zo overweldigende busreis (van 2 minuten!) gehad… Merci voor je 
hulp en focus op TCB (Taking Care of Business)! 
Dr. NAJM Sommerdijk – Beste Nico, ik ken weinig mensen met een vrijwel onbeperkt ruime visie op 
onderzoeksgebied, maar jij beschikt hierover! Het echte verrassende aan jou is echter dat je deze 
breedte weet te combineren met diepte. Dit bleek vooral tijdens de vele meetings en uit je kritische blik 
bij de totstandkoming van de publicaties. Ongetwijfeld heeft jouw inbreng geleid tot een toename in 
de kwaliteit van het onderzoek. Merci hiervoor! 
Dr. MRJ Vos  –  Beste Matthijn, in 2002 zijn we samen ingestapt in het onderzoek naar DNA-coatings 
voor implantaten. Met jouw chemische achtergrond heb je de basis gelegd voor de volledig gelaagde 
coatings en de mogelijkheid tot functionalisatie van het niet-DNA gedeelte van de coating. Bedankt 
voor je didactische uiteenzetting van de chemische wereld: het heeft mijn inzicht in deze materie 
enorm vergroot! Succes met je baan bij het NKI in Amsterdam! 
Dr. T Hayakawa, dr. T Fukushima & prof. dr. Y Okahata – Dear Tohru, Tadao, and Yoshio, the three of you 
have been of great help in 2003, when we were exploring the possibilities to fabricate DNA-based 
coatings. It was a privilege for me to work with you! Tohru, thank you very much for your kindness 
during my stay. As DNA as a biomaterial will remain a research topic in the next years, I think we will 
definitely meet again. Tadao, I have really appreciated your help with preparing DNA-lipid complexes. 
Evidently, your gift (the year of the monkey) has helped, although it was not 2004 when our first success 
in DNA-based coatings worked out! Yoshio, thanks for your contribution to our work. It was definitely of 
added value for our research! 
Dr. OC Boerman, dr. TH van Kuppevelt, drs. STM Nillesen –  Beste Otto, hartelijk dank voor je snelle 
bereidheid tot meewerken aan het BMP-artikel: het gemak waarmee deze samenwerking gepaard ging 
is fantastisch!! Beste Toin en Suzan, hartelijk dank voor jullie bijdrage aan het VEGF-artikel. Dit artikel 
was het laatste uit dit project, maar ik zou wensen dat het als voorbeeld had kunnen dienen voor de 
andere publicaties uit dit project! Dank voor jullie bijdrage! 
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Prof. dr. LH Koole – Beste Leo, ik waardeer je openheid en bereidheid tot meewerken aan onze ideeën 
enorm. Helaas heeft onze samenwerking niet geleid tot bruikbare resultaten voor in een publicatie voor 
dit project. Echter, ik verwacht zeker dat deze vruchtbare basis van samenwerking haar vruchten zal 
gaan afwerpen. Merci voor alles! 
 
Behalve bovengenoemde personen, is er een groot aantal anderen waaraan ik dank verschuldigd ben. 
In eerste instantie de directe (ex-)collega’s van de afdeling Parodontologie & Biomaterialen: Anne, 
Afsheen, Corinne, Daniel, Dennis, Diederik, Dimitris, Edwin Ooms, Edwin vd Wal, Esther, Fang, Harry, 
Henriette, Hongbin, Jacky, Joop, Juliet vd Dolder, Juliet Moeljoredjo, Jurgen, Lise, Manal, Martijn, 
Marijke, Meike, Natasja, Olga, Peter, Quinten, Remco, Sander, Vincent, Walter, Weibo, Wouter, Xuechao 
en Yonggang. Zonder jullie aanwezigheid was promoveren zeker niet zo leuk (lees: gezellig!!!) geweest. 
Van deze groep mensen verdient een aantal een speciale vermelding. Allereerst Anja en Joop, 
fantastische steun heb ik aan jullie gehad, zowel inhoudelijk als relativerend. Kenmerk daarbij was 
‘recht voor z’n raap’, wat ik zeer zeker weet te waarderen – dank hiervoor! Dan Marijke, steun en 
toeverlaat in bange tijden. Dank voor je gezelligheid en ordentelijkheid – dit heeft me enorm geholpen, 
al had mijn buro vaker mogen worden opgeruimd… Speciale dank ook aan de mede-leden van de club 
van vier: Diederik, Sander en Quinten. Het was prettig om met jullie te kunnen genieten van de 
geneugten des levens in het Nijmeegse. Hopelijk zal de traditie van op z’n tijd lekker eten met mekaar 
worden voortgezet, zeker nu Q weer op het oude nest terugkomt! En (the award-winning) Sander, 
chapeau voor jouw inzet voor zowel werk als vriendschap!! Tot slot Corinne, Dennis en Lise: mede 
dankzij jullie initiatief voor borrels (vooral van de dames, sorry Dennis!) en vermakelijke verhalen (nu 
doe je wel mee, Dennis!) is de laatste fase van mijn promotie een feest geweest! Laten we proberen ook 
deze traditie in stand te houden… 
Ook indirecte (ex-)collega’s zijn belangrijk geweest. De groupies van Orthopedie – Chris, Gerjon, Luc en 
René – zijn waardige partners gebleken voor het vieren van een feestje, maar ook voor een goed 
gesprek. Verder was het jaarlijkse treffen met Erik van de Mesjtreechter Universiteit altijd een goede 
Lunterse afsluiting van het jaar – merci hiervoor! Ook een woord van dank aan de mensen die het 
Centraal Dieren Lab (CDL) gezicht geven: Debby, Geert, Ilona, Alex en Jeroen. Zonder jullie back-up is 
uitvoering van dierexperimenten in Nijmegen onmogelijk! 
Tijdens mijn promotie-onderzoek heb ik verder verschillende studenten begeleid, welke ik wil 
bedanken voor hun inzet voor en bijdrage aan mijn onderzoek. Joost, Martijn & Erik, Guido & Iraj en 
Ellen & Noortje: merci! 
Tevens wil ik graag mensen bedanken die dan wel inhoudelijk geen bijdrage hebben geleverd, maar 
zeker broodnodig waren! De vrienden- en vriendinnengroep uit Kessel en Maasbree (en inmiddels 
omstreken) – dank voor jullie gezelligheid! Verder de vakantievriendinnen – Yvonne en Judith – tijdens 
de vakanties in de villa’s in Spanje. Heerlijk om daar met jullie te relaxen en genieten van tapas, zon, zee 
& strand! Tevens bedankt voor jullie bijdrage aan mijn introductie in ski-vakanties! 
Tot slot wellicht de belangrijkste personen. Mijn ouders – Harrie en Corrie – wil ik ongelooflijk bedanken 
voor hun onvoorwaardelijke steun tijdens mijn eerste drie decennia in deze wereld. Jullie weten dat ik 
dat waardeer, maar ik kan het nooit voldoende benadrukken!! De waarde die jullie voor mij 
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